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Chapter 1 
General introduction 
General introduction 
The objective of this chapter is to provide the background information and 
rationale for the studies described in the following chapters that deal mainly with 
the molecular diversity of bifidobacteria and lactobacilli in the human 
gastrointestinal tract. First, a general overview of the intestinal microbial 
community is given, followed by a description of the role of Bifidobacterium 
and Lactobacillus spp. in the gut ecosystem and the taxonomy of these bacteria. 
Furthermore, new molecular methods to study the intestinal bacteria and the 
achievements obtained with new techniques are reviewed with specific emphasis 
on bifidobacteria and lactobacilli. Finally, approaches to modify the intestinal 
microbial communities by diet are summarised, which is followed by the outline 
of this thesis. 
The normal human intestinal microbiota 
Acquisition and composition of the intestinal microbiota 
Microbes colonise the external surface of the human body, the skin and mucosal 
epithelium in different locations, including the oral cavity and the 
gastrointestinal (GI) tract (78, 140). The microbial communities in different 
body sites are commonly referred to as the normal indigenous microbiota. The 
composition of this microbiota varies between different body locations and 
individuals. The most abundant indigenous microbiota can be found in the 
intestinal tract, particularly in the colon, where the microbial cells reach a 
density up to 1011 to 1012 colony forming units (cfu) per gram of faeces (37,140). 
Our present knowledge about the Gl-tract microbiota is largely based on 
cultivation studies, but in the past decade molecular approaches based on rRNA 
are increasingly being applied. These new approaches also allow detection of the 
members of the uncultured part of the microbiota, which may constitute up to 
85 % of the total community (73,134). 
The acquisition of the normal microbiota starts at birth when the germ-
free newborn comes into contact with the environment. The colonisation of the 
intestine of a newborn proceeds in several stages (29). The first one or two 
weeks of life are considered as the initial period of microbial colonisation, 
during which diverse microbes transit through the infant's Gl-tract and can be 
found in its faeces. Facultative anaerobic bacteria, Escherichia coli, Streptococcus 
and Enterococcus colonise the gut during this period. They create a reduced 
environment favourable for the subsequent colonisation by anaerobes, such as 
bifidobacteria, Bacteroides and Clostridia, which are typically cultivated from 
faeces. Molecular methods, such as fluorescent in situ hybridisation (FISH) of 
16S rRNA (see below), have confirmed the presence of these bacterial groups 
(47). In addition bacteria of the Coriobacterium-group {Coriobacterium and 
Collinsella) were found to be present in high numbers in faeces of formula-fed 
infants (49). In nursing infants dietary supplementation, the so-called weaning 
stage, causes shifts in the intestinal microbiota (133). By about the second year 
of life the composition of the intestinal microbiota resembles that of an adult in 
the level of major microbial groups (133), although in the level of species and 
strains prominent changes are still likely to occur for several years. 
The adult intestinal microbiota is an extremely complex ecosystem both in 
itself and in the network of factors affecting it that include host factors, the 
environment of the host and microbial interactions (37, 66, 137). Microbial 
communities vary in different parts of the Gl-tract both in composition and 
numbers, becoming richer and more abundant from the practically germ-free 
stomach and upper small intestine to the colon (37, 62, 66) (Table 1). The very 
low pH in the stomach, normally less than pH 3.0 in resting stage, prevents 
microbial growth and in the upper part of the small intestine (duodenum) 
digestive secretions such as bile and pancreatic enzymes also have a bactericidal 
effect. Moreover, the strong flow of intestinal contents prevents extensive 
colonisation in the small intestine. In the lower parts of the small intestine 
(jejunum and ileum) the pH becomes more neutral, oxygen tension drops, 
digestive secretions are diluted and the flow is reduced. The microbial 
community becomes more diverse and increases in numbers towards the end of 
the small intestine. In the large intestine the pH is near to neutral, the flow rate is 
low and the oxygen tension drops, which creates favourable conditions for a rich 
anaerobic microbial ecosystem. In addition to the above mentioned factors, the 
gut associated lymphoid tissue (GALT) also plays an important role in 
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controlling the microbiota by producing secretory immunoglobulin A (slgA), 
which is released to the gut lumen and coats bacteria thereby preventing 
adhesion and facilitating removal of bacteria from the intestine (90). 
Initially, most knowledge of bacterial numbers and diversity in the GI-
tract was derived from culturing studies. Sophisticated anaerobic culturing 
techniques and selective media were developed to determine the viable counts of 
different bacterial groups, and subsequent genus and species identification was 
done by using phenorypic characterisation. Bacteroides, Bifidobacterium, 
Eubacterium, Ruminococcus, Peptococcus, and Peptostreptococcus are the main 
cultivable bacterial genera in the large intestine and in many subjects they are 
present at populations of at least 1010 cfu per gram of faeces (37). These and 
other important groups of bacteria in the large intestine are listed in Table 1. In 
the large intestine anaerobic bacteria outnumber aerobes and facultative 
anaerobes more than thousand fold (37, 66). Also yeast, fungi and protozoa were 
found in the colon by cultivation (37). Presently, molecular methods such as 
FISH and dot blot hybridisation, which rely on the use of phylogenetic probes 
targeting 16S rRNA or the corresponding genes (16S rDNA) are increasingly 
used to enumerate and quantify microbial groups in faeces (40, 85, 126, 135). It 
is noteworthy that 16S rRNA probes for bacterial groups target phylogenetic 
groups rather than taxonomically defined families or genera. The probes 
available today cover up to 70 % of the faecal bacterial community (126) and 
detect also uncultured bacteria (151). FISH and dot blot hybridisation studies 
have shown that Bacteroides, Clostridium coccoides - Eubacterium rectale, and 
Clostridium leptum groups constitute together 44 to 68 % of the total bacterial 
community in faeces (40, 85, 126). In addition, Fusobacterium prausnitzii and 
related species belong to the dominant microbiota accounting for 17 % of total 
bacteria in faeces (135). 
Cultivation studies indicated that more than 85 % of the bacterial 
community is composed of 30 to 40 species and it was estimated that at least 400 
bacterial species reside in the human large intestine (94). In a recent molecular 
study the diversity of a single individuals faecal microbiota was investigated by 
large scale cloning and sequencing of the 16S rDNA sequences (134). It was 
found that 76 % of the 284 retrieved rDNA sequences derived from hitherto 
unknown species. 
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Table 1. Composition of the human Gl-tract microbiota. 
Location Total Main Microbial Groups 
Microbial 
Count (cfu) 
Stomach 
Duodenum 
and jejunum 
Ileum 
< 10 /ml Lactobacillus, Streptococcus, Candida 
< 103/ml Lactobacillus, Streptococcus, Veillonella, Candida 
103 -108 / ml Bacteroides, Bifidobacterium, Enterobacteriaceae, 
Veillonella, Enterococcus, Lactobacillus, 
Streptococcus 
Colon 101 0-101 2 /g Bacteroides, Clostridium, Eubacterium, 
Ruminococcus, Fusobacterium, Bifidobacterium, 
Peptostreptococcus, Atopobium*, 
Enterobacteriaceae, Lactobacillus, Enterococcus, 
Streptococcus, Veillonella, Peptococcus, 
Propionibacterium, Actinomyces 
* Atopobium-chxsler that includes Atopobium, Coriobacterium, Eggerthella and Collinsella (49). 
Activity of the intestinal microbiota 
The gut microbiota has a variety of important functions that may be beneficial to 
the host, including colonisation resistance against pathogenic organisms, 
positive effects on host's nutrition and stimulation of the immune system (78). 
Non-digested food components that are not degraded and absorbed during the 
passage through the stomach and small intestine reach the colon, where they 
serve as substrates for microbial fermentation. During carbohydrate fermentation 
gases, ethanol, lactate and short-chain fatty acids (SCFA) such as butyrate, 
propionate, and acetate are produced. Butyrate is metabolised by the colonic 
epithelium, whereas acetate and propionate are generally absorbed and used in 
other host tissues (30). The metabolic end products from the carbohydrate 
fermentation are considered harmless or even beneficial to the host whereas the 
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end products from protein fermentation that include phenolic and indolic 
compounds and ammonia, are potentially harmful (30, 77). Besides non-digested 
food components, the Gl-tract microbiota has another major source of nutrients, 
which is host-derived. Mucus and dead enterocytes that are released into the gut 
lumen as a result of epithelial cell renewal become nutrients for the microbiota 
(106). 
Recently, new techniques have been developed that allow the assessment 
of functionality of microbiota and the host-microbial interactions at molecular 
level. Hooper et al. (56) used DNA microarray technology to monitor the 
expression of genes in the enterocytes of mice in response to the presence of gut 
commensal bacteria. It was found that commensal bacteria modulate expression 
of genes involved in several fundamental intestinal functions such as nutritional 
absorption, mucosal barrier fortification and postnatal intestinal maturation. 
The role of bifidobacteria and lactobacilli 
in the microbial balance of intestine 
It is assumed that both beneficial and potentially harmful microbes constitute a 
balanced Gl-tract community where the overgrowth of opportunistic pathogenic 
microbes is normally suppressed by other members of the microbiota. This 
microbial balance may be disturbed by antimicrobial agents, ingested pathogenic 
microorganisms or changes in the hosts physiological condition such as stress or 
ageing (66,118). Bifidobacteria and lactobacilli are considered to be members of 
the beneficial microbiota that is important in maintaining a healthy, balanced 
microbial community in the Gl-tract and they are also proposed to induce 
systemic effects that improve the host's health (14, 103, 117). Proposed health 
effects of bifidobacteria and lactobacilli and possible mechanisms are illustrated 
in Figure 1. 
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antagonism, 
prevention of intestinal 
infections and diarrhoea 
inhibition of faecal enzymes, 
reduced toxicity and 
mutagenicity of faeces 
stimulation of the immune system, 
alleviation of food intolerance and allergy 
Figure 1. Hypotheses on the health-promoting effects of bifidobacteria and 
lactobacilli. 
Taxonomy of lactobacilli and bifidobacteria 
The genus Lactobacillus is comprised of Gram-positive, catalase-negative, non-
sporulating, microaerophilic rods, which produce lactic acid as the major end 
product during the fermentation of carbohydrates (9). The genus Lactobacillus is 
one of the largest genera and contains presently around eighty species (5). 
Traditionally lactobacilli have been divided into three groups according to the 
type of sugar fermentation. Obligately homofermentative lactobacilli ferment 
hexose sugars by glycolysis and produce mainly lactic acid, while obligately 
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heterofermentative lactobacilli use the 6-phospho-gluconate/phosphoketolase 
(6PG/PK) pathway and produce other end products (C02, ethanol) in addition to 
lactic acid (9). The third group includes the facultative heterofermentative 
lactobacilli that ferment hexoses via the glycolysis and pentoses via the 6PG/PK 
pathway. Further classification into species has been largely based on 
phenotypic and biochemical characteristics, but in many cases it is further 
supported by genotypic analyses, usually by DNA-DNA homology or 16S 
rDNA (45,68). 
Modern bacterial phylogeny is based on the idea that the degree of 
similarity of rRNA sequences between two organisms is comparable to their 
evolutionary distance (76, 153). Due to the conservation of the process of 
protein synthesis in living cells and the fact that rRNAs consist of alternating 
conserved and variable regions, these molecules are extremely suitable as 
evolutionary chronometers (76, 153). The division of lactobacilli into three main 
groups according to the type of fermentation is not in accordance with their 
natural relations as revealed by analysis of their 16S rDNA sequences (9). In the 
latter phylogenetic analysis, lactobacilli cluster in the subdivision of the low 
G + C Gram-positive bacteria together with other lactic acid bacteria, anaerobes 
such as Clostridia, peptococci and ruminococci, as well as aerobes and 
facultative aerobes such as bacilli, staphylococci and listeria. Lactobacillus 
species branch further into several groups and they do not form a coherent 
phylogenetic unit (Figure 2). Thus, the taxonomy of the genus Lactobacillus is 
unsatisfactory. 
The species belonging to the genus Bifidobacterium, unlike lactobacilli, 
form a coherent phylogenetic unit and show generally over 93 % similarity of 
16S rRNA sequences with other members of the genus (74, 93) (Figure 2). In the 
phylogenetic tree of bacteria the Bifidobacterium cluster is in the subdivision of 
high G + C Gram-positive bacteria together with other genera such as Propioni-
bacterium, Actinomyces and Streptomyces. 
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Bifidobacteria are gram-positive, strictly anaerobic, non-motile and non 
spore-forming pleomorphic rods with a particular cell morphology ranging from 
regular rods to various branched and club-shaped forms. Fructose-6-phosphate 
phosphoketolase (F6PPK) is the key enzyme of hexose fermentation and F6PPK 
activity is one of the main phenotypic features used to identify bifidobacteria at 
the genus level (10). Lactic and acetic acid are produced as metabolic end 
products from hexose fermentation. Genus-specific probes are also available for 
the recognition of strains belonging to bifidobacteria (64, 73). The identification 
of Bifidobacterium species by phenotypic features such as sugar fermentation 
patterns, cell morphology and electrophoretic mobility of enzymes is difficult 
and therefore DNA-DNA reassociation studies have been widely used in 
bifidobacterial taxonomy (10, 41, 42). Species identification by 16S rRNA 
sequence analysis is hampered by the high level of sequence relatedness between 
closely related bifidobacterial species that show more than 97 % sequence 
similarity (93). However, in many cases subtle differences in the 16S rRNA 
sequences have been successfully utilised to design species specific probes and 
PCR primers that can be applied in species identification (see below). The 
sequence analysis of conserved genes other than 16S rDNA such as recA, coding 
for the recombinase RecA, and Idh, coding for L-lactate dehydrogenase, has been 
proposed as a method for identification of closely related bifidobacteria (71, 
112). 
Molecular tools for the detection and identification of 
bifidobacteria and lactobacilli 
This section provides an overview of the different molecular techniques 
presently used in studying the microbial ecology of the Gl-tract and then-
applications to bifidobacteria and lactobacilli. Specific attention is given to the 
design, validation and use of 16S rDNA-based oligonucleotides as hybridisation 
probes or primers in PCR amplification. The main strengths and weak points of 
the various techniques are summarised in Table 2. 
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Table 2. Advantages and drawbacks of various techniques for analysis of 
intestinal microbiota. 
Method Advantages Drawbacks 
Culturing 
•Colony hybridisation 
•Molecular 
fingerprinting 
Direct molecular 
approaches 
•FISH 
•Dot blot hybridisation 
»(RT)PCR-T/DGGE 
•16S rDNA sequencing 
"Standard" method, 
recovery of isolates for 
further analysis 
•Microarrays 
Improved selectivity with 
probes 
Superior strain 
discrimination 
Pre-treated samples can be 
stored for later analysis, no 
culturing required, 
uncultured microbes can be 
detected 
Enumeration without 
cultivation, potential for 
high throughput 
Relative quantification 
without culturing 
Rapid diversity assessment 
and comparative analysis 
Identification, sequence 
data of unculturable 
microbes obtained 
High throughput, 
automated analysis 
Laborious, requires 
immediate processing of 
samples and anaerobic 
techniques, inadequate 
selective media, part of the 
gut microbiota so far 
unculturable 
Requires probe design and 
validation 
Laborious and slow 
Isolates not recovered 
Requires probe design and 
validation, laborious 
without automation 
Requires probe design and 
validation, relative 
abundance difficult to 
relate to cell numbers 
Further identification of 
fragments by sequencing 
laborious, PCR-biases 
Large scale monitoring 
laborious 
No validation yet available 
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Molecular fingerprinting of bacterial strains 
The application of fingerprinting techniques requires prior cultivation in order to 
obtain separate colonies of bacterial strains or pure cultures. DNA-based typing 
methods of pure cultures differ in many respects from the conventional 
phenotypic methods. The nucleotide sequence of the DNA is kept constant 
during growth and thus DNA-based typing methods are not influenced by the 
physiological state of the cells. However, extrachromosomal elements, such as 
plasmids, can be lost or acquired while chromosomal sequences may be subject 
to rearrangements. DNA-based methods are usually more rapid than the 
phenotypic methods, since they do not depend on microbial growth. Moreover, 
they are often also more discriminating and allow identification below the 
species level. The most commonly used typing methods, which have been 
adapted to bifidobacteria and lactobacilli are summarised below. 
Amplified ribosomal DNA restriction analysis (ARDRA) is essentially 
restriction fragment length polymorphism analysis of the amplified rRNA genes. 
The entire rRNA gene or part of it is amplified by PCR and cut with one or more 
restriction endonucleases. The number and size of resulting DNA fragments 
varies according to the restriction sites within the specific rDNA sequences and 
thus, sequence-specific fragment patterns are produced. The discrimination 
power of the method to distinguish between different bacterial species or strains 
is dependent on the restriction enzymes used and length of the amplified 
fragment. A longer fragment contains potentially more restriction sites and 
produces a more complex pattern upon restriction. Some bacterial species show 
high rDNA sequence similarity and therefore it may be difficult to select 
restriction endonucleases that produce distinct restriction patterns for closely 
related species and strains (112). Typing of L. acidophilus, L. helveticus, L. 
delbrueckii and L. sake by ARDRA resulted in good discrimination at the 
species but not at the strain level (45, 120). ARDRA patterns are highly 
reproducible and comparable between laboratories. 
In the randomly amplified polymorphic DNA (RAPD) technique, also 
known as arbitrarily primed PCR (AP-PCR), oligonucleotides with a random 
sequence are used as a primer in low stringency PCR. The primer(s) anneals to 
the complementary or partially complementary sequences in the target DNA (the 
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complete genome) and the DNA between the binding sites on opposite strands 
can be amplified. The RAPD fingerprint pattern consists of an array of 
anonymous DNA amplicons. Generally, RAPD fingerprinting allows the 
differentiation between species and, to some extent, also between strains within 
the same species. It has been widely applied for the typing of lactobacilli and 
bifidobacteria from various environments, including the intestinal tract (34, 61, 
95,105,114,144,146). 
Apart from RAPD, other PCR fingerprinting techniques have been 
developed such as the so-called rep-PCR techniques which are based on the use 
of repetitive DNA sequences that are dispersed throughout the bacterial genome 
(13). PCR-based fingerprinting techniques are simple and rapid, but for the 
reproducibility of the results careful optimisation and standardisation are needed. 
Differences in thermal cyclers, DNA polymerase suppliers and concentrations, 
DNA preparation methods, primer-to-template ratios and magnesium con-
centrations can cause variations in the RAPD and rep-PCR patterns (143). 
Consequently, the fingerprint patterns obtained in different laboratories are not 
always comparable. 
Pulsed field gel electrophoresis (PFGE) allows the separation of large 
DNA fragments in a continuously reorienting electric field. In a uniform electric 
field, very large DNA molecules tend to migrate independently of their size, but 
in the changing electric field large molecules need more time to reorientate than 
smaller molecules and the migration velocity in the net field direction depends 
primarily on the size of the DNA molecule. PFGE has been widely applied in the 
analysis of bacterial genomes. The complete genome is digested with rare 
cutting enzymes such as Apal, Smal, BgH, Sacll, Notl, Sfil, and Xbal, and the 
resulting macrofragments are separated by PFGE. PFGE protocols have been 
well established for both lactobacilli and bifidobacteria and the techniques have 
shown superior discriminatory power in comparison over other typing methods 
in strain differentiation (16, 23, 65, 89, 97, 101, 111, 113, 144, 158). 
Macrorestriction fragment analysis by PFGE is highly discriminating and a very 
reproducible typing method, but rather laborious, which restricts the number of 
isolates that can be typed. 
Ribotyping is a variation of the restriction fragment length polymorphism 
(RFLP) analysis of the genomic DNA, where certain fragments are high-lighted 
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by probing in order to obtain less complex patterns that are easier to interpret. In 
ribotyping, the fingerprint pattern consists of chromosomal DNA fragments that 
are derived from the rDNA operon and its adjacent regions that hydridise to the 
rDNA probe. First, genomic DNA is cleaved by restriction enzymes and the 
resulting fragments are separated by agarose gel electrophoresis. The fragments 
are then transferred to a membrane and hydridised with a rDNA fragment. The 
probes used in ribotyping vary from partial sequences of the rDNA genes or 
their spacer regions (46, 83, 97) to the whole rDNA operon. The latter is also 
used as a probe in the automated ribotyping device, marketed as the RiboPrinter* 
by Qualicon, USA. If the probe contains conserved regions of rDNA, it can be 
used for the ribotyping of a wide range of bacteria, even those that are 
phylogenetically distant. Evidently, more fragments hybridise with probes that 
encompass a larger region of the rDNA operon than with shorter probes (109). 
Thus, the discriminatory power of the technique is dependent on the size of the 
probe, but also on the restriction enzyme(s) used. Using this approach it was 
possible to divide 26 L. helveticus strains into five, nine and ten ribotypes using 
EcoRl, Pvull and Mlu\, respectively using the intergenic 16S-23S rDNA as a 
probe (46). Moreover, ribotyping has been shown to be a useful tool in 
differentiating human intestinal lactobacilli and bifidobacteria at both the species 
and strain level (65, 83, 89,144). 
Probe and primer design based on ribosomal RNA sequences 
The prokaryotic ribosomes consist of proteins and three ribonucleic acids: the 5S 
rRNA (120 nucleotides), 16S rRNA (1540 nucleotides) and the 23S rRNA (2900 
nucleotides). The rRNA sequences consist of alternating conserved and variable 
regions with nine variable regions being found in the 16S rRNA. The rRNA 
genes (rDNA) are organised into one or more rrn operons, where they are 
separated by hypervariable spacer regions, and in many cases also one or more 
tRNA genes are found between the 16S and 23S rRNA genes (25, 100). Most 
organisms carry several rrn operons in their genome and in most cases the 
intragenomic sequences of the structural rRNA genes are highly similar. So far 
bifidobacteria and lactobacilli have been found to harbour from two to six rrn 
operons (23, 28, 97, 121, 157). Microheterogeneities have been described for the 
21 
16S rDNA of Bifidobacterium adolescentis (121). Analysis of rDNA sequence 
data, especially that of 16S rDNA, has revealed variable regions in the gene 
sequences that contain information specific for different phylogenetic levels; 
group, genus, species or subspecies. Thus, sequences unique to certain 
organisms or a group of organisms can be found. This has been utilised 
extensively to design species- and group-specific nucleic acid probes for the 
detection and identification of bacteria (Table 3). 
Specific oligonucleotide probes and primers targeting rRNA or rDNA 
have been designed for different species of Bifidobacterium and Lactobacillus 
that occur in the human intestine and these have been used in various 
applications. Examples of validated probes and primers for bifidobacteria and 
lactobacilli are presented in Table 3. As mentioned above lactobacilli are 
phylogenetically heterogeneous, which causes difficulties in the design of a 
strictly genus-specific probe, but group-specific probes and primers have been 
designed. Two Lactobacillus group-specific primers cover in addition to 
Lactobacillus also Leuconostoc, Pediococcus, and Weissella (52, 148). In 
addition, two probes cover also other related genera such as Enterococcus, 
Streptococcus, Vagococcus and Oenococcus (Table 3). Presently, probes are 
available for all Bifidobacterium species found in the human intestine. However, 
the probe panel for lactobacilli is incomplete and lacks specific probes for 
intestinal species such as L. vaginalis, L. mucosae, L. catenaformis, L. buchneri 
andZ. rogosae. 
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Table 3. rRNA/rDNA targeted oligonucleotide 
Bifidobacterium and Lactobacillus species found 
probes and PCR primers for 
in the human intestine. 
Specificity 
Bifidobacterium-
genus 
B. adokscentis 
B. angulation 
B. bifidum 
B. breve 
B. catenulatuml 
pseudocatenulatum 
B. dentium 
B. gallicum 
B. infantis 
B. longum 
B. lactisc 
Sequence (5'to 3') 
CATCCGGCATTACCACCC 
CCACCGTTACACCGGGAA 
CGGGTGCTI*CCCACTTTCATG 
GATTCTGGCTCAGGATGAACG 
GCTCCCAGTCAAAAGCG 
CTCCAGTTGGATGCATGTC 
CGAAGGCTTGCTCCCAGT 
CAGTCCATCGCATGGTGGT 
GAAGGCTTGCTCCCCAAC 
GCAGGCTCCGATCCGA 
CCACATGATCGCATGTGATTG 
CCGAAGGCTTGCTCCCAAA 
AAGGTACACTCAACACA 
CCGGATGCTCCATCACAC 
ACAAAGTGCCTTGCTCCCT 
CGGATGCTCCGACTCCT 
CGAAGGCTTGCTCCCGAT 
ATCCCGGGGGTTCGCCT 
GAAGGGCTTGCTCCCGA 
TAATACCGGATGTTCCGCTC 
ACATCCCCGAAAGGACGC 
TCACGCTTGCTCCCCGATA 
TTCCAGTTGATCGCATGGTC 
GGAAACCCCATCTCTGGGAT 
TCTCGCTTGCTCCCCGATA 
TTCCAGTTGATCGCATGGTC 
GGGAAGCCGTATCTCTACGA 
GTGGAGACACGGTTTCCC 
CACACCACACAATCCAATAC 
Target 
16S 
16S 
16S 
16S 
16S 
16S 
16S 
16S 
16S 
16S 
16S 
16S 
16S 
16S 
16S 
16S 
16S 
16S-23S IS 
Target site" 
181-164 
679-662 
1432-1412 
15-35 
451-435 
182-200 
474-442 
185-203 
473-441 
1317-1303 
184-204 
475-442 
491-475 
175-192 
475-444 
176-192 
474-442 
72-89 
473-443 
170-189 
479-454 
459-441 
182-201 
1027-1007 
459-441 
182-201 
1028-1008 
991-1009" 
1671-1651" 
Use 
FISH 
PCR; CH 
DBH 
PCR 
PCR 
DBH 
PCR 
DBH 
PCR 
PCR 
PCR 
PCR 
DBH 
PCR 
DBH 
PCR 
PCR 
Ref. 
73 
64 
156 
88 
88 
156 
88 
156 
88 
88 
87 
87 
156 
87 
156 
87 
145 
23 
Table 3. Continued. 
Specificity Sequence (5'to 30 Target Target site* Use Ref. 
Lactobacillus-
groupd 
L. acidophilus 
L. brevis 
L. casei 
L. casei/paracasei 
L. casei/ 
rhamnosus 
L. casei/paracasei/ 
rhamnosus 
L. crispatus 
L. delbrueckii 
L.fermentum 
L. gasseri 
CACCGCTACACATGGAG 
AGCAGTAGGGAATCTTCCA 
ATTY*CACCGCTACACATG 
Y*CACCGCTACACATGR*AGTTCCACT' 
GGTATTAGCAYCTGTTTCCAf 
GAATCTGTTGGTTCAGCTCGC 
AGCTGAACCAACAGATTCAC 
TCTAAGGAAGCGAAGGAT 
CTCTTCTCGGTCGCTCTA 
TGCAAAGTGGTAGCGTAAGC 
TGTTGAAATCAGTGCAAG 
TGATCTCTCAGGTGATCAAAA 
TGCACTGAGATTCGACTTAA 
GCGATGCGAATTTCTTTTTC 
GCACCGAGATTCAACATGGAA 
GCAGGCAATACACTGATG 
CTGATGTGTACTGGGTTC 
GTAATGACGTTAGGAAAGCG 
CAATCTCTTGGCTAGCAC 
AGGATATGGAGAGCAGGAAT 
CAACTATCTCTTACACTGCC 
ACCTATCTCTAGGTGTAGCGCA 
ACGGATGGATGGAGAGCAG 
GCAAGTTTGTTCTTTCGAACTC 
AAGGATAGCATGTCTGCA 
ACAGATGGATGGAGAGCAGA 
CAATCAATTGGGCCAACGCGT 
GCGACCAAAATCAATCAGG 
GTTGTTCGCATGAACAACGCTTAA 
CTGATCGTAGATCAGTCAAG 
ACTAACTTGACTGATCTACGA 
TTCACTGCTCAAGTAATCATC 
GAGTGCGAGAGCACTAAAG 
CTATTTCAAGTTGAGTTTCTCT 
AGCGACCGAGAAGAGAGAGA 
TGCTATCGCTTCAAGTGCTT 
16S 
16S 
16S 
16S 
16S 
16S 
16S-23S IS 
23S 
16S 
16S 
16S 
16S-23S IS 
16S 
23S 
683-667 
362-380 
705-688 
746-722 
177-158 
86-66 
70-89b 
107-90" 
1049-1028" 
65-84" 
89-110" 
PCR 
PCR 
DBH 
FISH 
DBH 
PCR 
PCR 
PCR 
DBH 
PCR 
PCR 
PCR 
PCR 
DBH 
52 
148 
125 
48 
53 
149 
142 
130 
147 
33 
150 
149 
27 
55 
23S DBH 55 
16S 
23S 
16S-23S IS 
23S 
16S 
16S-23S IS 
23S 
16S-23S IS 
16S 
16S 
16S 
16S-23S IS 
16S-23S IS 
23S 
16S-23SIS 
66-85" 
1046-1024" 
86-66 
110-92" 
160-183" 
PCR 
Reverse 
DBH 
PCR 
PCR 
PCR 
DBH 
PCR 
DBH 
DBH 
PCR 
PCR 
PCR 
PCR 
149 
35 
130 
33 
142 
55 
130 
53 
147 
27 
149 
130 
149 
23S PCR 130 
24 
Table 3 continued. 
Specificity Sequence (S'to 3") Target Target site* Use Ref. 
L. helveticus 
L.jensenii 
L.johnsonii 
L. paracasei 
L. paracasei/casei 
L. paracasei/ 
rhamnosus 
L. plantarum 
L. reuteri 
L. rhamnosus 
L. ruminis 
L. sakei 
L. salivarius 
L.zeae 
GAAGTGATGGAGAGTAGAGATA 
CTCTTCTCGGTCGCCTTG 
AAGAAGGCACTGAGTACGGA 
GAGCTTGCCTAGATGATTTTA 
CACCGAGATTCAACATGG 
CACTGACAAGCAATACAC 
GCGATGCGAATTTCTTTTTC 
GGCCAGCTATGTATTCACTGA 
CCGAGATTCAACATGG 
CAGACTGAAAGTCTGACGG 
GTACTGACTTGCGTCAGCGG 
CCAATCAATACCAGAGTTCG 
ATCATGATTTACATTTGAGTG 
TTACCTAACGGTAAATGCGA 
ATTCATAGTCTAGTTGGAGGT 
CCTGAACTGAGAGAATTTGA 
GATCCATCGTCAATCAGG 
TGAATTGACGATGGATCACCAGTG 
AACACTCAAGGATTGTCTGA 
CAGACAATCTTTGATTGTTTAG 
GCTTGTTGGTTTGGGCTCTTC 
GCGATGCGAATTTCTATTATT 
CTTGCATCTTGATTTAATTTTG 
TGCATCTTGATTTAATTTTG 
GCGATGCGAATTTCTATTATT 
TTCGGTGAAAGAAAGCTTCG 
TTAATGATAATACTCGATT 
ATTCACTCGTAAGAAGT 
AATCGCTAAACTCATAACCT 
CACTCTCTTTGGCTAATCTT 
TGTTTAGTTTTGAGGGGACG 
ATGCGATGCGAATTTCTAAATT 
16S-23S IS 
16S-23SIS 
16S 
16S 
23S 
16S-23S IS 
23S 
16S 
16S-23SIS 
16S 
16S 
16S-23SIS 
23S 
16S 
16S 
16S-23S IS 
16S-23S IS 
23S 
16S-23SIS 
16S 
16S 
16S-23S IS 
16S 
23S 
16S 
16S-23S IS 
23S 
16S-23S IS 
61-81" 
67-84" 
69-84" 
86-67 
96-117" 
109-92" 
91-114" 
91-112 
65-84" 
86-67 
95-111" 
PCR 
PCR 
PCR 
PCR 
DBH 
PCR 
PCR 
PCR 
PCR 
DBH 
PCR 
PCR 
PCR 
DBH 
PCR 
PCR 
PCR 
PCR 
PCR 
PCR 
PCR 
DBH 
DBH 
PCR 
PCR 
PCR 
142 
130 
149 
150 
55 
142 
130 
27 
142 
53 
27 
149 
130 
147 
27 
149 
130 
142 
2 
150 
149 
53 
54 
27 
130 
149 
* Corresponds to the E. coli numbering orb corresponds to the numbering of the respective species sequence 
c
 Not a human intestinal species, but used as a probiotic. Reclassified as B. animalis. 
d
 Includes genera Lactobacillus, Leuconostoc, Pediococcus, and Weissella 
' Includes genera Lactobacillus, Leuconostoc, Pediococcus, Weissella, Enterococcus and Streptococcus 
f
 Includes genera Lactobacillus, Leuconostoc, Pediococcus, Weissella, Enterococcus, Oenococcus and 
Vagococcus 
* I = Inosine, matches all four nucleotides (A, C, G, and T); Y = C or T; R = A or G 
IS = intergenic sequence 
CH = colony hybridisation; DBH = dot blot hybridisation; FISH = fluorescent in situ hybridisation; PCR = 
polymerase chain reaction 
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Direct detection of bacteria by using specific primers and probes 
Amplification of DNA by the polymerase chain reaction (PCR) is one of the 
easiest and most rapid ways of detecting specific sequences. rRNA may be used 
as a measure of cellular activity and reverse transcription-PCR (RT-PCR) of the 
rRNA is performed prior to the PCR in order to detect this molecule. In 
(RT-)PCR nucleic acids are amplified rapidly in vitro using a thermostable DNA 
polymerase enzyme (e.g. Taq polymerase) and synthetic oligonucleotide primers 
in a thermo-cyclic process. The specificity of (RT-)PCR is mainly dependent on 
the primers, but also reaction conditions and thermo-cycling programs have to 
be adjusted for optimal performance. Due to the exponential amplification of 
nucleic acids in PCR, the sensitivity of detection is high. Specific PCRs are 
widely used in detecting the presence of a certain microbe in a sample or to 
verify the identity of a cultivated isolate. Quantification of PCR is possible by 
using an internal standard, which is added to the reaction in a known amount. 
The amount of the amplification products is then measured and the initial 
amount of the target sequence is calculated using the amplification efficiency of 
the standard as a reference. In real-time PCR, fluorescent markers are 
incorporated into the amplicons and the kinetics of amplification of products 
with different melting temperatures is observed directly, which greatly facilitates 
the quantification. A set of species-specific 16S rDNA primers and real-time 
PCR was used to successfully monitor and quantify several bacterial species in 
the rumen of cows (138). However, due to the many factors affecting the 
amplification reaction (152) quantification of nucleic acids by PCR is only 
approximate and the determination of bacterial numbers is hampered by 
variation of the rrn operon copy number and the ribosomal content of cells in 
different bacteria. 
Direct hybridisation of an oligonucleotide probe to the target microbial 
nucleic acid (dot blot hybridisation) is a straightforward method to detect 
specific nucleic acid sequences or genes. DNA or RNA is extracted from a 
sample or cultured microbes, fixed to a positively charged membrane (nylon, 
nitrocellulose) and hybridised with an oligonucleotide or a fragment of DNA 
that has a radioactive, chemiluminescent or digoxigenin label. The dot blot 
technique can be quantified to measure the amount of specific target 
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rRNA/rDNA in a mixture relative to the total amount of rRNA/rDNA (32, 126). 
Microbial cells can be also directly transferred to a membrane after which cells 
are lysed and DNA fixed to the membrane. In colony hybridisation, bacterial 
colonies are transferred to a membrane, lysed, and hybridised to a probe. This 
allows one to enumerate the target microbes and to recover the colonies from 
replica plates for further analysis. 
Ehrmann et al. (35) presented a reverse dot blot hybridisation technique 
for simultaneous detection of different lactic acid bacteria. A sample was first 
subjected to a non-specific PCR amplification of rDNA and the labelled PCR 
products were then hybridised with Lactobacillus species-specific capture 
probes that were bound to filter membranes. An important further step in 
hybridisation techniques is the development of DNA-chips, also called DNA 
microarrays (38). With this new technique up to thousands of probes can be 
bound on small glass slides and samples can be tested simultaneously against 
many probes, analogously to the reverse dot blot hybridisation. Hybridisations 
with fluorescent sequences are detected by using a laser. Recently, DNA 
microarrays containing 16S rDNA probes have been reported and they may be 
promising tools for the characterisation of complex microbial communities (4). 
In FISH technique, the detection of rRNA sequences within morpho-
logically intact cells is achieved using fluorescently labelled oligonucleotide 
probes. Special permeabilisation procedures may be required in order to aid 
passage of the probe into cells of some bacteria (12, 110). The multiple rRNA 
molecules present in bacterial cells capture the probe, the signal is intensified 
and the cells can be detected and enumerated by using an epifluorescence 
microscope or flow cytometry (58, 159). The detection limit of FISH with 
automated, microscopy-based enumeration is approximately lxlO7 cells per 
gram of faeces (58). FISH and dot blot techniques have proved to be invaluable 
tools for the quantification of bacteria in faeces (40,49, 85,126,135). 
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Profiling of bacterial communities 
Nucleotide sequence analysis of 16S rRNA or rDNA provides a direct way of 
assessing the microbial diversity in an ecosystem. In practise, 16S rDNA (or 
rRNA) sequences present in the sample are PCR-amplified and cloned in order 
to construct a rDNA sequence library. Subsequently, the clones are sequenced 
and compared to sequences available in the rRNA databases such as GenBank, 
EMBL and Ribosomal Database Project (RDP) (79). In general, 16S rRNA 
sequences having more than 97 % similarity are considered to belong to the 
same molecular species or operational taxonomic unit (OTU). Molecular species 
and OTU are terms used to describe sequences with low sequence divergence, 
that are likely to be derived from the same species. Thus, it is reasonable to 
assume that a sequence has derived from a novel, hitherto undescribed species if 
its similarity is less than 97 % with the sequences of known species (132). The 
number of clones that needs to be sequenced in order to get a reasonable 
estimate of the diversity depends on the complexity of the ecosystem. An 
estimated 85 % coverage of one person's faecal 16S rDNA diversity was 
obtained when 284 clones were sequenced (134). The clones were classified into 
82 molecular species, the majority of which were found to be novel. While direct 
sequencing can indeed provide significant new information about the microbial 
diversity in the Gl-tract, the approach is rather laborious and hence, appropriate 
only for the screening of a limited number of samples. 
The rRNA heterogeneity among bacterial species can also be utilised in 
fingerprinting of bacterial communities (98, 99). In practise, RNA or DNA is 
extracted from an environmental sample and a fragment of the rRNA or rDNA is 
amplified using primers for bacteria or other phylogenetic groups. The PCR 
amplicons, all of approximately equal size but varying in sequence, are then 
separated by using specific electrophoretic techniques, temperature gradient gel 
electrophoresis (TGGE) or denaturing gradient gel electrophoresis (DGGE). 
During electrophoresis the DNA fragments migrate in an increasing gradient of 
denaturing agents (temperature or denaturing chemicals) which gradually leads 
to the separation of the two strands of double-stranded DNA (melting). One end 
of the fragment is held together with a so-called CG-clamp, which is an 
approximately 30 to 50 bp long C + G -rich sequence that is attached to the 5'-
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end of one of the primers. In theory, a DNA fragment stops migrating in the 
T/DGGE gel when it reaches its melting point. PCR amplicons with different 
sequences have different melting behaviour and consequently migrate unequal 
distances in the T/DGGE gel. After staining, the amplicons with different 
sequences are seen as separate fragments in the gel forming a "fingerprint" of the 
microbial community. 
The PCR-T/DGGE of 16S rRNA and rDNA is now widely used in 
molecular ecological studies to assess, in a culture-independent way, the 
diversity and community dynamics in microbial communities (99). In general, 
these techniques detect only the predominant community members that make up 
at least 1 % or more of the total community (99). Application of this method to 
study human adult faeces revealed unique TGGE patterns of bacterial 16S rRNA 
for each individual, reflecting a host-specific community of dominant bacteria 
(161). Furthermore, it was found that the host genotype contributes to 
determining the bacterial composition in the Gl-tract (160). PCR-DGGE was 
likewise successfully used to monitor day by day the succession of bacteria in 
the faeces of new-born infants (36). The achievements in profiling predominant 
bacterial communities lead to the further refinement of the method. In order to 
obtain a better sensitivity of detection for less abundant bacteria, PCR reactions 
that target restricted bacterial groups were used. Recently, PCR-DGGE methods 
for the selective monitoring of bifidobacteria and lactic acid bacteria were 
developed (52, 121, 148). The T/DGGE method is a convenient tool to monitor 
the complexity of microbial community and changes occurring in it, while 
individual members of the community can be identified by subsequent cloning 
and sequencing of the fragments. Another possibility to obtain additional 
information about particular species or bacterial groups is to hybridise T/DGGE 
profiles with phylogenetic probes. 
As with every method, there are also problems associated with the use of 
PCR for the analysis of microbial community structure, primarily due to the 
formation of artefacts such as chimeric and heteroduplex molecules when a 
particular gene is amplified from a mixed community of DNA (152). In the 
subsequent sequence analysis, such chimeras can be readily discovered by 
performing a chimera-check and subsequently omitted from the diversity 
estimates. However, artefact fragments can not be directly pointed out from the 
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T/DGGE profiles, and therefore may lead to an overestimation of the microbial 
diversity. On the other hand, 16S rDNA fragments with different sequences can 
have similar melting behaviour and co-migrate to the same position in the gel. 
Thus, T/DGGE profiles provide a general picture of the diversity rather than the 
exact number of community members. Other, more recent community 
fingerprinting methods such as single strand conformation polymorphism 
(SSCP) of DNA (124), terminal restriction fragment length polymorphism (T-
RFLP) (84), and RAPD-based community fingerprinting (39) have not gained 
great popularity in Gl-tract ecology so far. Overall, it is easy to see the benefits 
of molecular methods, used either directly or in combination with cultivation, in 
acquisition of new and more detailed information about the Gl-tract microbiota. 
Molecular studies of bifidobacteria and lactobacilli 
in the Gl-tract 
Traditionally bacterial numbers and diversity in the Gl-tract were assessed by 
culturing on selective media and subsequent identification to genus and species 
level by phenotypic characterisation. The realisation that a considerable part of 
the intestinal microbiota is not culturable using present techniques and media 
(73, 94), and advances in molecular biology have lead to the development and 
application of culture-independent molecular methods in Gl-tract ecology 
studies. Some common molecular approaches and the roles of different 
techniques in analysing the Gl-tract microbiota are schematically illustrated in 
Figure 3. 
The traditional culturing strategy is well applicable to study the ecology of 
bifidobacteria and lactobacilli, which are culturable and can be adequately 
recovered from various selective media (11, 50, 51, 108). Recently, a number of 
molecular fingerprinting methods have been adapted to bifidobacteria and 
lactobacilli leading to a more detailed description of these populations in the Gl-
tract and new ecological observations. The composition of the Bifidobacterium 
and Lactobacillus populations was found to be host-specific and in general, 
bifidobacterial populations seem to be rather stable both in numbers and 
composition over time, whereas more fluctuation is seen in the lactobacilli 
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populations (65, 82, 89, 141). Interestingly, an ingested Lactobacillus strain 
established itself better in individuals lacking a stable indigenous lactobacilli 
population than in those stably harbouring lactobacilli (141). The culturing 
approach is often used in monitoring of dietary intervention studies, because for 
example an ingested probiotic (see below) strain can be recovered from the 
plates and identified unequivocally by using highly discriminating typing 
methods (70, 141). Analysis of the microbial diversity by this approach is, 
however, laborious and the effective recovery of bifidobacteria requires strict 
anaerobic practise. A major advantage of culturing is the acquisition of isolates, 
whose activity and properties can be studied further. 
(selective) 
cultivation 
colony 
hybridisation 
" ^ 
FISH 
dot blot 
hybridisation 
(RT)PCR 
specific 
detection / 
identification 
with probes 
and primers 
enumeration 
C^ 
molecular 
fingerprinting 
(PFGE, ARDRA, 
RAPD, ribotyping) 
J 
relative 
quantification 
T/DGGE 
cloning and 
sequence 
analysis 
J diversity assessment 
Figure 3. Molecular approaches to study the intestinal microbiota. 
Recently developed genus and group-specific PCR-DGGE methods allow 
a convenient way to monitor the diversity and dynamics of bifidobacterial and 
lactobacilli populations (52,121, 148). The PCR-DGGE approach confirmed the 
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earlier observations that adult faecal bifidobacterial populations are host-specific 
and stable in time (121). PCR-DGGE monitoring of faecal bifidobacteria in a 
probiotic and prebiotic feeding trial revealed that while a probiotic strain B. 
lactis Bbl2 transiently colonised the gut the indigenous populations of 
bifidobacteria remained unaffected (122). Likewise galactooligosaccharide 
administration did not affect the qualitative composition of indigenous 
Bifidobacterium populations (122). 
The problems related to the enumeration of bifidobacteria by cultivation 
can be bypassed by using FISH, which has shown counts that are comparable to 
those obtained by cultivation (typically 109 to 1010 cfu/g faeces in adults), yet 
slightly lower due to better selectivity (40, 73, 141). However, due to the 
improved enumeration of other bacterial groups by FISH, it was discovered that 
bifidobacteria usually constitute only 1 to 3 % of the total faecal bacterial 
community in adults (40, 73) instead of 7 to 10 % estimated by cultivation (32, 
73, 94). The smaller proportion of bifidobacteria has also been confirmed by 
quantitative rRNA dot blot studies (32, 85, 126). Likewise the proportion of 
lactobacilli was found to represent less than 1 % of the total faecal bacteria by 
dot blot technique (126) in comparison to the approximately 2 % obtained by 
cultivation (94). 
Species-specific PCR and dot blot hybridisation have mostly been used in 
combination with cultivation to confirm the identity of (tentatively identified) 
faecal isolates, either indigenous or probiotic strains (2, 24, 96, 149). However, 
when applied directly to faecal samples these techniques can also reveal minor 
species, which would not be detected when a limited number of colonies are 
analysed, due to the abundance of other dominant species (87). Similarly, L. 
sakei and Leuconostoc mesenteroides and other species that are typically 
detected in food products but not in human faeces, were revealed in faecal 
samples by using culture-independent community profiling based on 
Zacto6a«7/us-group-specific PCR and DGGE and subsequent identification of 
PCR amplicons by cloning and sequencing (52, 148). The pitfall of PCR 
approaches is that they can also detect DNA from dead bacterial cells, if present 
in sufficient amounts. 
32 
Approaches to increase the numbers of bifidobacteria 
and lactobacilli in the gut 
The general recognition of bifidobacteria and lactobacilli as beneficial members 
of the intestinal microbiota has lead to attempts to increase their numbers in the 
Gl-tract by administration of living bifidobacteria or lactobacilli (probiotics) or 
compounds that stimulate their growth (prebiotics). 
Probiotics 
Probiotics can be defined as viable microorganisms that exhibit a positive effect 
on the health of the host when they are ingested (119). In practise, probiotic 
strains are selected not only according to their functional properties, but also 
considering safety and technological aspects (115). Most commonly, probiotics 
are selected from strains of Bifidobacterium and Lactobacillus, while 
representatives of other microbial groups are rather exceptional, such as 
Saccharomyces boulardii or Bacillus subtilis. A myriad of health claims has 
been associated with probiotics (117), some of which have been substantiated 
for certain probiotic strains in clinical trials (Table 4). It must be emphasised that 
probiotic properties may be strain-dependent and can not be generalised to other 
probiotic strains even if they belong to the same species. 
Prebiotics 
Prebiotic compounds are defined as non-digestible food ingredients, that 
beneficially affect the host by selectively stimulating the growth and/or activity 
of one or a limited number of bacteria in the colon, and thus improve host health 
(44). Most potential prebiotics are carbohydrates, either polysaccharides, such as 
inulin, or oligosaccharides including fructooligosaccharides (FOS) and 
galactooligosaccharides (GOS). The fermentation of carbohydrates by the 
intestinal microbiota results in end products that are beneficial to the host, in 
contrast to the potentially toxic protein fermentation end products and thus, the 
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metabolic activity of microbes on prebiotics may improve the host's health. 
Prebiotics are assumed to stimulate the growth of bifidobacteria, and possibly 
lactobacilli, that are generally considered beneficial, although this is not 
specified in the definition of prebiotics. Human milk contains N-
acetylglucosamine containing oligosaccharides that have been shown to promote 
the growth of bifidobacteria (72). Numerous human feeding trials have been 
conducted to elucidate the effect of prebiotics on the gut microbiota (Table 5). 
The potential of prebiotics to modulate the gut microbiota was studied by 
assessing the shifts in the numbers of bifidobacteria and other bacterial groups 
usually by selective plating. The bifidogenic effect of fructose-based prebiotics 
inulin and FOS has been showed in several studies (22, 43, 67), whereas the 
results concerning GOS remain conflicting with some studies demonstrating a 
bifidogenic effect (21, 57) that was not confirmed by other studies (1, 3). 
Molecular monitoring of faecal bifidobacteria using the PCR-DGGE approach 
revealed that GOS administration (8 g per day for two weeks) did not have an 
effect on the qualitative composition of indigenous Bifidobacterium population 
(122). 
Synbiotics 
A synbiotic is a mixture of probiotics and prebiotics that beneficially affects the 
host by improving the survival and implantation of live microbial dietary 
supplements in the gastrointestinal tract, by selectively stimulating the growth 
and/or by activating the metabolism of one or a limited number of health-
promoting bacteria, and thus improving host welfare (44). The feasibility of the 
synbiotic concept to prolong the colonisation by a probiotic strain has been 
tested in several in vivo trials (1, 20, 69, 122) but only in one case the results 
suggested an improved survival of the probiotic strain due to a simultaneous 
prebiotic administration (69). 
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Outline of the thesis 
The aim of the research presented in this thesis was to develop and apply new 
molecular methods for the identification and detection of Bifidobacterium and 
Lactobacillus spp. in the human intestine. 
Bifidobacteria are one of the major cultivable groups of bacteria in the 
intestine. Enumeration of bifidobacteria can be done in a straightforward way 
either using selective plating or FISH of 16S rRNA, while the assessment of 
species and/or strain diversity has necessitated the use of labour-intensive 
approaches, such as molecular fingerprinting of cultivated isolates. Chapter 2 
describes the development and validation of a method for the qualitative analysis 
of complex bifidobacterial populations based on genus-specific PCR on 16S 
rDNAandDGGE. 
The L. casei -group of lactobacilli, which includes L. casei, L. paracasei, 
L. rhamnosus, and L. zeae, forms an important group of intestinal lactobacilli. 
The identification of the L. casei -group species is not reliable by phenotypic 
methods. In Chapter 3 three molecular fingerprinting methods, including PFGE, 
RAPD and ribotyping were compared for the characterisation and identification 
of L. casei -group lactobacilli. Moreover, Chapters 3 and 4 describe the 
development and validation of L. rhamnosus species-specific PCR. 
The attempts to increase the potentially beneficial bifidobacteria and 
lactobacilli in the human gut include administration of probiotics and prebiotics. 
In Chapters 4 and 5 the survival of two probiotic strains, L. rhamnosus GG and 
B. lactis Bbl2, in the Gl-tract was traced using the newly developed molecular 
methods. The identity of LGG colonies was verified using species-specific PCR 
(Chapter 4) and Bbl2 was detected using the PCR-DGGE method modified for 
this purpose (Chapter 5). In addition, in Chapter 5 the effect of Bbl2 or/and 
galactooligosaccharide administration on the qualitative composition of the 
indigenous Bifidobacterium populations in healthy adults was studied by using 
Bifidobacterium genus-specific PCR-DGGE method. 
Diet is generally considered one of the major factors determining the 
composition of the intestinal microbiota in infancy. In Chapter 6 PCR-DGGE 
followed by the cloning and sequencing of amplified 16S rDNA fragments was 
37 
used to compare bifidobacterial and lactobacilli communities as well as the 
major bacterial groups in breast-fed and formula-fed infants. The summary and 
concluding remarks are presented in Chapter 7. 
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We describe the development and validation of a method for the qualitative analysis of complex bifidobac-
terial communities based on PCR and denaturing gradient gel electrophoresis (DGGE). Bifidobacterium 
genus-specific primers were used to amplify an approximately 520-bp fragment from tbe 16S ribosomal DNA 
(rDNA), and the fragments were separated in a sequence-specific manner in DGGE. PCR products of the same 
length from different bifidobacterial species showed good separation upon DGGE. DGGE of fecal 16S rDNA 
amplicons from five adult individuals showed host-specific populations of bifidobacteria that were stable over 
a period of 4 weeks. Sequencing of fecal amplicons resulted in Bifidobacterium-like sequences, confirming that 
the profiles indeed represent the bifidobacterial population of feces. Bifidobacterium adolescentis was found to 
be the most common species in feces of the human adult subjects in this study. The methodological approach 
revealed intragenomic 16S rDNA heterogeneity in tbe type strain of B. adolescentis, E-981074. The strain was 
found to harbor five copies of 16S rDNA, two of which were sequenced. The two 16S rDNA sequences of B. 
adolescentis E-981074' exhibited microheterogeneity differing in eight positions over almost the total length of 
the gene. 
The human gastrointestinal (GI) tract hosts a rich and com-
plex microbiota. Bifidobacteria are part of the normal micro-
biota of the human intestine, and they are considered to be 
important in maintaining well-balanced intestinal microbiota 
(4, 31). It has been postulated that Bifidobacterium spp. have 
several health-promoting effects, including the prevention of 
diarrhea and intestinal infections, alleviation of constipation, 
production of antimicrobials against harmful intestinal bacte-
ria, and immunostimulation (4, 31). Therefore, many attempts 
have been made to increase the number of bifidobacteria in the 
intestine by administration of certain bifidobacterial strains 
(probiotics) or oligo- and polysaccharides that stimulate the 
growth of bifidobacteria (prebiotics) (2, 7, 10, 13). For the 
enumeration and isolation of bifidobacteria, several selective 
plating techniques have been developed (5, 14, 32). So far, 12 
species have been associated with the human host: Bifidobac-
terium adolescentis, Bifidobacterium infantis, Bifidobacterium 
longum, Bifidobacterium bifidum, Bifidobacterium breve, Bi-
fidobacterium catenulatum, Bifidobacterium pseudocatenulatum, 
Bifidobacterium angulatum, Bifidobacterium gallicum, Bifidobacte-
rium inopinatum, Bifidobacterium dentium, and Bifidobacterium 
denticolens, the last three being found primarily in the oral 
cavity (6, 11, 20, 23, 25). 
Our present knowledge of the GI tract microbiota is largely 
based on cultivation studies, but according to recent estimates 
up to 85% of the entire microbial population in the human 
intestine might be uncultured (19, 36). Consequently, our pic-
ture of the intestinal microbiota has been biased in favor of the 
* Corresponding author. Mailing address: Laboratory of Microbiol-
ogy, Wageningen University, Hesselink van Suchtelenweg 4, 6703 CT 
Wageningen, The Netherlands. Phone: 31 317 483742. Fax: 31 317 
483829. E-mail: reetta.satokari@algemeen.micr.wau.nl. 
more easily cultured members of the community. Moreover, 
cultivation techniques are laborious and time-consuming, es-
pecially if bacterial isolates are to be identified. In order to 
overcome the limitations associated with culturing techniques, 
molecular biological methods are increasingly being applied to 
study the GI tract ecology (38). One of the most widely used 
approaches in ecological studies has been the use of rRNA and 
its encoding genes as target molecules (3). Specific PCR prim-
ers and probes can be designed based on the variable regions 
of this molecule to detect certain species or groups of bacteria. 
Numerous genus- and species-specific PCR primers and 
probes have been developed also for bifidobacteria (15,19, 23, 
24,40). Species-specific primers and probes are excellent tools 
for targeting certain Bifidobacterium species in mixed popula-
tions, providing valuable help in identification, which is labo-
rious and sometimes unreliable by phenotypic characteriza-
tion. However, the use of specific primers and probes in 
ecological studies rules out the possibility of finding other than 
the target Bifidobacterium species possibly also present in the 
sample. On the other hand, genus-specific primers or probes 
can give a good overall picture of the bifidobacterial popula-
tion, but no information is obtained about the species or strain 
composition. 
Another way of utilizing the rRNA sequence heterogeneity 
in microbial ecology is to use universal bacterial PCR primers 
to amplify a fragment of rRNA or ribosomal DNA (rDNA) 
and then separate the obtained PCR products in a sequence-
specific manner in temperature gradient gel electrophoresis 
(TGGE) or denaturing gradient gel electrophoresis (DGGE) 
(27, 28). The TGGE or DGGE profile thus obtained repre-
sents the prominent bacteria in the community. This technique 
has already been successfully applied to monitor the most 
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TABLE 1. Bifidobacterium strains used in the present study 
Species Strain Code in other collection 
B. adolescentis 
B. angulalum 
B. animalis 
B. bifidum 
B. breve 
B. catenulatum 
B. denticolens 
B. dentium 
B. gallicum 
B. infantis 
B. lactis 
B. longum 
B. pseudocatenulatum 
E-981074'1 
E-991436 
CSCC 19251' 
E-96663' 
E-97795' 
Bb-11 
E-981075'' 
CSCC 1967' 
E-9914341' 
E-9914381' 
CSCC 5492' 
E-977961' 
Bb-02 
E-97847'1' 
E-94508 
E-966641 
E-94505 
E-96702 
E-9914391 
VTT Culture 
VTT Culture 
CSCC 
VTT Culture 
VTT Culture 
Chr. Hansen 
VTT Culture 
CSCC 
VTT Culture 
VTT Culture 
CSCC 
VTT Culture 
Chr. Hansen 
VTT Culture 
VTT Culture 
VTT Culture 
VTT Culture 
VTT Culture 
VTT Culture 
Collection 
Collection 
Collection 
Collection 
A/S 
Collection 
Collection 
Collection 
Collection 
A/S 
Collection 
Collection 
Collection 
Collection 
Collection 
Collection 
ATCC 15703 
ATCC 15705 
ATCC 27535 
ATCC 25527 
ATCC 29521 
ATCC 15700 
ATCC 27539 
DSM 10105 
ATCC 27534 
ATCC 49850 
ATCC 15697 
DSM 10140 
Chr. Hansen A/S Bb-12 
ATCC 15707 
Chr. Hansen A/S Bb-46 
ATCC 27919 
predominant bacterial populations in human fecal samples 
(43). 
In this study we describe the development and validation of 
a method that combines Bifidobacterium genus-specific PCR 
with D G G E that allowed us to analyze complex bifidobacteria! 
communities. This approach was applied to study the bi-
fidobacteria! communities in the feces of adult subjects. The 
newly developed method also revealed intragenomic 16S 
rDNA heterogeneity in B. adolescentis E-981074T that was 
demonstrated to contain at least two distinct copies of 16S 
rDNA. 
MATERIALS AND METHODS 
Strains and growth conditions. The 19 strains of bifidobacteria belonging to 13 
different species used in this study are presented in Table 1. Bifidobacterium lactis 
and Bifidobacterium animalis species are often utilized in probiolic preparations 
for human and animal use whereas the other species listed in Table 1 are 
associated with the human host. Bacteria were obtained from the VTT Culture 
Collection (VTT Biotechnology, Espoo, Finland), Chr. Hansen A/S (H0rsholm, 
Denmark), and CSIRO Starter Culture Collection (CSCC) (Melbourne, Aus-
tralia). The strains were grown in Man-Rogosa-Sharpc medium supplemented 
with 0.5 g of cysteine liter ' in anaerobic jars with Anaerocult A-strips (Merck, 
Darmstadt, Germany) at 37°C. 
Fecal samples. Fecal samples were collected from six Finnish individuals 
(subjects I to VI) of different ages (21 to 55 years) and sex (three women and 
three men). Samples were frozen at -70°C immediately after defecation. Bi-
fidobacteria! counts of fecal samples were determined by selective plating on 
Becrens agar (5) under anaerobic conditions in a Whitley Anaerobic Cabinet 
(model MK II; Don Whitley Scientific Ltd., Shipley, United Kingdom) with an 
atmosphere of N2 (81)%), C02 (10%), and H, (10%). The plates were incubated 
at 37°C for 4 days in anaerobic jars filled with mixed gas (85% N2,5% C02, and 
10% H2) by evacuation-replacement method (Anoxomal; Hart, Lichtenvoorde, 
The Netherlands). 
Nucleic acid isolation. Isolation of chromosomal DNA from pure cultures was 
performed as described elsewhere (1). When necessary, the method was slightly 
modified by prolonging the lime for enzymatic lysis from 1 h to 2 or 3 h. Methods 
previously described (43) were used to extract RNA from pure cultures and 
DNA from fecal samples. 
Primers. All primers used in the study are listed in Table 2. Bifidobacterium 
genus-specific PCR was performed using 16S rDNA-targeted primers Bif164-f 
and Bif662-r or Im26-f and Im3-r, which produce approximately 520- or 1,420-bp 
PCR amplicons, respectively. For DGGE analysis of PCR products a 40-bp GC 
clamp was attached to the 5' end of either Bifl54-f or Bif662-r (Tabic 2). 
TABLE 2. Primers used in the present study 
Primer Sequence (5' to 3') Specificity or target 
Bifl64-f GGGTGGTAATGCCGGATG 
Bif662-r CCACCGTTACACCGGGAA 
Bifl64-GC-f CGCCCGGGGCGCGCCCCGGGCGGGGCGGGGGCA 
CGGGGGG-GGGTGGTAATGCCGGATG 
Bif662-GC-r CGCCCGCCGCGCGCGGCGGGCGGGGCGGGGGCA 
CGGGGGG-CCACCGTTACACCGGGAA 
Im26-f GATTCTGGCTCAGGATGAACG 
Im3-r CGGGTGCnCCCACTTTCATG 
7-f AGAGTTTGAT(GT)(A/C)TGGCTCAG 
1510-r ACGG(C/T)TACCTTGTTACGACTT 
1401-r CGGTGTGTACAAGACCC 
338-r CTGCTGCCTCCCGTAGGAGT 
338-f CTCCTACGGGAGGCAGCAG 
515-r ATCGTATTACCGCGGCTGCTGGCAC 
968-f AACGCGAAGAACCTTA 
1100-r GGGTTGCGCTCGTTG 
T7 TAATACGACTCACTATAGGG 
Sp6 GATTTAGGTGACACTATAG 
PCR 
PCR 
PCR 
PCR 
PCR 
PCR 
PCR 
PCR 
RT-PCR 
Sequencing 
Sequencing 
Sequencing 
Sequencing 
Sequencing 
Sequencing 
Sequencing 
Bifidobacterium 16S 
Bifidobacterium 16S 
Bifidobacterium 16S 
Bifidobacterium 16S 
Bifidobacterium 16S 
Bifidobacterium 16S 
Eubacterial 16S 
Eubacterial 16S 
Eubacterial 16S 
Eubacterial 16S 
Eubacterial 16S 
Eubacterial 16S 
Eubacterial 16S 
Eubacterial 16S 
pGEM1 
pGEM1 
17, 19 
17, 19 
This study 
This study 
15 
15 
18 
18 
30 
18 
18 
18 
18 
18 
Promega 
Promega 
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Complete 16S rDNA was amplified using primers 7-f and 1510-r. For reverse 
transcription of 16S rRNA to cDNA, primer 1401-r was used. Primers T7, Sp6, 
338-r, 515-r, 1100-r, 338-f, and 968-f labeled with IRD800 were used for sequenc-
ing. All primers were purchased from MWG-Biotcch (Ebersberg, Germany). 
Reverse transcriptase PCR (RT-PCR) and PCR amplification. PCRs were 
performed using a Tag DNA polymerase kit from Life Technologies (Gaithers-
burg, Md.). The reaction mixture consisted of 20 mM Tris-HCl (pH 8.4), 50 mM 
KC1, 3 mM MgCl2, 0.2 mM deoxynucleosidc triphosphate (dNTP). a 0.2 u.M 
concentration of each primer, 1.25 U of Tag polymerase, and 1 |xl of appropri-
ately diluted template DNA in a final volume of 50 u.1. In PCR with primers 7-f 
and 1510-r, the dNTP concentration was increased lo 0.3 mM and the amount of 
Tag polymerase was increased to 1.5 U. The PCR thermocycling program with 
Bifl64-f and Bif662-r primers was the following: 94°C for 5 min; 35 cycles of 94°C 
for 30 s, 62°C for 20 s, and 68°C 40 s; 62°C for 20 s; and 68°C for 7 min. The 
reactions were subsequently cooled to 4°C. For the amplification with primers 7-f 
and 1510-r the denaturation and elongation times were prolonged to 1 min 30 s 
and the annealing step was performed at 52°C for 30 s. The thermocycling 
program with primers Im26-f and Im3-r was: 94°C for 5 min; 30 cycles of 94°C for 
30 s, 57°C for 30 s, and 68°C for 1 min 30 s; 57°C for 30 s; and 68°C for 7 min. 
RT-PCR was performed with the Geneamp Thermostable r'Tth Reverse Tran-
scriptase RNA PCR kit (Perkin-Elmcr, Norwalk, Conn.). Reverse transcription 
reaction mixtures (10 u.1) consisted of 10 mM Tris-HCl (pH 8.3), 90 mM KC1,1 
mM MnCl2, 0.25 mM dNTP, 0.75 u.M primer 1401-r. 1.25 U of recombinant Tth 
DNA polymerase, and 1 u.1 of appropriately diluted RNA. The RT reaction was 
performed at 68°C for 30 min and followed by the addition of 40 \L\ of PCR 
mixture consisting of 5% glycerol, 10 mM Tris-HCl (pH 8.3), 100 mM KCt, 
0.05% Tween 20, 0.75 mM EGTA, 3.75 mM MgCl2, 0.2 mM dNTP, and a 0.25 
ixM concentration of each of the primers Bifl64-f and Bif662-GC-r. The PCR 
thermocycling program was the same as described above for these primers. 
The size and amounts of PCR products were estimated by analyzing 5-|xl 
samples by 1.2% agarose gel (wt/vol) electrophoresis and ethidium bromide 
staining. 
DGGE analysis of PCR products. DGGE analysis of PCR amplicons was 
performed essentially as described previously (27, 29) using the DCode or D 
GENE System apparatus (Bio-Rad, Hercules, Calif.). Polyacrylamide gels (8% 
[wt/vol] acrylamidc-bisacrylamide [37.5:1]) in 0.5 X Tris-acetic acid-EDTA buffer 
with a denaturing gradient were prepared with a gradient mixer and Econo-
pump (Bio-Rad) using solutions containing 45 and 55% denaturant. A 100% 
denaturant corresponds to 7 M urea and 40% (vol/vol) formamide. PCR ampli-
cons were separated by electrophoresis at a constant voltage of 85 V and a 
temperature of 60°C for 16 h. The DNA fragments were visualized by AgNO? 
staining and developing basically as described previously (35). 
Cloning of the PCR products. The PCR products were purified with the 
QIAquick PCR purification kit (Qiagen, Hilden, Germany) according to the 
manufacturer's instructions and cloned in E. coli JM109 by using the pGEM-T 
vector system (Promega, Madison, Wis.). Colonies were picked and transferred 
into 20 fxl of 10 mM Tris-HCl (pH 8.0>-l mM EDTA and boiled for 15 min to 
lyse the cells, and the ceil lysates were used to screen the transformants by PCR 
with Bifl64-f and Bif662-GC-r primers followed by DGGE analysis. Plasmid 
DNA of selected transformants was isolated using a QIAprep spin miniprep kit 
(Qiagen). 
Sequence analysis. Sequence analysis was carried out using purified plasmid 
DNA and sequencing primers T7 and Sp6 complementary to the adjacent se-
quences of the pGEMT cloning site and other primers complementary to the 16S 
rDNA sequences (see Table 2). Sequencing was performed with the Sequenasc 
sequencing kit (Amersham, Slough, United Kingdom) according to manufactur-
er's instructions. The sequences were analyzed with an automatic LI-COR (Lin-
coln, Nebr.) DNA sequencer 4000L and corrected manually. Pairwisc and mul-
tiple sequence alignments and similarity comparisons between individual 
sequences were carried out using BCM services available on the Internet (http:// 
www.hgsc.bcm.tmc.edu/SearchLaunher/) or from the DNASTAR (Madison, 
Wis.) program. Homology searches of 16S rDNA sequences derived from fecal 
clones and the DNA databases were carried out by using the BCM Nucleic acid 
sequence search service. In addition to the comparison with sequences in the 
databases, sequences of fecal clones were compared to the B. adolescentis 
E-9810747" sequences determined in this study, because the B. adolescentis 16S 
rDNA sequence deposited in the GenBank appears to contain many ambiguous 
bases. 
Southern hybridization. Chromosomal DNA (2u,g) was digested with EcoRl, 
EcoRV, or Nrul restriction enzymes (GibcoBRL, Paisley, United Kingdom) and 
the DNA fragments were separated by electrophoresis in 1% agarose. Fragments 
larger than 500 bp were transferred to Hybond-N+ membrane (Amersham, 
Aylesbury, United Kingdom) by vacuum blotting with a VacuGene XL vacuum 
O 
o 
w 
o 
6 15 .8 
-Q CO 5 
CM 
O 
r~ 
UJ 
S 
o o 
5 w 
O 
o 
W 
o 
I 
iS 3 C 
•8 
8 $ g 
(0 5 <? 
S * t! 
UJ 5 ! 3 .3 i 1 
& 5 
O Q G Q G b G Q G Q G Q G Q C Q C Q G Q C Q Q Q 
FIG. 1. Separation of PCR products from different Bifidobacterium 
species with genus-specific primers in 45 to 55% DGGE (increasing 
gradient of denaturant from top to bottom). 
blotting system (Pharmacia, Uppsala, Sweden), and hybridizations were carried 
out according lo established protocols (34). The Bifl64-f-to-Bif662-r PCR am-
plicon from strain B. adolescentis E-981074T was labeled with [a-32P]ATP by nick 
translation and used as a probe. 
Extraction of chromosomal Nnil fragments from agarose gel. Chromosomal 
DNA (10 M.g) was digested with Nrul restriction enzyme, and the DNA fragments 
were separated by agarose gel electrophoresis as mentioned above. DNA frag-
ments of a size between 3 and 23 kb were recovered using Concert matrix gel 
extraction system (GibcoBRL) and checked for the presence of 16S rDNA by 
PCR with primers Bifl64-f and Bif662-GC-r. 
Nucleotide sequence accession numbers. The sequences of the two different 
16S rDNA copies of B. adolescentis E-981074T were deposited in the GenBank 
database and have been assigned accession numbers AF275881 (nru-1) and 
AF275882 (nru-5). The accession numbers of the fecal clones in GenBank arc 
the following (clone code in parenthesis): AF275890 (7B), AF275891 (7G), 
AF275892 (9A), AF275893 (9B). AF275894 (9C), AF275884 (13D), AF275885 
(15A), AF275883 (15B), AF275886 (15D), AF275887 (16B), AF275888 (16C), 
and AF275889 (16F). 
RESULTS 
Development of the DGGE method for separation of bi-
fidobacteria. In order to set up the method based on genus-
specific PCR and DGGE, primers that amplify a fragment that 
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TABLE 3. Bifidobacteria! counts of the fecal samples 
Subject 
Bifidobacteria! count (CFU g [wet wt] l) at wk: 
I 
II 
III 
IV 
V 
VI 
0 
9.0 X 108 
1.8 X 10* 
2.2 x 109 
2.8 x 10* 
5.7 X 107 
4.1 X 104 
3 
2.2 X 10' 
3.4 X 10"' 
2.9 x 10' 
4.3 x 107 
2.3 X 10* 
<104 
4 
1.3 x 10' 
2.5 X 10' 
7.3 X 10' 
1.8 X 10' 
1.1 X 10* 
3.9 X 10" 
is separable by DGGE were selected and tested. The specificity 
of the previously described Bifidobacterium genus-specific 
primers Bifl64-f and Bif662-r (17, 19) was confirmed using 
numerous bacterial species occurring in feces as the reference 
material. The primers showed good specificity for the genus 
Bifidobacterium, and the approximately 520-bp product was 
amplified exclusively from bifidobacteria (data not shown). In 
order to separate the bifidobacteria! sequences by DGGE, a 
GC clamp was attached to either of the primers (Table 2). The 
use of primers Bifl64-GC-f and Bif662-r to amplify bifidobac-
teria! 16S rDNA resulted in PCR fragments from different 
species that showed very limited separation upon 45 to 55% 
DGGE (data not shown). In contrast, when the GC clamp was 
attached to the reverse primer (Bif662-GC-r) instead of the 
forward (Bifl64-f), a good separation of different species in 
DGGE was obtained (Fig. 1). However, some closely related 
species could not be separated from each other by this ap-
proach. B. longum and B. infantis gave fragments in the same 
position in the gel as well as B. catenulatum and B. pseudo-
catenulatum. Also B. breve and B. dentium PCR fragments 
migrated to the same position. Different strains of the same 
species (Table 1) gave fragments in the same position upon 
DGGE. Two species, B. breve and B. gallicum gave diffuse 
fragments. An individual fragment from one strain was fre-
quently observed as a doublet with two fragments very close to 
each other. This is very likely due to abortion of the elongation 
reaction during PCR caused by the GC clamp (hairpin forma-
tion), resulting in DNA molecules with slightly different mi-
gration behavior (30). However, B. adolescentis produced three 
strong fragments relatively far apart from each other (Fig. 1), 
and the cause for this was further examined in detail (see 
below). 
Host-specific and stable DGGE patterns of bifidobacteria 
from human feces. The applicability of the DGGE method to 
monitoring complex bifidobacteria! communities was first 
tested by using DNA from several Bifidibacterium species as 
the template in a competitive PCR. Fragments from all species 
were found in the DGGE profile, but in addition some extra 
fragments appeared above the single-stranded DNA in the 
DGGE profile (data not shown). These fragments are presum-
ably heteroduplexes, which are more unstable and therefore, 
remain in the upper part of the DGGE gel. 
IV V ml m2 
B. adolescentis 
B. bifidum 
B. angulatum 
B. longum/infantis 
B. denticolens 
B. dentium 
B. catenulatum 
/pseudocatenulatum 
FIG. 2. DGGE of bifidobacterial PCR products of fecal samples from adult individuals (lanes I to V) and mixed PCR products from pure 
cultures (lanes ml and m2). Single-stranded DNA and presumed heteroduplexes are above the line indicated with arrowheads. Indications 7B to 
16F refer to the corresponding clones in Table 4. 
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FIG. 3. DGGE of bifidobacteria! PCR products of fecal samples 
from two adult individuals (II and V) from a 4-week period (samples 
from weeks 0, 3, and 4). In samples 0', 3', and 4' 10-fold-diluted DNA 
was used for PCR. Single-stranded DNA and presumed heterodu-
plexes are above the line indicated with arrowheads. 
The bifidobacterial composition in fecal samples from six 
adult subjects (subjects I to VI) was studied. PCR products 
were obtained from samples I to V that had bifidobacterial 
counts reaching approximately 108 to 10'° CFU/g (wet weight) 
(Table 3), but no PCR product was obtained from subject VI, 
whose sample gave a low bifidobacterial count (approximately 
104 CFU/g [wet weight]). The cultivation was performed from 
frozen samples, which is likely to have introduced a bias to the 
bifidobacterial counts, but allowed us to monitor fluctuations 
in the counts over time. DGGE analysis of bifidobacterial PCR 
products of fecal samples revealed complex host-specific pat-
terns of bifidobacteria (Fig. 2, lanes I to V). In order to identify 
the Bifidobacterium species present in the feces, two samples 
consisting of a mixture of PCR products from identified species 
were run alongside the fecal samples (Fig. 2). However, most 
APPL. ENVIRON. MICROBIOL. 
fragments of the fecal samples migrated to a different position 
than those of the culture collection strains and could not be 
identified in this way. 
The stability of the bifidobacterial community over a period 
of 4 weeks was studied (Fig. 3). Analysis of three samples taken 
within this period showed stable bifidobacterial profiles, indi-
cating that the composition of bifidobacterial community did 
not alter over this period despite some slight fluctuation in the 
bifidobacterial numbers (Table 3). Only subject II had a minor 
change in profile, where a faint fragment present in the first 
sample disappeared in the following samples (Fig. 3). DGGE 
profiles from undiluted and 10-fold-diluted fecal DNA samples 
were similar (Fig. 3), indicating that the template DNA from 
fecal samples can be diluted at least 10 times to avoid possible 
inhibition of the PCR without affecting the DGGE profile. 
Validation of bifidobacterial profiles from feces. In order to 
identify some of the fragments in fecal profiles, a longer frag-
ment of approximately 1,400 bp was amplified from the fecal 
samples with another set of Bifidobacterium-spedhc primers, 
lm26-f and lm3-r. The amplified fragments were cloned into E. 
coli JM109 by using pGEM-T, and transformants were ampli-
fied with primers Bifl64-f and Bif662-GC-r. The mobility of 
these PCR products in DGGE was compared to the PCR 
pattern of the fecal sample obtained with the same primer set 
in order to determine which fragment they corresponded to. 
The plasmids from selected clones were purified, and the 16S 
rDNA insert was sequenced from both ends. The sequencing 
results confirmed that the DGGE profiles obtained with the 
primers Bifl64-f and Bif662-GC-r indeed represent the bi-
fidobacterial population in feces, since all sequenced fragments 
were derived from Bifidobacterium species. Clone sequences 
showed very high similarity to many Bifidobacterium species, 
and therefore could not be unambiguously identified to the 
species level (Table 4). All sequenced clones had the highest 
similarity to the sequence of B. adolescentis or its close phylo-
genetic relative species (B. ruminantium and B. dentium) or to 
B. pseudocatenulatum. 
B. adolescentis shows 16S rDNA heterogeneity. The B. ado-
lescentis E-981074T PCR product obtained with the primers 
Bifl64-f and Bif662-GC-r appeared in the DGGE gel as three 
distinct fragments (bands A to C in Fig. 4). In order to study 
TABLE 4. Sequencing of bifidobacterial clones from fecal samples 
Subject Clone Sequence length (bp) 
Ambiguity 
bp 
16 
15 
11 
5 
8 
12 
5 
6 
10 
18 
15 
17 
% 
1.3 
1.1 
0.8 
0.4 
0.6 
0.9 
0.4 
0.4 
0.7 
1.4 
1.2 
1.3 
Closest relatives (% sequence similarity6) 
I 
I 
II 
II 
II 
III 
IV 
IV 
IV 
V 
V 
V 
7B 
7G 
9A 
9B 
9C 
13D 
15A 
15B 
15D 
16B 
16C 
16F 
1,267 
1,365 
1,346 
1,360 
1,267 
1,297 
1,363 
1,357 
1,365 
1,268 
1,287 
1,362 
ft adolescentis (98)°, ft ruminantium (97), ft. dentium (95) 
B. adolescentis (98)", B. ruminantium (97), B. dentium (96) 
B. adolescentis (97)°, B. ruminantium (96), B. dentium (95) 
B. pseudocatenulatum (98), B. angulalum (97), B. dentium (96) 
ft adolescentis (98)°, B. ruminantium (97), ft dentium (96) 
ft pseudocatenulatum (98), ft ruminantium (97), B. adolescentis (97)° 
ft adolescentis (99)°, ft ruminantium (98), ft. dentium (97) 
ft adolescentis (99)°, ft ruminantium (98), ft. dentium (96) 
ft adolescentis (98)°, ft ruminantium (97), ft. dentium (96) 
ft. adolescentis (97)°, ft ruminantium (96), ft. dentium (96) 
ft ruminantium (97), ft adolescentis (9iy, ft. pseudocatenulatum (96) 
ft adolescentis (98)°, ft ruminantium (97), ft. dentium (96) 
" Compared to the 16S rDNA sequences determined in this study. 
b
 Percent similarity values from pairwise sequence alignments. 
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a 
2 3 4 
b 
5 6 7 8 
FIG. 4. DGGE profiles of B. adolescentis E-981074T 16S PCR 
product and its derivative clones, (a) Heteroduplex formation experi-
ment by PCR. Templates used in PCR are as follows: lane 1, plasmid 
from clone bl; lane 2, plasmid from clone cl; lane 3, plasmids from 
clones bl and c2; lane 4, DNA from E-9810741. (b) Heteroduplex 
formation experiment by melting PCR products. PCR products are as 
follows: lane 5, clone bl; lane 6, clone cl; lane 7, clones bl and cl heat 
denaturated together and cooled slowly to allow reannealing of com-
plementary strands; lane 8, E-981074T. Single-stranded DNA is indi-
cated with an arrowhead. 
the possible differences in sequences of the PCR fragments 
migrating to different positions, the PCR product was purified 
and cloned into E. coli JM109 using pGEM-T vector. The 
rDNA inserts of 40 clones were amplified by PCR with the 
primers Bifl64-f and Bif662-GC-r, and analysis of their migra-
tion in DGGE showed that the majority of them produced 16S 
rRNA PCR amplicons that corresponded to either the middle 
fragment (B) or the lowest fragment (C) (clones b and c, 
respectively) but none that corresponded to the upper frag-
ment (A). However, one clone (al) was obtained that pro-
duced all three fragments, A, B, and C (data not shown). In 
order to obtain a clone corresponding to the single fragment A, 
we repeatedly colony purified the clone but only obtained 
colonies that upon PCR produced fragments corresponding to 
either B or C or all three fragments. Fragment A had the 
uppermost migration position in DGGE, indicating that it 
melts under weaker denaturing conditions than fragments B 
and C and thus is the most unstable fragment. We therefore 
came to the assumption that fragment A was a heteroduplex of 
fragments B and C formed during melting and reannealing of 
sequences in the PCR thermocycling. Presumably, clone al 
contained at least two plasmids carrying either fragment B or 
C and thereby produced all three fragments during PCR. Fur-
ther evidence that fragment A was a heteroduplex of fragments 
B and C was obtained with the following experiments (Fig. 4). 
Firstly, purified plasmids from clones bl and cl were used 
separately and together as templates in PCR with the primers 
Bifl64-f and Bif662-GC-r. Plasmid from clone bl produced 
fragment B in DGGE, and similarly, clone cl produced frag-
ment C. When plasmids of bl and cl were both present in the 
PCR the three fragments (A, B, and C) could be observed after 
DGGE (lanes 1 to 3 in Fig. 4a). The same result was obtained 
following a nested-PCR amplification using fragments B and C 
separately and in combination as template in a subsequent 
PCR with the same primers (data not shown). Secondly, when 
PCR products B and C were mixed, heat denatured, and 
cooled to room temperature, analysis by DGGE showed the 
presence of all three fragments again (lanes 5 to 7 in Fig. 4b). 
Moreover, the inserts of four clones (bl, b2, cl, and c2) were 
sequenced. Sequence comparison revealed a minor difference 
in the sequences between clones b and c, i.e., a T deletion at 
position 219 (numbering begins at the 5' end of the 16S rDNA) 
in clones cl and c2 (Fig. 5). 
Heterogeneity, complete sequence analysis, and expression 
of the 16S rRNA gene of B. adolescentis E-981074T. The above 
observations prompted us to determine whether the microhet-
erogeneity found in the PCR products resulted from sequence 
heterogeneity in the V2 region of different copies of 16S rDNA 
in the chromosome, thus ruling out the possibility of a PCR 
76 105 
nru-1 CGGCTGGAGCTTGCTCCGGCCGTGAGAGTG 
nru-5 CC-CAGGAGCTTGCTCCTGG-GTGAGAGTG 
M58729 CGGCTNGAGCTTGCTCCGGCTGTGAGAGTG 
210 225 
nru-1 GAAAGATTCTATCGGT 
nru-5 GAAAGATTC-ATCGGT 
M58729 GAAAGATTCTATCGGT 
bl GAAAGATTCTATCGGT 
b2 GAAAGATTCTATCGGT 
cl GAAAGATTC-ATCGGT 
c2 GAAAGATTC-ATCGGT 
391 405 
GATGCAGCGACGCCG 
GATGCAGCGACGCCG 
AATGCAGCGACGCCG 
GATGCAGCGACGCCG 
GATGCAGCGACGCCG 
GATGCAGCGACGCCG 
GATGCAGCGACGCCG 
451 465 
AGCAAGCCCTTCGGG 
AGCAAGCCCTTCGGG 
AGCAAGCC-TTCGGG 
AGCAAGCCCTTCGGG 
AGCAAGCCCTTCGGG 
AGCAAGCCCTTCGGG 
AGCNAGCCCTTCGGG 
466 480 
GCGAGTGTACCTTTC 
GTGAGTGTACCTTTC 
GTGAGTGTACCTTTC 
GTGAGTGTACCTTTC 
GTGAGTGTACCTTTC 
GTGAGTGTACCTTTC 
GTGAGTGTACCTTTC 
991 1005 
nru-1 CCGACAG-CCCCAGA 
nru-5 CCGACAG-CCCCAGA 
M58729 CCGACAGGCCCCAGA 
1396 1410 
TCAAGTCATGAAAGT 
TCAAGTCATGAAAGT 
TCAAGCCATGAAAGT 
FIG. 5. Sequence alignment of B. adolescentis E-9810741 clones with the B. adolescentis sequence from GenBank (M58729), showing sequence 
differences that were found (in boldface type), bl, b2, cl, nru-1, and nru-5 are double-stranded sequences, and c2 is a single-stranded sequence. 
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FIG. 6. Southern blot analysis of rm operons of B. adolescentis 
E-9810741. The genomic DNA cleaved with EcoSl (lane 1), EcoRV 
(lane 2), and Nml (lane 3) and hybridized with 16S rDNA probe. 
bias. Genomic DNA of B. adolescentis was prepared from a 
culture grown from a single colony and cleaved with restriction 
enzymes £coRI, EcoRV, and Nrul. According to the GenBank 
sequence data (accession number M58729) (D. Yang and C. R. 
Woese, unpublished data) the first two enzymes cut the B. 
adolescentis 16S rDNA sequence only once at positions 660 
and 691, respectively, while Nrul has no cleavage site within 
the 16S rDNA. Subsequent Southern hybridization was per-
formed with a fragment homologous to the 16S rDNA se-
quence between bp 164 and 662 (Fig. 6). Hence, the number of 
fragments in £coRI and EcoRV digests that hybridize with the 
probe correspond to the copy number of rm operons in the 
chromosome. Four fragments were visible in the £coRI digest, 
and five were visible in the EcoRV digest. The approximately 
2.7-kb £coRI fragment (lane 1 in Fig. 6) was relatively more 
intense than the other fragments and probably contains two 
fragments containing 16S rDNA sequences. From these results 
we concluded that B. adolescentis E-9810741 harbors five cop-
ies of rm operon, a conclusion which is also supported by the 
observation that five Nrul fragments (Nrul-\ to Nrul-5) (Fig. 
6), supposedly containing intact copies of the 16S rDNA, hy-
bridized with the probe. The five Nrul fragments were isolated, 
and parts of the 16S rDNA sequences were amplified using 
primers Bifl64-f and Bif662-GC-r. The resultant PCR prod-
ucts were analyzed by DGGE, and this showed that fragment 
B was produced from four of the 16S rDNA copies (Nrul-1 to 
Nrul-4 fragments) and that fragment C was produced from one 
copy (Nrul-5 fragment) (Fig. 6). Fragment A was not produced 
from any of the copies. Next, primers 7-f and 1510-r were used 
to amplify the full-length 16S rDNA from fragments Nrul-1 
and Nrul-5, and the PCR products were cloned into E. coli 
JM109 using pGEM-T, generating clones nru-1 and nru-5. The 
heteroduplex formation experiments were repeated with the 
plasmids of these clones, and results analogous to those de-
scribed above were obtained; i.e., clone nru-1 produced frag-
ment B and nru-5 produced fragment C, but together they 
produced the additional fragment A. 
The full-length 16S rDNA fragments from clones nru-1 and 
nru-5 were sequenced and compared. The two copies of 16S 
rDNA had a similarity of 99.4%, showing differences in eight 
positions. The difference previously described for the b and c 
clones was confirmed (Fig. 5); i.e., the T deletion in clones cl 
and c2 at position 219 was also found in clone nru-5. In addi-
tion, clone nru-1 had a substitution of T to C at position 467. 
Thus, the deletion of one T at position 219 in clones cl, c2, and 
nru-5 changed the migration of the PCR fragment in DGGE, 
but the T-to-C substitution in clone nru-1 was not sufficient to 
alter its migration. The most prominent heterogeneity between 
the two chromosomal copies of 16S rDNA was, however, found 
outside the region that was amplified with primers Bif 164-f and 
Bif662-r. Clones nru-1 and nru-5 differed in several base pairs 
between positions 77 to 80 and 93 to 96 (Fig. 5) in the VI 
region of the 16S rDNA. The numerous ambiguous nucleo-
tides present in the B. adolescentis 16S rDNA GenBank se-
quence (M58729) were determined in this study. Both se-
quences nru-1 and nru-5 are different from M58729 at 
positions 96, 391, 459, 998, and 1401, while nru-5 shows addi-
tional differences in the aforementioned positions in the VI 
region. 
In order to get a picture of the expression of the different 
16S rDNA copies in B. adolescentis, an RT-PCR experiment 
was performed. First the 16S rRNA was transcribed to cDNA, 
which was then amplified in PCR with the primers Bifl64-f and 
Bif662-GC-r. When the PCR product was analyzed by DGGE, 
the same pattern of three fragments, A, B, and C, was ob-
tained. This showed that the 16S rDNA copy producing frag-
ment C is transcribed together with the copies producing frag-
ment B. As fragment B appeared significantly more intense 
than fragment C in DGGE, we estimated that more than one 
copy and possibly all four corresponding to fragment B are 
transcribed. Consistently, the intensity of the heteroduplex 
fragment A corresponded to that of fragment C. 
DISCUSSION 
In this study we describe the development and validation of 
a sensitive method for the qualitative analysis of complex bi-
fidobacteria! communities based on genus-specific PCR and 
DGGE. During the optimization of the method it was noticed 
that the location of the GC clamp in the DNA fragment greatly 
influenced the melting behavior and subsequently the migra-
tion of the fragment in the DGGE gel. Due to the use of 
different sequences in the GC clamps, direct comparison of the 
results obtained with the two primer pairs, Bifl64-GC-f-
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Bif662-r and Bifl64-f-Bif662-GC-r, was not possible, but it is 
more than likely that the location of the GC clamp has more 
effect on the separation than its sequence. When the GC clamp 
was attached to the forward primer (Bifl64-GC-f) the separa-
tion of different Bifidobacterium species by DGGE was not 
good, whereas an efficient separation was obtained when the 
GC clamp was attached to the reverse primer (Bif662-GC-r). 
Alignment of bifidobacteria! sequences from GenBank showed 
considerable sequence heterogeneity close to the Bifl64-f 
primer end (data not shown), which is apparently critical for 
the sequence-specific separation of the PCR products from 
different Bifidobacterium species. 
The developed method based on genus-specific PCR and 
DGGE allows us to monitor the qualitative composition of the 
whole bifidobacteria! population with merely a single PCR. In 
DGGE the PCR products from all culture collection strains of 
the same species migrated to the same position, but it was not 
possible to identify species in fecal samples by comparing the 
position of the fragment to those of the identified culture 
collection strains. Molecular typing methods such as ribotyping 
and pulsed-field gel electrophoresis have shown considerable 
genomic heterogeneity in strains of the same Bifidobacterium 
species (8, 22, 33). This heterogeneity is also present in the 
16S-to-23S internally transcribed spacer sequences, but 16S 
rDNA sequences are very conserved among bifidobacteria and 
show 93% similarity between most of the species of the genus 
Bifidobacterium (21, 26). Even minor differences in the 16S 
rDNA sequence may, however, alter the migration behavior of 
a PCR fragment in DGGE, as shown in the case of B. adoles-
centis E-9810741. This allows us to rapidly monitor changes 
occurring in the predominant members of the bifidobacterial 
community. The method may provide a valuable alternative to 
molecular typing techniques (22, 25) in rapidly monitoring 
qualitative changes in the bifidobacterial populations, although 
it does not allow definite discrimination or quantification of 
different strains. The DGGE method has an advantage of 
being independent of prior time-consuming culturing of the 
isolates on selective medium, which may favor the growth of 
some strains, thereby biasing the results. The PCR approach 
can also, however, lead to some distortions, because some 
sequences may amplify better than others, and heteroduplexes 
can be formed during PCR (39), as also observed in this study 
and further discussed below. In the PCR-DGGE approach 
identification of fragments can be done by subsequent cloning 
and sequencing of the PCR products, but it is hampered by the 
high similarity of 16S rDNA sequences between different Bi-
fidobacterium species and the inadequate sequence data qual-
ity for many of the sequences in GenBank. We contributed to 
the construction of a more comprehensive database by depos-
iting to the GenBank two accurate 16S sequences of B. ado-
lescentis E-981074T, which can be used for identification of new 
strains and phylogenetic studies. 
The DGGE profiles of 16S PCR amplicons of bifidobacteria 
were found to be unique for each individual. This supports the 
results of previous studies that intestinal Bifidobacterium com-
munities, like the dominant microbial populations, are host 
specific (16, 22, 25). The bifidobacterial populations were also 
found to be stable in composition during the 4-week study 
period. In general, the bifidobacterial population in the adult 
gut seems to be relatively stable for strain composition over 
several months or even a year, although some individual vari-
ations have also been detected (22, 25). In contrast, in the 
developing gut microbiota of infants bifidobacterial species 
change in time (C. Favier, E. E. Vaughan, W. M. de Vos, and 
A. D. L. Akkermans, unpublished data). Further studies with 
larger test groups are needed to make conclusions about de-
velopment and the long-term stability of bifidobacterial com-
munities. 
Matsuki et al. (23) applied species- and group-specific PCR 
directly to fecal samples and found B. catenulatum group spe-
cies (B. catenulatum and B. pseudocatenulatum) in 92% of 
adult fecal samples and B. longum, B. adolescentis, and B. 
bifidum in 65, 60, and 38% of the samples, respectively. Com-
parison of the species-specific PCR method with the classical 
culture method revealed that some species, most frequently B. 
adolescentis, were detected by the direct PCR method but not 
by culturing followed by specific PCR of the isolates (23). In 
these individuals B. adolescentis either was not among the most 
numerous bifidobacteria or it failed to grow on the selective 
media used. Our results indicate that B. adolescentis or closely 
related species are numerically the most prevailing bifidobac-
teria in some individuals, as it was most frequently found in the 
clone library. B. adolescentis was also the most widely distrib-
uted Bifidobacterium species among the subjects of the test 
group. Taking into account the possible heteroduplex forma-
tion and the fact that some species or strains may give more 
than one fragment in DGGE, it is difficult to give accurate 
estimates on the diversity of bifidobacteria in the fecal samples. 
The DGGE patterns show that the bifidobacterial diversity in 
individual samples is quite restricted, and according to se-
quence data some of these strains may belong to the same 
species. This result is in good agreement with previous studies 
showing that in most adults the bifidobacterial community is a 
combination of one to four species and that several distinct 
strains of the same species can coexist in one community (22, 
23). 
Our results show that B. adolescentis E-9810741 carries five 
rRNA gene clusters and exhibits intragenomic 16S rDNA se-
quence heterogeneity. Previously, B. breve has been found to 
have at least three rm operons, and B. bifidum has been found 
to have two (8, 42). The two 16S rDNA copies of B. bifidum 
were sequenced, but no differences were found between the 
sequences (42). It is anticipated that the greater the number of 
rRNA operons is the higher the possibility of heterogeneity 
among rRNA genes within an organism is. Indeed, a Paeniba-
cillus polymyxa strain that harbors at least twelve rrn operons 
was found to display a high degree of sequence diversity among 
its 16S rRNA genes (30). Intragenomic 16S rDNA heteroge-
neity, both microheterogeneities and larger changes, has been 
found also in other bacteria (9, 12, 37, 41). Microheterogene-
ities of a few base changes most likely result from mutations 
during DNA replication, whereas higher levels of sequence 
variation are considered to be a result of horizontal gene trans-
fer (37, 41). The two 16S rDNA sequences of B. adolescentis 
E-9810741 differed in only eight bases over the almost total 
length of the gene and showed the highest similarity (99.4%) to 
each other over all the sequences available in GenBank. 
Therefore, we consider that the variability has resulted from 
mutations in one copy of the 16S rRNA gene. Intragenomic 
sequence variation has effects on the phylogeny of organisms 
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and biodiversity estimates. The heterogeneities may also inter-
fere with analysis of denaturing gel patterns, and therefore 
some caution must be exercised when interpreting the results, 
especially when estimating strain and species numbers and 
diversity. 
Probiotic and prebiotic research aims at developing func-
tional food products that are able to modify the gut microbiota 
to a potentially more healthy one. A particular interest in these 
studies is to follow the marker organisms of well-balanced gut 
microbiota or the probiotic strains, often bifidobacteria and 
lactobacilli, and the changes of their proportions in the intes-
tinal microbiota. Recently, genus-specific primers were de-
signed for Lactobacillus spp. and also used successfully in com-
bination with DGGE to analyze communities of lactobacilli 
(G. H. J. Heilig, E. G. Zoetendal, E. E. Vaughan, P. Marteau, 
A. D. L. Akkermans, and W. M. de Vos, unpublished data). In 
conclusion, this study demonstrates that the combination of 
genus- or group-specific PCR with DGGE is a powerful tool to 
study targeted microbial populations in the complex GI tract 
ecosystem. The approach opens new possibilities to follow the 
qualitative changes in the bifidobacteria! and lactobacilli pop-
ulations in response to probiotic or prebiotic administration as 
well as to study the effect of age, genetic background and other 
factors on the composition and diversity of these bacterial 
groups. 
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A total of 24 strains, biochemically identified as members of the Lactobacillus casei group, were identified by 
PCR with species-specific primers. The same set of strains was typed by randomly amplified polymorphic DNA 
(RAPD) analysis, ribotyping, and pulsed-field gel electrophoresis (PFGE) in order to compare the discrimi-
natory power of the methods. Species-specific primers for L. rhamnosus and L. casei identified the type strain 
L. rhamnosus ATCC 7469 and the neotype strain L. casei ATCC 334, respectively, but did not give any signal 
with the recently revived species L. zeae, which contains the type strain ATCC 15820 and the strain ATCC 393, 
which was previously classified as L. casei. Our results are in accordance with the suggested new classification 
of the L. casei group. Altogether, 21 of the 24 strains studied were identified with the species-specific primers. 
In strain typing, PFGE was the most discriminatory method, revealing 17 genotypes for the 24 strains studied. 
Ribotyping and RAPD analysis yielded 15 and 12 genotypes, respectively. 
Lactobacilli have a worldwide industrial use as starters in the 
manufacturing of fermented milk products. Moreover, some 
Lactobacillus strains have probiotic characteristics and are 
therefore included in fresh fermented products or used in 
capsular health products, such as freeze-dried powder. The use 
of some Lactobacillus strains as probiotics is based on studies 
which show that these species belong to the normal intestinal 
flora and that the strains have beneficial effects on human and 
animal health (for reviews, see references 16 and 19). Lacto-
bacillus rhamnosus and L. casei do not belong to the group of 
primary starters used in the dairy industry, but these species 
include many important probiotic strains, e.g., L. casei Shirota 
(26) and L. rhamnosus GG (20). These species are also natu-
rally found in raw milk and in high numbers in cheese after it 
ripens (8, 15). 
Traditionally, the identification of lactobacilli has been 
based mainly on fermentation of carbohydrates, morphology, 
and Gram staining, and these methods are still used. However, 
in recent years, the taxonomy has changed considerably with 
the increasing knowledge of the genomic structure and phylo-
genetic relationships between Lactobacillus spp. (14, 24, 30). 
The identification of some Lactobacillus species by biochemi-
cal methods alone is not reliable (6,14,22), as evidenced by the 
L. casei group (21,32). The L. casei group includes L. casei, L. 
paracasei, L. rhamnosus, and L. zeae; the rejection of L. para-
casei and its inclusion in L. casei has been proposed (7, 9, 10, 
17). 
Probiotic health products can contain, perhaps due to the 
lack of good identification methods, Lactobacillus species 
other than those declared on the product specifications (13,14, 
32). Difficulty in identification has also been reported for clin-
ical isolates (21, 32). The need for rapid and reliable species-
specific identification, e.g., by PCR, is obvious. Recently, spe-
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cies-specific oligonucleotide primers for L. paracasei and L. 
rhamnosus were described (1, 29). 
The identification of lactobacilli at the strain level is impor-
tant for their industrial use. The biotechnology industry needs 
tools to monitor, e.g., the use of patented strains or to distin-
guish probiotic strains from natural isolates in the host gastro-
intestinal tract. As for safety aspects, it is crucial to be able to 
compare clinical isolates and biotechnological strains and also 
to monitor the genetic stability of the strains (11, 14). Geno-
typic methods used for strain typing are typically PCR methods 
(e.g., randomly amplified polymorphic DNA [RAPD] analysis) 
or variations of restriction enzyme analysis (e.g., pulsed-field 
gel electrophoresis [PFGE] and ribotyping) (30). In RAPD 
analysis (31), short arbitrary sequences are used as primers in 
PCR, which yields strain-specific amplification product pat-
terns. In PFGE and ribotyping analysis, genomic DNA is di-
gested with restriction enzymes. In PFGE (23), rare-cutting 
enzymes are used and large genomic fragments are separated, 
while in ribotyping (25), rRNA genes and/or their spacer re-
gions are used as probes that hybridize with genomic restric-
tion fragments. These basic methodological differences may 
cause divergences in typing results. 
The aims of this study were (i) to compare the identification 
of L. casei and L. rhamnosus strains by the API 50 CHL test 
and by species-specific PCR and (ii) to compare PFGE, RAPD 
analysis, and ribotyping techniques for the discrimination of 
closely related L. casei and L. rhamnosus strains. 
MATERIALS AND METHODS 
Bacterial strains and growth conditions. The bacterial strains used throughout 
the study are listed in Table 1. The strains were maintained at -80°C and 
subcultured in MRS broth or on MRS agar plates (LabM, Bury, England) 
anaerobically at 37°C. An API 50 CHL kit and APILAB Plus software using the 
API 50 CHL version 4.0 database (bioMerieux, Lyon, France) were used to 
identify strains biochemically. 
L. riiamnosus and L. paracasei species-specific PCR. Template DNA for the L. 
rhamnosus species-specific PCR was extracted as described previously (1) or, 
alternatively, PCR was performed with a fresh single colony grown overnight. 
The / - rhamnosus species-specific PCR assay described by Alander ct al. (1) was 
used. The sequences of the primer pair (Table 2, Rhal) designed into the 16S 
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TABLE 1. Lactobacillus strains used in the study 
Bacterial strain Identification by API 50 CHL (identification comment)" 
L. rhamnosus 
GG (ATCC 53103) 
VS 1030 
VS 1031 
VS 1032 
VS 1033 
VS 1034 
E-78080 
VS872 
E-97800 
Lactophilus 
VS495 
VS 1017 
VS 1018 
VS 1019 
VS 1020 
VS 1021 
VS 1022 
ATCC 7469 
ATCC 11443 
L. casei 
ATCC 393c 
ATCC 334 
ATCC 4646 
L. paracasei VS 1023 
L. zeae ATCC 15820' 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
L. rhamnosus 
(doubtful) 
(doubtful) 
(doubtful) 
(doubtful) 
(unacceptable) 
(good) 
(veiy good) 
(very good) 
(doubtful) 
(excellent) 
(good) 
(doubtful) 
(unacceptable) 
(doubtful) 
(good) 
(good) 
(very good) 
(excellent) 
(very good) 
L. rhamnosus (good) 
L. rhamnosus (doubtful) 
L. paracasei (very good) 
L. paracasei (excellent) 
L. paracasei (unacceptable) 
Human isolate, Valio Ltd.fr 
Human isolate, Valio Ltd. 
Human isolate, Valio Ltd. 
Human isolate, Valio Ltd. 
Human isolate, Valio Ltd. 
Human isolate, Valio Ltd. 
Isolated from beer, VTTC Culture Collection 
Isolated from milk, Valio Ltd. 
Human isolate, VTT Culture Collection 
Isolated from Lactophilus^ powder 
Isolated from cheese, Valio Ltd. 
Human isolate, Valio Ltd. 
Human isolate, Valio Ltd. 
Human isolate, Valio Ltd. 
Human isolate, Valio Ltd. 
Human isolate, Valio Ltd. 
Human isolate, Valio Ltd. 
American Type Culture Collection 
American Type Culture Collection 
American Type Culture Collection 
American Type Culture Collection 
American Type Culture Collection 
Human isolate, Valio Ltd. 
American Type Culture Collection 
" Identification by the API 50 CHL kit and the profile status by APILAB Plus software using the API 50 CHL version 4.0 database. Identification comment given 
by APILAB Plus software: excellent, the percentage of identification (%ID) > 99.9 and the T index (T) > 0.75; very good, %ID > 99.0 and T ^ 0.5; good, %ID & 
90.0 and T > 0.25; acceptable, %ID > 80.0 and T == 0; doubtful, several tests against identification (e.g., a rare biotype); unacceptable, below threshold value. 
b
 Valio Ltd., Helsinki, Finland. 
c
 VTT Biotechnology and Food Research, Espoo, Finland. 
d
 Manufactured by Laboraloires Lyocentre, Aurillac, France. 
e
 Recently proposed to belong to L. zeae (10, 17). f
 L. zeae type strain (10,17). 
rRNA gene were 5'CTTGCATCTTGATTTAATnTG.V (forward) and 5'CC 
GTCAATTCCTTTGAGTTT3' (reverse). The specificity of the primer pair was 
defined by the forward primer, and the expected PCR product size was 863 bp. 
The primers were made with a PCR Mate 391 DNA synthesizer (Perkin-Elmer 
Applied Biosystems, Foster City, Calif.) according to the manufacturer's instruc-
tions. Taq DNA polymerase and PCR buffer (final concentrations of 10 mM 
Tris-HCl, 1.5 mM MgCl2, and 50 mM KCl [pH 8.3]) were obtained from Boehr-
inger Mannheim (Mannheim, Germany). The amount of Taq DNA polymerase 
used was 2.0 U in a total reaction volume of 100 u,l. The concentration of each 
primer was 0.5 u,M, and that of each deoxynucleotide (Finnzymes Oy, Espoo, 
Finland) was 200 u.M. The amount of template used was 1 u.) of an appropriate 
dilution of the extracted DNA. A Gene Amp PCR System 9600 apparatus 
(Perkin-Elmer Applied Biosystems) was used for the PCR cycling. Initial dena-
turation was carried out at 94°C for 5 min, followed by a touch-down thermo-
cycling program with 30 amplification cycles (annealing for 30 s at 62°C in cycles 
1 to 10, 60°C in cycles 11 to 20, and 58°C in cycles 21 to 30; extension for 1 min 
at 72°C; and dcnaluration for 40 s at 94°C) and final extension for 10 min at 72°C. 
Reaction mixtures were subsequently cooled to 4°C. The PCR products were 
analyzed by agarose gel electrophoresis with 1% agarose in 0.5X Tris-boratc-
EDTA (10X is 89 mM Tris, 89 mM boric acid, and 25 mM EDTA [pH 8.0]) 
(TBE) buffer and etnidhim bromide staining. 
Other sets of species-specific primers, designed into the 16S-23S ribosomal 
DNA (rDNA) spacer region, were used to identify L. rhamnosus (Table 2, 
Rhall) and L. paracasei (Table 2, Cas) as described previously (29). Primer 
5'CAGACTGAAAGTCTGACGG3' was used with primers 5'GCGATGCGA 
ATTTCTATTATT3' and 5'GCGATGCGAA1T1CT1TITC3' to amplify L 
rhamnosus and /.. paracasei species-specific sequences, respectively. PCR ampli-
fication was performed with a DyNAzymc DNA polymerase kit (Finnzymcs Oy) 
according to the instructions of the manufacturer. The PCR buffer contained 10 
mM Tris-HCl, 1.5 mM MgCl,, 50 mM KCl, and 0.1 % Triton X-100 (pH 8.8). The 
primers were used at 1 |i.M and deoxynucleotides were used at 200 yM- Initial 
denaturalion was at 94°C for 2 min, and the thermocycling program was 94°C for 
1 min, 55°C for 1 min, and 72CC for 1 min. With both the L. rhamnosus and L. 
paracasei primers, two PCR products of 350 and 185 bp were amplified. 
RAPD genotyping. Template DNA for RAPD analysis was extracted from 
lactobacilli according to a modification of the method of Bollet el al. (4). Briefly, 
bacterial cells from a plate of a single-colony subculture of lactobacilli on MRS 
agar were harvested and transferred to Eppendorf lubes containing 100 u,l of 
Tris-EDTA (TE) buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). Tubes were 
vortexed well, 50 u.1 of 10% sodium dodccyl sulfate was added, and after vor-
texing, the tubes were incubated for 30 min at 65°C. The bacterial suspension was 
centrifuged (2,200 x g for 5 min), the supernatant was discarded, and the 
Eppendorf tubes containing the cells were healed in a microwave oven for 5 min 
at a power of 650 W. The pellets were dissolved in 500 |xl of TE buffer, and a 
1:100 dilution of cell lysatc in water was used as a template in RAPD analysis. 
RAPD analysis was performed in a 50-u.l reaction volume consisting of 200 u.M 
deoxynuclcoside triphosphate (Finnzymes Oy) a 0.4 u,M concentration of ran-
dom sequence primer 5'AGTCAGCCAC3\ 10 mM Tris-HCl (pH 8.3), 50 mM 
KCl, 4 mM MgCl2,2.5 U of Taq DNA polymerase (Bochringcr Mannheim), and 
5 u,l of template. The temperature profile in the Gene Amp PCR System 9600 
thermocycler was 35 cycles as follows: 94°C for 1 min, 32°C for 2 min, and 72°C 
for 2 min. The initial denaturalion was performed at 94°C for 5 min, and the final 
extension was done at 72°C for 5 min. Amplification products were analyzed 
elcctrophoretically in 1% (wt/vol) agarose gels containing elhidium bromide (0.5 
u,g/ml) and visualized under UV light. RAPD profiles of the strains were visually 
compared, and every clearly distinguishable profile was considered one RAPD 
genotype (Al, etc.) 
Ribotyping. Ribotyping was performed by the automated ribotyping device 
RiboPrinter microbial characterization system (Qualicon, Wilmington, Del.). 
Standard reagents were used in all steps of the analysis. The method involves the 
release of DNA from cells, EcoK\ digestion of chromosomal DNA, and the 
separation of the resulting fragments by agarose gel electrophoresis, followed by 
Southern hybridization probing with the rmB rRNA operon from Escherichia coli 
(5) as a chemiluminesccnt probe. Images were acquired with a charge-coupled-
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TABLE 2. Bacterial species detected by PCR with species-specific 
primer pairs 
3&ctcri3l slrtiin 
L. rhamnosus 
GG 
VS 1030 
VS 1031 
VS 1032 
VS 1033 
VS1034 
E-78080 
VS872 
E-97800 
Lactophihis 
VS495 
VS 1017 
VS 1018 
VS 1019 
VS 1020 
VS 1021 
VS 1022 
ATCC 7469 
ATCC 11443 
L. casei 
A T C C 393d 
A T C C 334 
A T C C 4646 
VS 1023 
L. zeae A T C C 15820 
Rhal" 
+ 
+ 
+ 
+ 
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
-
-
-
Result with primer pair 
Rhall* 
+ 
+ 
+ 
+ 
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
-
-
-
Casf 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+ 
+ 
+ 
-
a
 L. rhamnosus species-specific primers designed into the 16S rDNA gene (1). 
* L. rhamnosus species-specific primers designed into the 16S-23S rDNA 
spacer region (29). 
c
 L casei species-specific primers designed into the 16S-23S rDNA spacer 
region (29). 
d
 Recently proposed to belong to L. zeae (10, 17). 
device camera and processed by RiboPrinter analysis software that normalizes 
fragment pattern data for band intensity and relative band position compared to 
the molecular weight marker. Similar fingerprint patterns (similarity of >0.95) 
were automatically clustered into ribogroups (Rl, etc.). All strains were ri-
botyped at least twice to ensure the reproducibility of the fingerprint patterns. 
PFGE. The preparation of genomic DNA in situ in agarose blocks was per-
formed by a slight modification of the method of Tanskanen et al. (27). Lacto-
bacillus strains were grown to an A^ of 0.6 in MRS broth containing 1% glycine 
to facilitate lysis. Chloramphenicol (100 fig/ml) was added, and incubation was 
continued for 1 to 2 h. Cells were harvested from 1.5 ml of culture, washed with 
10 mM Tris-20 mM NaCI-50 mM EDTA (pH 7.2), and suspended in 300 ul of 
the same buffer. The suspension was healed in 50°C. and 300 u.1 of 2% agarose 
in 0.5X TBE buffer at the same temperature was added before solidifying the 
suspension in molds. The agarose blocks were incubated overnight at 37°C in 
lysis buffer, 6 mM Tris-1 M NaCl-100 mM EDTA-1% sarcosyl-0.2% deoxy-
cholate (pH 7.6), containing 2.5 mg of lysozymc (Sigma, St. Louis, Mo.) per ml 
and 20 U of mutanolysin (Sigma) per ml. Proteinase K (1 mg/ml) treatment was 
performed in 100 mM EDTA-1% sarcosyl-0.2% deoxycholate buffer (pH 8.0) 
for 18 h at 50°C. The agarose blocks were washed four times for 1 h per wash with 
20 mM Tris-50 mM EDTA (pH 8.0), the two first washes containing 1 mM 
phenylmcthylsulfonyl fluoride (Sigma). Before restriction enzyme digestion, the 
agarose blocks were washed twice for 1 h per wash with TE buffer and then 
balanced for 1 h in an appropriate restriction enzyme buffer. Restriction enzyme 
digestions with Notl and Sfil were performed overnight at 37°C. Electrophoresis 
was carried out with a CHEF DRII apparatus (Bio-Rad, Hercules, Calif.) in 1 % 
PFGE certified agarose (Bio-Rad) with 0.5X TBE buffer. The pulse time was 1 
to 15 s, the current was 5 V/cm, the temperature was 14°C, and the running time 
was 22 h. The agarose gel was stained with ethidium bromide (0.5 u,g/ml) and 
visualized under UV light. The PFGE profiles of the strains were visually com-
pared, and every clearly distinguishable profile was considered one Noil or Sfi\ 
genotype. The final classification of PFGE genotypes (PI, etc.) combines the 
separate results obtained with these two restriction enzymes. 
RESULTS 
Identification of bacterial species. Biochemical identifica-
tion of species was performed with an API 50 CHL kit. The 
identification results given by APILAB Plus software with the 
API 50 CHL version 4.0 database are shown in Table 1. For 13 
strains, identification levels from good to excellent were ob-
tained, and identification levels of 11 strains were considered 
doubtful or unacceptable due to atypical fermentation reac-
tions. 
The ribosomal intergenic regions are reported to be more 
variable between species than are the 16S or 23S RNA genes 
(2). Therefore, two sets of L. rhamnosus species-specific oligo-
nucleotide primers were used to identify bacterial strains; the 
first pair of primers was designed into 16S rDNA (1) and the 
second into the 16S-23S rDNA spacer region (29). Both L. 
rhamnosus primer pairs gave PCR products of expected sizes 
with all strains except L. zeae ATCC 15820, L. rhamnosus VS 
1033, L. paracasei VS 1023, and L. casei ATCC 393, ATCC 
334, and ATCC 4646 (Table 2). The L. paracasei species-
specific primers produced PCR products of expected sizes with 
L. paracasei VS 1023 and L. casei ATCC 334 and ATCC 4646. 
All three of these strains were classified as L. casei since the 
rejection of L. paracasei has been proposed (9,10,17); further, 
only the name L. casei is used. The L. zeae type strain, ATCC 
15820, and L. casei ATCC 393, which was recently reclassified 
as L. zeae (10,17), were not identified by either L. rhamnosus-
OTL. c<w«'-specific primers. L. rhamnosus VS 1033 gave an API 
50 CHL profile (Table 1) and was earlier identified as belong-
ing to the L. casei group by 16S rRNA sequencing (unpub-
lished results). It did not, however, give positive results with 
either of the L. rhamnosus or L. casei primers. This very likely 
indicates that this strain also belongs to L. zeae. PCR identi-
fications of bacterial strains with the L. rhamnosus and L. casei 
species-specific oligonucleotide primers are in Table 2. 
RAPD analysis. Twelve RAPD genotypes (Al to A12) were 
detected among the 24 Lactobacillus strains. Genotypes Al 
(Fig. 1, lanes 1 to 6), A2 (lanes 7 to 12), A3 (lanes 13 and 14), 
and A5 (lanes 15 and 18) were represented by six, six, two, and 
two strains, respectively, whereas the remaining eight strains 
each had a unique RAPD genotype (Fig. 1 and Table 3). All L. 
rhamnosus strains (Fig. 1, lanes 1 to 18) except for VS 1033 
(Fig. 1, lane 20) produced a strong 1-kb amplification product 
that was either missing or weak in the L. zeae (Fig. 1, lanes 21 
and 22) and L. casei (Fig. 1, lanes 19, 23, and 24) strains. 
Ribotyping. Ribotyping with the £coRI restriction enzyme 
produced 15 distinct fingerprint patterns for the 24 strains 
studied (Fig. 2 and Table 3). The triple band located between 
4.8 and 6.2 kb seemed to be a feature typical of the L. rham-
nosus fingerprint patterns; 16 of the 18 L. rhamnosus strains 
(identified by species-specific PCR) gave this type of finger-
print (Fig. 2, Rl to R4, R6, R7, and R9). L. casei VS 1023 
(Rll) , ATCC 334 (R13), and ATCC 4646 (R14) (identified by 
species-specific PCR) shared bands of approximately 4.2 and 
6.5 kb; in addition, strains VS 1023 (Rll) and ATCC 334 
(R13) shared bands of approximately 5 and 7 kb. The band 
pattern of L. rhamnosus VS 1030 (R8) resembled those of 
strains of both L. rhamnosus and L. casei. L. zeae ATCC 15820 
(R15) and L. casei ATCC 393 (R12), which was proposed to 
belong to L. zeae (10, 17), had bands of approximately 1, 3.5, 
and 7 kb and a double band between 4.5 and 5.5 kb in common. 
VS 1033 (R10), which we suggest belongs to L. zeae according 
to the results of species-specific PCR, shared the bands of 
approximately 1 and 3.5 kb and the larger band of the double 
band between 4.5 and 5.5 kb with the L. zeae strains. The 
fingerprint of L. rhamnosus VS 1020 (R5) did not show simi-
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FIG. 1. RAPD patterns and genotypes (in parentheses) of the strains. Lanes: 1 to 18, /.. rhamnosus GG (A1), VS 1031 (Al), VS 1032 (Al), VS 1034 (Al), VS 1017 
(Al), VS 1018 (Al), ATCC 7469 (A2). ATCC 11443 (A2), E-78080 (A2), VS 872 (A2), VS 495 (A2), VS 1022 (A2). VS 1020 (A3), VS 1021 (A3), E-97800 (A4), VS 
1030 (A5), Lactophilus (A6), and VS 1019 (A5). respectively; 19, L. casei VS 1023 (A7); 20, /.. rhamnosus VS 1033 (A8); 21. L zeae ATCC 15820 (A9); 22, /.. casei 
ATCC 393 (A10); 23, L. casei ATCC 334 (All); 24, /.. casei ATCC 4646 (A12); 25, molecular weight marker (in kilobasc pairs). 
larity to any other fingerprints. Strains belonging to the same 
species were found to also share bands of >10 kb (Fig. 2). 
These bands are not listed individually because it was difficult 
to estimate the sizes of the bands with the coarse scale. 
PFGE. L. rhamnosus genomic DNA digested with Sfil and 
Notl yielded fragments of approximately 23 to 250 and 4 to 250 
TABLE 3. Abilities of RAPD analysis, ribotyping, and PFGE to 
differentiate L. rhamnosus and L. casei strains 
Genotype by: 
L. rhamnosus 
GG 
VS 1032 
VS 1034 
VS 1018 
VS 1031 
VS 1017 
ATCC 7469 
ATCC 11443 
E-78080 
VS872 
VS 1022 
VS495 
VS 1020 
VS 1021 
E-97800 
VS 1019 
VS 1030 
Lactophilus 
VS 1033 
L. casei 
VS 1023 
ATCC 393* 
ATCC 334 
ATCC 4646 
L. zeae ATCC 15820 
RAPD analysis 
Al 
Al 
Al 
Al 
Al 
Al 
A2 
A2 
A2 
A2 
A2 
A2 
A3 
A3 
A4 
A5 
A5 
A6 
A8 
A7 
A10 
Al l 
A12 
A9 
RiboPrint 
Rl 
Rl 
Rl 
Rl 
Rl 
Rl 
R2 
R2 
R2 
R3 
R3 
R4 
R5 
R6 
R7 
R7 
R8 
R9 
R10 
R l l 
R12 
R13 
R14 
R15 
PFGE" 
PI 
PI 
PI 
PI 
P2 
P3 
P4 
P4 
P4 
P5 
P5 
P6 
P7 
P7 
P8 
P9 
P10 
P l l 
P13 
P12 
P14 
P15 
P16 
P17 
kb, respectively (Fig. 3 and 4). Sfil revealed 16 (SI to S16) and 
Notl revealed 15 (Nl to N15) distinct genotypes. Combining 
the results (Table 3), 17 distinct genotypes (PI to P17) were 
found in the 24 Lactobacillus strains studied. Thirteen unique 
genotypes were found, and genotypes PI, P4, P5, and P8 were 
represented by four, three, two, and two strains, respectively 
(Table 3). All L. rhamnosus and L. zeae strains produced a 
typical double band (approximately 250 kb) and, possibly, ad-
ditional bands with restriction enzyme Sfil (Fig. 3a and b). Notl 
cut L. rhamnosus genomic DNA more often, and similar kinds 
of typical bands were not distinguishable (Fig. 4a and b). With 
the L. casei strains, a typical restriction pattern was not pro-
duced by either enzyme (Fig. 3c and 4c). 
L. rhamnosus GG (Fig. 3a, lane 1, and 4a, lane 1), VS 1032 
(Fig. 3b, lane 2, and 4b, lane 2), VS 1034 (Fig. 3b, lane 3, and 
4b, lane 3), and VS 1018 (Fig. 3b, lane 7, and 4b, lane 7) had 
Rl R2 R3 R4 R5 R6 R.7 K2 R9 R10R11R12 R13 R14R15 
" Combines the separate results obtained with Sfil (genotypes SI to S16) and 
Noll (genotypes Nl to N15). 
6
 Recently proposed to belong to L. zeae (10, 17). 
FIG. 2. RiboPrint patterns of L. rhamnosus, L. casei, and L. zeae strains. The 
patterns are composites of several individual patterns. Ribotypes: Rl, L. rham-
nosus GG, VS 1032, VS 1034, VS 1018, VS 1031, and VS 1017; R2, L rhamnosus 
ATCC 7469, ATCC 11443, and E-78080; R3, L. rhamnosus VS 872 and VS 1022; 
R4, /.. rhamnosus VS 495; R5, L rhamnosus VS 1020; R6.L. rhamnosus VS 1021; 
R7, L rhamnosus E-97800 and VS 1019; R8, L. rhamnosus VS 1030; R9, /-. 
rhamnosus Lactophilus; R10, L. rhamnosus VS 1033; Rll, L. casei VS 1023; R12, 
/.. casei ATCC 393; R13, L. casei ATCC 334; R14, L. casei ATCC 4646; R15, U 
zeae ATCC 15820. 
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b 
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identical PFGE profiles with both enzymes and could not be 
distinguished from each other (Table 3, genotype PI). The 
S/il-produced profiles of L. rhamnosus VS 1017 (Fig. 3b, lane 
6) and VS 1031 (Fig. 3b, lane 1) differed from those of the 
previous group by one and two extra bands, respectively. An-
other group with identical PFGE profiles (Table 3, genotype 
P4) with both enzymes consisted of L. rhamnosus ATCC 7469 
(Fig. 3a, lane 2, and 4a, lane 2), ATCC 11443 (Fig. 3a, lane 3, 
and 4a, lane 3), and E-78080 (Fig. 3a, lane 4, and 4a, lane 4). 
The third group with identical PFGE patterns (Table 3, geno-
type P5) contained L. rhamnosus VS 872 (Fig. 3a, lane 5, and 
4a, lane 5) and VS 1022 (Fig. 3b, lane 10, and 4b, lane 10), and 
the last group (Table 3, genotype P7) contained strains L. 
rhamnosus VS 1021 (Fig. 3a, lane 9, and 4a, lane 9) and VS 
1020 (Fig. 3b, lane 9, and 4b, lane 9). All the other PFGE 
profiles of the L. rhamnosus strains were unique. The L. casei 
and L. zeae strains all had unique profiles. 
DISCUSSION 
Polyphasic taxonomy, which integrates phenotypic, geno-
typic, and phylogenetic information, has changed the classifi-
cation of lactobacilli in recent years (for a review, see reference 
30). Reliable identifications of some species are not obtained 
by traditional biochemical methods alone; genotypic methods 
mm* mm^-^^l^^^^^^WW^ 
kb 
.242.5 
1-194 
-145.5 
1-97 
1-48.5 
|_23.1 
FIG. 3. PFGE profiles and genotypes (in parentheses) of the strains as de-
termined with restriction enzyme Sfil. (a) Lanes: 1 to 9, L rhamnosus GG (SI), 
ATCC 7469 (S2), ATCC 11443 (S2), E-78080 (S2), VS 872 (S2), E-97800 (S3), 
VS 1030 (S4), VS 1033 (S5), and VS 1021 (S6), respectively; 10, L. zeae ATCC 
15820 (S7). (b) Lanes: 1 lo 10, L. rhamnosus VS 1031 (S8), VS iai2 (S1). VS 
1034 (SI), Lactophilus (S9), VS495 (S10), VS 1017 (Sll) , VS 1018(SI), VS 1019 
(S12), VS 1020 (S6), and VS 1022 (S2). respectively, (c) Lanes: 1 to 4, I. casei VS 
1013 (S13), ATCC 393 (S14), ATCC 334 (S15), and ATCC 4646 (S16), respec-
tively. 
are needed as well. This may cause problems for routine lab-
oratories performing analyses if reliable and easy genetic 
methods, e.g., species-specific PCR, are not available. 
We tested two pairs of recently published L. rhamnosus 
specific primers, one pair complementary to 16S rDNA and the 
other complementary to the spacer between 16S and 23S 
rDNA. Similar results were obtained with the primer pairs, and 
their specificity to the studied strains was good. No PCR signal 
was obtained with either L. rhamnosus- or L. casei'-specific 
primers for L. zeae ATCC 15820 or L. casei ATCC 393, which 
was recently reclassified as L. zeae. Neotype strain L. easel 
ATCC 334 and the L. rhamnosus type strain, ATCC 7469, were 
correctly identified with their species-specific primers. Primers 
specific for L. zeae are needed for the complete identification 
of this bacterial group. All the strains studied were identified as 
belonging to the L. casei group, i.e., to L. casei, L. rhamnosus, 
or L. zeae, by the API 50 CHL test. However, the exact iden-
tifications of these closely related species were not reliable. 
Identifications of 11 strains were doubtful or unacceptable, and 
one strain, L. casei ATCC 393 (reclassified as L. zeae), was 
misidentified as L. rhamnosus with a good identification level. 
At the species level, RAPD analysis yielded typical amplifi-
cation products of 1 kb from all L. rhamnosus strains except for 
VS 1033, whose identification by the API 50 CHL test was 
unacceptable; we suggest that VS 1033 belongs to L. zeae, 
according to the results of species-specific PCR. The band 
representing the 1-kb amplification product was missing or 
weak with the L. casei and L. zeae strains. Ribotyping revealed 
a triple band (between 4.8 and 6.2 kb) which seems to be 
typical for most L. rhamnosus strains. In PFGE, all L. rham-
nosus and L. zeae strains yielded a typical double band (over 
250 kb) when cut with Sfil, while no typical bands were distin-
guished by Notl. Typical bands in the fingerprints are very 
helpful but, of course, are not adequate alone for the identi-
fication of L. rhamnosus. 
For strain typing, PFGE was the most discriminating meth-
od; it revealed 17 genotypes of the 24 strains studied, while 15 
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1 2 3 4 5 6 7 8 9 10 
and 12 genotypes were distinguished by ribotyping and RAPD 
analysis, respectively. PFGE was performed with two enzymes, 
Sfil and Notl, which increased its discrimination capability. 
However, even if the results obtained with Sfil (which revealed 
16 genotypes) or Notl (15 genotypes) are considered sepa-
rately, PFGE remains the most discriminating or at least as 
discriminating as ribotyping. All non-L. rhamnosus strains (ac-
cording to species-specific PCR) were distinguished from the 
L. rhamnosus strains by all three methods. The 18 L. rhamno-
sus strains were typed into 11 (10 genotypes by Sfil and 9 by 
Notl), 9, and 6 genotypes by PFGE, ribotyping, and RAPD 
analysis, respectively. Table 3 shows that some L. rhamnosus 
strains were typed as belonging to the same genotype group by 
all three methods, which can be considered a very reliable 
identification. Based on our experience, PFGE analysis alone, 
performed with two or three appropriate enzymes, can be used 
for reliable strain typing. In several Lactobacillus studies, 
PFGE has been shown to be the most powerful method for 
strain typing (3, 12, 18), and it is also used in epidemiological 
studies (28). However, it is a laborious and expensive method; 
therefore, only a limited number of samples can be analyzed. 
Screening new primers in RAPD analysis and using other re-
striction enzymes in ribotyping could possibly increase their 
specificity for strain typing. Ribotyping can be done automat-
ically (RiboPrinter) and is therefore easily applied, but the 
equipment is rather expensive. RAPD analysis is a rapid and 
1 2 3 4 5 6 7 8 9 10 
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FIG. 4. PFGE profiles and genotypes (in parentheses) of the strains as de-
termined with restriction enzyme Noll, (a) Lanes: 1 to9. /.. rhamnosus GG (Nl), 
ATCC 7469 (N2), ATCC 11443 (N2), E-78080 (N2), VS 872 (N3), E-97800 (N4), 
VS 1030 (N5), VS 1033 (N6). and VS 1021 (N7), respectively; 10, L. zeae ATCC 
15820 (N8). (b) Lanes: 1 to 10, L. rhamnosus VS 1031 (Nl), VS 1032 (Nl), VS 
1034 (Nl), Lactophilus (N9). VS 495 (N10), VS 1017 (Nil) , VS 1018 (Nl), VS 
1019 (N5), VS 1020 (N7), and VS 1022 (N3), respectively, (c) Lanes: 1 to 4, L. 
casei VS 1023 (N12), ATCC 393 (N13), ATCC 334 (N14), and ATCC 4646 
(N15), respectively. 
cheap method, but careful optimization is needed to ensure the 
repeatability of the results. 
To conclude, species-specific PCR, due to rapid and easy 
performance, is a very useful method for identifying species of 
the L. casei group. RAPD analysis, ribotyping, and PFGE are 
all primarily typing methods, but they do have the potential to 
also give species-specific information. Highly standardized and 
automated ribotyping could be suitable in forming large data-
bases, giving rise to the possibility of using a typing method for 
identification purposes. Principal identification is still based on 
microbiological and biochemical methods, but for thorough 
analysis, conventional identification methods should be com-
bined with genotypic methods. 
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Lactobacillus rhamnosus GG is one of the most thoroughly studied probiotic strains. Its advantages in the 
treatment of gastrointestinal disorders are well documented. The aim of the present study was to demonstrate 
with colonic biopsies the attachment of strain GG to human intestinal mucosae and the persistence of the 
attachment after discontinuation of GG administration. A whey drink fermented with strain GG was fed to 
human volunteers for 12 days. Fecal samples were collected before, during, and after consumption. L. 
rhamnosus GG-like colonies were detected in both fecal and colonic biopsy samples. Strain GG was identified 
by its characteristic colony morphology, a lactose fermentation test, and PCR. This study showed that strain 
GG was able to attach in vivo to colonic mucosae and, although the attachment was temporary, to remain for 
more than a week after discontinuation of GG administration. The results demonstrate that the study of fecal 
samples alone is not sufficient in evaluating colonization by a probiotic strain. 
Oral consumption of health-promoting lactic acid bacteria 
or probiotics has been associated with the prevention, allevia-
tion, or cure of diverse intestinal disorders such as lactose 
intolerance, viral and bacterial diarrhea, adverse effects of ab-
dominal radiotherapy, constipation, inflammatory bowel dis-
ease, and food allergy (3,5,11). Much of the early evidence on 
the actual health effects of probiotics was anecdotal, but during 
the last few years data based on rigorous clinical studies indi-
cating real health-promoting properties of certain well-charac-
terized strains have started to accumulate (8). 
Adhesion to the intestinal epithelium is one of the selection 
criteria for new probiotic strains (6). The adhesion properties 
have generally been deduced from in vitro experiments with 
intestinal cell lines, although, for example, rectal mucosal sam-
ples have been successfully used to demonstrate intestinal col-
onization by lactobacillar strains (7). 
Lactobacillus rhamnosus GG (ATCC 53103) (previously 
known as Lactobacillus casei GG) is one of the most thor-
oughly studied probiotics (11). The reviewed beneficial effects 
(9,12,13) include prevention of antibiotic-associated diarrhea, 
treatment and prevention of rotavirus diarrhea, treatment of 
relapsing Clostridium difficile diarrhea, prevention of acute di-
arrhea, and enhancement of intestinal immunity. The ability of 
strain GG to survive passage through the gastrointestinal tract 
has been demonstrated in both adults and children by the use 
of fecal samples (4,10,14). Recently, adhesion of the strain to 
human colonic mucosae has been demonstrated with colonic 
biopsy samples (1). The aims of the present study were to 
confirm with colonic biopsy samples the attachment of L. rham-
nosus GG to human intestinal mucosae and to evaluate the 
persistence of this attachment after discontinuation of strain 
GG administration. 
* Corresponding author. Present address: University of Kuopio, De-
partment of Biochemistry and Biotechnology, P.O. Box 1627, FIN-
70211 Kuopio, Finland. Phone: 358 17 162087. Fax: 358 17 2811510. 
E-mail: Atte.vonWright@uku.fi. 
Volunteers and L. rhamnosus GG administration. The three 
experimental groups in this study each consisted of six to eight 
adults undergoing routine diagnostic colonoscopy. The exper-
imental protocol was designed to fit within the normal diag-
nostic schedule of the volunteers. Informed consent from all 
subjects was obtained before the experiment. With the excep-
tion of various gastric symptoms, all subjects considered them-
selves healthy. No antibiotic therapy was applied either during 
the trial or during the month immediately preceding the ad-
ministration period. The volunteers had no immediate past 
history of consuming L. rhamnosus GG-containing products. 
For this study they took 100 ml of a commercial drink based on 
lactose-hydrolyzed whey fermented with strain GG and fla-
vored with a peach-apricot concentrate (Gefilus; Valio Ltd., 
Kouvola Dairy, Kouvola, Finland) twice daily for 12 days. The 
daily dose of strain GG was approximately 6 x 1010 CFU. 
After administration of strain GG, the volunteers were divided 
into three groups (see Fig. 1): those having undergone colonos-
copy immediately after the 12-day GG administration period 
(one male, five females, 34 to 78 years old), those having 
undergone colonoscopy 1 week after stopping GG administra-
tion (five males, three females, 42 to 68 years old), and those 
having undergone colonoscopy 2 weeks after stopping GG 
administration (four males, three females, 27 to 73 years old). 
Colonoscopy and biopsies. In preparation for colonoscopy, 
evacuation of the colon was induced by three doses of a laxa-
tive (Pico-salax; Malmo, Sweden) consumed within 36 h. The 
instrument used for colonoscopy and sampling of biopsies was 
a Pentax ES-3801L (Tokyo, Japan). The diameter of the biop-
sies was approximately 3 mm. Three parallel biopsies were 
taken from the descending colon. This location was selected on 
the basis of previous results (1) showing preferential adhesion 
of L. rhamnosus GG to this part of the large intestine. 
Cultivation of L. rhamnosus GG from fecal and biopsy sam-
ples. Fecal samples were collected as indicated in Fig. 1. The 
samples were immediately stored at about -20°C in the home 
freezers of the patients (for up to 3 weeks) and afterwards at 
-20°C in the laboratory until analysis (within 9 weeks after 
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collection). Biopsy samples from the descending colon were 
immediately transferred into a thioglycolate medium (Difco, 
Detroit, Mich.) and stored at 4°C until analysis (within a day). 
The samples were homogenized for 30 s in a stomacher (Stom-
acher 400; Seward, London, United Kingdom) before dilution 
and cultivation on MRS agar (Merck, Darmstadt, Germany). 
The plates were incubated under anaerobic conditions 
(Anaerocult A; Merck) for 3 days at 37°C. 
L. rhamnosus GG forms large, creamy, white colonies on 
MRS agar that are generally distinct from other lactic acid 
bacterial colonies. Strain GG is further distinguished from 
most other lactic acid bacteria by its inability to efficiently 
ferment lactose (4), which was tested by selecting one to four 
typical GG-like colonies from each fecal and biopsy sample 
and further cultivating them for 48 h in lactose MRS broth with 
indicator dye (bromocresol purple, 0.04 g/liter). One or two 
lactose-negative isolates per sample were further confirmed as 
L. rhamnosus by species-specific PCR. 
PCR confirmation of L. rhamnosus isolates. Bacterial cells 
were collected from 1 ml of an overnight culture by centrifu-
gation, washed with 50 mM Tris buffer (pH 8.0), and sus-
pended in 100 uJ of 50 mM Tris-EDTA buffer (pH 8.0). Ly-
sozyme (100 u.1, 20 mg/ml) (Sigma, St. Louis, Mo.) and 
mutanolysin (8 u.1, 0.5 mg/ml) (Sigma) were added, and the 
mixture was incubated at 37°C for 1 h. The cells were lysed by 
addition of 20 u.1 of 20% sodium dodecyl sulfate and 12 u.1 of 
proteinase K solution (14.6 mg/ml) (Boehringer, Mannheim, 
Germany) followed by a 10-min incubation at 65°C. The vol-
ume was adjusted to 500 u,l with sterile ultrapure water. 
Deproteinization was done by extraction with 1 volume of 
Tris-saturated phenol (Amresco, Solon, Ohio). The water 
phase was extracted once more with phenol-chloroform (1:1). 
Finally, DNA was precipitated by adding 0.1 volume of 3 M 
sodium acetate to the water phase followed by 2 volumes of 
94% ethanol and incubating the mixture in an ice bath for 30 
min. The DNA was collected by centrifugation at 13,000 rpm 
for 15 min, and the pellet was washed with 70% ethanol and 
finally dissolved in 20 |A1 of sterile ultrapure water. 
The universal 16S rRNA gene forward and reverse primers 
(5' to 3') were AGAGTTTGATCCTGGCTCAGG and ACG 
GCAACCTTGTTACGAGTT, respectively. The species-spe-
cific primers (CTTGCATCTTGATTTAA1TT1G, forward; 
CCGTCAATTCCTTTGAGTTT, reverse) were designed on 
the basis of the L. rhamnosus (previously L. casei subsp. rham-
nosus) 16S ribosomal DNA sequence (GenBank accession no. 
M58815) specifying the 863-bp fragment between positions 91 
and 953 in the gene. The primers were made with a PCR Mate 
EP 391 DNA synthesizer, model 391 (Applied Biosystems, 
Foster City, Calif.), according to the manufacturer's instruc-
tions. 
Taq DNA polymerase and PCR buffer (final concentrations 
of 10 mM Tris-HCl, 1.5 mM MgCl2 and 50 mM KC1 [pH 8.3]) 
were obtained from Boehringer, and the deoxynucleotides 
were purchased from Sigma. The primer concentrations were 
0.5 JJLM with specific primers and 0.25 u,M with universal prim-
ers, and those of the deoxynucleotides were 200 p,M. The 
amount of template was 1 u.1 of the DNA extracted from fecal 
isolates or 1 u,l of an appropriate dilution of the DNA ex-
tracted from pure cultures. The amount of Taq DNA polymer-
ase used was 2.0 U in a total reaction volume of 100 u,l. A Gene 
Amp PCR System 9600 apparatus (Perkin-Elmer Cetus, Nor-
walk, Conn.) was used for PCR cycling. Initial denaturation 
was carried out at 94°C for 5 min followed by a touch-down 
thermocycling program with 30 amplification cycles (annealing 
for 30 s at 62°C in cycles 1 to 10, at 60°C in cycles 11 to 20, and 
at 58°C in cycles 21 to 30, with extension for 1 min at 72°C and 
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FIG. 1. Fecal counts of lactic acid bacteria (•) and L. rhamnosus GG-like 
colonies (A). The solid line shows the mean counts of lactic acid bacteria, and the 
dashed line shows the mean counts of strain GG. In this context, lactic acid 
bacteria are defined as colonies growing on MRS agar without further taxonomic 
characterization, with the exception of GG-like colonics. The end of L. rham-
nosus GG administration is marked by a vertical arrow below the horizontal axis. 
denaturation for 40 s at 94°C) and a final extension for 10 min 
at 72°C. Reaction mixtures were subsequently cooled to 4°C. In 
the PCR with universal primers, the annealing temperature 
was 55°C. 
The specificity of the L. rhamnosus primers was confirmed 
with 8 different L. rhamnosus strains and 17 other lactobacillar 
species or strains as references (data not shown). To exclude 
the possibility of DNA extraction failure or the presence of 
inhibitors in samples, reference strains were subjected to 
PCR with universal primers prior to PCR with specific prim-
ers. 
L. rhamnosus GG-like colonies in biopsy and fecal sam-
ples of different test groups. The counts of total fecal lactic 
acid bacteria and strain GG-like colonies in the three ex-
perimental groups are presented in Fig. 1. The results of 
PCR (Fig. 2) were in good agreement (88%) with screening 
based on colony morphology and the lactose fermentation 
test, confirming the general reliability of identification of the 
strain. The counts of strain GG-like colonies decreased as a 
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2 3 4 5 6 7 8 9 10 II 12 13 14 15 16 17 18 1920 21 TABLE 2. Counts of L. rhamnosus GG-like colonies in biopsy 
specimens and final fecal samples in group B 
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FIG. 2. Detection of/., rhamnosus by PCR coupled with gel electrophoresis. 
Lanes: 1, molecular weight marker; 2 through 19, strain GG-like findings from 
fecal samples; 20, positive control (L rhamnosus GG VTT E-96666); 21, control 
reaction with no template DNA. 
function of time after discontinuation of GG administration. 
Strain GG was detected in biopsy specimens and final fecal 
samples of all volunteers in group A (Table 1). The counts 
of lactic acid bacteria in biopsy samples were 3 x 102 to 4 x 
104 CFU per biopsy (mean, 6 x 103 CFU per biopsy). The 
corresponding counts of strain GG-like colonies were 6 x 
101 to 4 x 104 CFU per biopsy. 
In group B, L. rhamnosus GG-like colonies were detected in 
seven of eight biopsy samples (Tables 1 and 2), with counts 
varying between 2 x 103 and 1 x 106 CFU per biopsy. The 
total counts of lactic acid bacteria were 3 x 103 to 2 x 106 CFU 
per biopsy (mean, 1 x 105 CFU per biopsy). Only two of the 
eight subjects, however, had strain GG-like colonies at detect-
able levels in the final fecal samples; these counts were 6 x 103 
and 5 x 105 CFU/g (wet weight). The individual counts of 
GG-like colonies in the biopsies and final fecal samples of the 
group B volunteers are presented in Table 2. 
None of the seven subjects in group C had strain GG-like 
colonies in the final fecal samples (Table 1). However, GG-like 
colonies were detected in the biopsy samples of two of the 
seven volunteers at counts of 1 x 102 and 1 x 104 CFU per 
biopsy. The total counts of lactic acid bacteria in biopsies of 
group C were 6 x 102 to 2 x 105 CFU per biopsy (mean, 2 x 
104 CFU per biopsy). 
L. rhamnosus GG has been shown to adhere in vitro to the 
Caco-2 intestinal cell line (2) and in vivo to human colonic 
mucosae (1). The finding reported here that strain GG can 
persist in colonic mucosae even after its disappearance from 
fecal samples may have significance in the elucidation of the 
colonization mechanisms of probiotic strains. The fact that the 
strain GG counts observed in the biopsy samples from group B 
are rather similar to those obtained from group A is particu-
larly interesting, since it indicates that GG can survive in high 
TABLE 1. Recovery of L. rhamnosus GG from colonic biopsy 
samples and final fecal samples" 
No. of subjects with the indicated characteristics/ 
Group Day of 
colonoscopy 
total 
no. of subjects 
Both biopsy 
and feces 
positive 
Biopsy 
positive, 
feces 
negative 
Biopsy 
negative, 
feces 
positive 
Both biopsy 
and feces 
negative 
A 
B 
C 
14 
21 
28 
6/6 
2/8 
0/7 
0/6 
5/8 
2/7 
0/6 
0/8 
0/7 
0/6 
1/8 
5/7 
Volunteer 
1 
2 
3 
4 
5 
6 
7 
8 
Strain GG-like colony count in: 
Biopsy 
(CFU/biopsy)" 
1.0 X 106 
7.8 x 104 
4.6 X 10s 
2.5 X 103 
2.2 X 103 
6.3 X 103 
1.0 X 104 
Final fecal sample 
(CFU/g [wet weight])'' 
-
_ 
6.0 X 103 
— 
_ 
— 
6.0 x 105 
" Final fecal samples were obtained a day before evacuation and 2 days before 
colonoscopy. 
" Detection level, 102 CFU per biopsy. Biopsies were performed on day 21. 
* Detection level, 103 CFU/g |wct weight]. Final fecal samples were obtained 
on day 18 or 19. 
c
 —, below detection level. 
numbers in colonic mucosae despite its rapid turnover. This 
finding suggests that L. rhamnosus GG can multiply on the 
colonic surface at a rate that partially counterbalances its shed-
ding. However, as can be seen from the results from group C, 
even an adherent strain can be gradually diluted out of the 
colon unless it is replenished with a fresh inoculum. The high 
counts of endogenous lactic acid bacteria associated with co-
lonic biopsies mean that the probiotic strain faces strong com-
petition when establishing itself. This may well be one of the 
reasons that permanent colonization by a probiotic strain sel-
dom, if ever, occurs. 
The present study confirms that L. rhamnosus GG is able to 
attach in vivo to colonic mucosae and to persist there for 
prolonged periods after discontinuation of administration of 
strain GG. In accounting for the findings reported here, the 
study of fecal samples alone may underestimate colonization 
by probiotic strains. 
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Summary 
A culture-independent approach based on genus-specific PCR and denaturing gradient gel electrophore-
sis (DGGE) was used to monitor qualitative changes in fecal bifidobacterial communities in a human 
feeding trial. DNA was extracted direcdy from feces and bifidobacterial 16S rDNA sequences were am-
plified using genus-specific PCR. The PCR fragments were subsequently separated in a sequence-specific 
manner by DGGE in order to obtain a profile of bifidobacterial fragments. The DGGE profiles revealed 
that in general, administration for two weeks of galactooligosaccharide and/or Bifidobacterium lactis 
Bb-12 (8 g and 3 x 1010 cfu per day, respectively) did not affect the qualitative composition of the indige-
nous Bifidobacterium population, while B. lactis Bb-12 transiently colonised the gut. 
Key words: PCR - DGGE - Bifidobacterium spp. - probiotic - prebiotic - feeding trial 
Introduction 
It is generally recognised that the extremely complex 
and numerous intestinal microbiota has an impact on the 
hosts health and well-being. Bifidobacteria and lacto-
bacilli are assumed to be beneficial to the human host 
(BALLONGUE, 1998; OUWEHAND et al., 1999). This poten-
tially beneficial microbiota can be fortified by the inges-
tion of probiotics, prebiotics or synbiotics (COLLINS and 
GIBSON, 1999; FOOKS et al., 1999). Probiotics are viable 
microorganisms that exhibit a positive effect on the 
health of the host when they are ingested (SALMINEN et 
al., 1998). Prebiotics can be defined as non-digestible 
food ingredients that beneficially affect the host by selec-
tively stimulating the growth and/or activity of one or a 
limited number of bacterial species already resident in the 
colon, and thus attempt to improve host health (GIBSON 
and ROBERFROID, 1995). Prebiotics include carbohydrates 
such as inulin, fructo-oligosaccharides (FOS) and galac-
toligosaccharide (GOS) (COLLINS and GIBSON, 1999). 
Synbiotics are products that consist of both probiotics 
and prebiotics. 
The effect of probiotics and prebiotics on the composi-
tion of the gut microbiota is commonly followed by enu-
meration of various bacterial groups by selective plating 
techniques. More recently, also fluorescent in situ hy-
bridisation (FISH) techniques with specific probes for dif-
ferent phylogenetic groups have been used to monitor 
changes in bacterial numbers (HARMSEN et al., 2000; 
TANNOCK et al., 2000). Moreover, various molecular bio-
logical techniques have been developed to facilitate the 
identification of colonies of probiotic strains and to fol-
low the fate of ingested probiotics through the gastroin-
testinal tract (ALANDER et al., 1999; BRIGIDI et al., 2000; 
BUNTE et al., 2000; KULLEN et al., 1997; O'SULLIVAN and 
KULLEN, 1998; TANNOCK et al„ 2000; VAUGHAN et al., 
2000). Recently, we described a new method based on 
genus-specific PCR and denaturing gradient gel elec-
trophoresis (DGGE) for the qualitative analysis of bifi-
dobacterial populations in human feces (SATOKARI et al., 
2001). DNA is extracted directly from feces without 
prior cultivation and used as template in Bifidobacterium 
genus-specific PCR. The PCR products of bifidobacterial 
16S rDNA sequences are subsequently resolved in a se-
quence specific manner by DGGE and a characteristic 
profile of DNA-amplicons is obtained. Thus, the bifi-
dobacterial community in feces can be monitored by a 
single PCR reaction. 
0723-2020/01/24/02-227 $ 15.00/0 
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The aim of this study was to investigate the effect of 
the administration of galactooligosaccharide and/or the 
probiotic strain Bifidobacterium lactis Bb-12 (OUWEHAND 
et al., 1999) on the qualitative composition of indigenous 
Bifidobacterium population using genus-specific PCR 
combined with DGGE. 
Materials and Methods 
Volunteers and prebiotic and probiotic administration 
The feeding trial is described in detail by ALANDER et al. 
(ALANDER et al.. sin press). Briefly, 30 healthy Finnish adult vol-
unteers (27 women. 3 men, mean age 32 years) participated in the 
study. They were randomly divided into three groups and volun-
teers of each group consumed Elix'or, a commercial food-grade 
syrup containing 60% galactooligosaccharide (GOS). 20% lac-
tose. 19% glucose, 1% galactose in 75% dry matter (Borculo 
Whey Products Ltd.. Borculo, The Netherlands) (group 1), probi-
otic bacteria Bifidobacterium lactis strain Bb-12 (Christian 
Hansen Ltd., Harsholm, Denmark) (group 2) or a combination of 
these two (group 3). The study period was six weeks consisting of 
two weeks pre-feeding period, two weeks feeding period, and two 
weeks post-feeding period. During the pre-feeding period the vol-
unteers consumed 125 ml of yoghurt twice a day and during the 
feeding-period 18 g Elix'or (8.1 g GOS per day) or freeze-dried 
Bb-12 (approximately 3 x 10'° cfu per day) or both were added to 
the yoghurt. During the post-feeding trial the volunteers had their 
normal diet. The volunteers were requested to reject products 
containing other probiotics or bifidobacteria during the study pe-
riod but to retain otherwise a normal diet. Two volunteers from 
group 1 interrupted the study, one because of an antibiotic treat-
ment and the other because of abdominal discomfort during the 
feeding period. Otherwise the products were well tolerated. 
Fecal samples and DNA extraction 
Fecal samples were collected at the end of the pre-feeding 
(sample 0) and feeding (sample 2) periods, and one and two 
weeks after the end of the administration (samples 3 and 4, re-
spectively). Fecal samples from one volunteer in group 1 and 
one volunteer from group 2 could not be provided for this study, 
because the samples were first used for cultivation and not 
enough feces remained for DGGE analysis. Hence, fecal samples 
from 7 volunteers of group 1 (1-1 to 1-7), 10 volunteers of 
group 2 (2-1 to 2-10) and 9 volunteers of group 3 (3-1 to 3-9) 
were analysed in this study. DNA was extracted from fecal sam-
ples preserved at -70 °C essentially as described previously 
(ZOETENDAL et al.. 1998). 
PCR amplification and DGGE analysis 
The qualitative analysis of intestinal bifidobacteria was carried 
out using PCR with primers Bifl64-f and Bif662-GC-r (5' to 3' 
GGGTGGTAATGCCGGATG and CGCCCGCCGCGCGCG-
GCGGGCGGGGCGGGGGCACGGGGGG-CCACCGTTA-
CACCGGGAA, respectively) combined with DGGE as de-
scribed previously (SATOKARI et al., 2001). The primers amplify 
an approximately 520 bp sequence of the 16S rDNA of bifi-
dobacteria and show perfect match to the 16S rDNA sequences 
of all Bifidobacterium species found in the human intestine with 
the exception of B. gallicum, which has one base mismatch in 
the primer region. However, B. gallicum can be considered as an 
extremely rare intestinal species, since the type strain remains 
the only isolate described from human feces (LAUER, 1990). 
The primer Bif 164-f has one nucleotide mismatch to the 16S 
rDNA sequence of B. lactis, which is not considered to be a 
human intestinal species. In order to detect the probiotic strain 
B. lactis Bb 12. the forward primer was modified by one nu-
cleotide (Bifl64-mod-f. 5' to 3' GGGTGGTAATACCGGATG) 
to precisely match the B. lactis target sequence and to amplify 
the 16S rDNA fragment from this species more efficiently. PCR 
reaction conditions and thermocycling program with primers 
Bif 164-f and Bif662-GC-r were described previously (SATOKARI 
et al.. 2001). The same reaction conditions were used with 
primers Bifl64-mod-f and Bif662-GC-r, but the annealing tem-
perature was set at 58 °C. PCR products were resolved by DGGE 
(denaturing gradient of 45 - 55%, where 100% corresponds to 7 
M urea and 40% formamide) (SATOKARI et al.. 2001) and visu-
alised by AgNO, staining (SANGUINETTI et al., 1994). 
Sequence analysis 
The PCR products were cloned in E. coli JM109 by using the 
pGEM-T vector system (Promega, Madison, Wis.) and se-
quenced using the Sequenase sequencing kit (Amersham, 
Slough, United Kingdom) according to manufacturer's instruc-
tions. The sequences were analyzed with automatic LI-COR 
DNA sequencer 4000L (Lincoln, Nebr.) and corrected manually. 
Homology searches, similarity comparisons, and sequence align-
ments were carried out using BCM services available in the in-
ternet (http://www.hgsc.bcm.tmc.edu/SearchLauncher/) or 
DNASTAR program (Madison. Wis). The sequences of the 16S 
rDNA clones of fecal bifidobacteria were deposited in the Gen-
Bank database and have been assigned accession numbers (clone 
code in parenthesis): AY013814 (1-2A); AY013815 (1-2B), 
AY013816 (3-3A), AY013817 (3-4A), AY013818 (3-4B), 
AY013819 (2-3A), and AY013820 (1-5A). 
Results and Discussion 
The effect of Elix'or and/or Bb-12 administration on 
the bifidobacteria! communities 
In the feeding trial most changes in the bifidobacterial 
populations were expected to occur during the period from 
pre-feeding (0-sample) to the end of the feeding (2-sample) 
and, therefore, we first analysed the 0- and 2-samples from 
all volunteers. The 16S rDNA of intestinal bifidobacteria 
was amplified using primers Bif 164-f and Bif662-GC-r. 
PCR products and profiles of bifidobacterial sequences in 
DGGE were obtained from all fecal samples 0 and 2 and 
compared (Table 1). Most volunteers showed no changes in 
the fecal bifidobacterial DGGE profiles between samples 0 
and 2 (Table 1), and in these cases the follow-up samples 3 
and 4 were not analysed. However, five volunteers out of 
26 showed a change in fecal bifidobacterial DGGE profiles 
(Table 1) and these are presented in Fig. 1 together with six 
other volunteers where no changes occurred. There was no 
correlation between the change in the bifidobacterial count 
(MINNA ALANDER, personal communication) and the occur-
rence of qualitative changes in the bifidobacterial DGGE 
profile i.e. volunteers with DGGE profile changes did not 
have any greater differences in their bifidobacterial counts 
compared to the other volunteers (data not shown). Three 
volunteers (Fig. 1; 1-2, 3-3 and 3-4) who consumed Elix'or 
either alone or together with Bb-12 showed a change in the 
relative intensity of the amplicons in the profile. Further 
analysis of the follow-up samples 3 and 4 from these volun-
teers revealed that the profiles reverted to resemble the 
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Table 1. Changes in the bifidobacteria! DGGE profile (other than the appearance of the Bb-12 amplicon) between fecal samples 0 
and 2 (before and after the administration, respectively) 
Group 1 (Elix'or) 
Volunteer 
l - l 1 
1-22 
1-3 
1-4 
1-52 
1-6 
1-7 
DGGE profile 
_ 
#<-
= 
= 
+2-> 
= 
= 
Group 2 (Bb-12) 
Volunteer 
2-1 
2-2 
2-31-2 
2-4 
2-5 
2-6 
2-7 ' 
2-8 
2-9 
2-10 
DGGE profile 
= 
= 
+2-> 
= 
= 
= 
= 
= 
= 
= 
Group 3 (Elix'or 
Volunteer 
3-1 
3-2 
3-32 
3-42 
3-5 
3-6 
3-7 
3-8 
3-9 
+Bb-12) 
DGGE profile 
= 
= 
#<-
#«-
= 
= 
= 
= 
= 
1
 male volunteer 
2
 also fecal samples 3 and 4 (one and two weeks after the end of the administration, respectively) were analysed 
= no change in the DGGE profile 
# change in the relative intensity of amplicons in the DGGE profile 
+ appearance of a number of amplicons in the DGGE profile 
<— or —> profile of the follow-up samples 3 and 4 reverted («—) or not reverted (—») to resemble the profile of 0-sample 
1-2 
0 2 
IP 
1-3 
0 2 
1-4 1-5 
0 2 0 2 
2-1 2-2 2-3 
0 2 0 2 0 2 
3-1 3-2 
0 2 0 2 
3-3 
0 2 
3-4 
0 2 
f f * * « 
•
'mm 
Fig 1. DGGE profiles of fecal bifidobacteria obtained by using primers Bifl64-f and Bif662-GC-r from eleven volunteers (1-2 to 
3-4, for test groups see Table 1) before (0) and after (2) the administration of Elix'or and/or Bb-12. Indications with letters A and B 
refer to the corresponding clones in Table 2. Unidentified changes are indicated with arrowheads (<). 
original one (sample 0) after the end of the administration 
(data not shown). In two other cases (Fig.l; 1-5 and 2-3) 
new amplicons appeared in the profile and these did not 
disappear in the following samples 3 and 4, but remained 
present even after the end of the administration. The five 
amplicons that showed intensity changes and the two new 
amplicons appearing in the profiles were cloned and se-
quenced. The other newly emerging amplicons or ampli-
cons with altered intensity could not be retrieved from the 
clone library with a reasonable screening because they were 
present in very low numbers, and hence, were not se-
quenced. Similarity comparison with sequences in the 
databases revealed that the sequenced 16S rDNA ampli-
cons were derived from different Bifidobacterium species 
(Table 2). This result and the unchanging profiles of most 
volunteers indicated that Elix'or and/or Bb-12 did not se-
lectively promote or suppress any particular Bifidobacteri-
um species in the intestine. 
Detection of the ingested probiotic strain B. lactis 
Bb-12 
Bb-12 did not show up as a new amplicon in the bifi-
dobacteria! profiles produced with primers Bifl64-f and 
Bif662-GC-r. B. lactis (GenBank accession number 
X89513) has one nucleotide mismatch to the Bifl64-f 
primer sequence which is likely to have caused weaker 
amplification from Bb-12 compared to the intestinal 
species of bifidobacteria. Consequently, Bb-12 was not 
detected in the bifidobacterial profiles, although it was 
found to be present in relatively high numbers in the feces 
of the volunteers compared to the indigenous bifidobacte-
ria (ALANDER et al., in press). Therefore, a modified for-
ward primer (Bif 164-f-mod) was used to monitor the 
presence of Bb-12 in the fecal samples from volunteers of 
groups 2 and 3. In order to identify the amplicon corre-
sponding to Bb-12 in the fecal samples a PCR product 
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Table 2. Identification of amplicons in the fecal DGGE profiles by sequencing 
Volunteer 
1-2 
1-2 
3-3 
3-4 
3-4 
2-3 
1-5 
Clone 
1-2A 
1-2B 
3-3A 
3-4A 
3-4B 
2-3A 
1-5A 
Change 
4. 
T 
T 
4. 
T 
+ 
+ 
Sequence (bp) 
479 
480 
478 
475 
481 
483 
478 
No-N 
1 
0 
0 
7 
8 
10 
3 
%-N 
0.2 
0 
0 
1.5 
1.7 
2.1 
0.6 
% similarity to ' 
99.6 B. adolescentis 
97.9 B. ruminantium 
99.6 B. angulation 
98.1 B.infantis 
97.1 B. adolescentis 
96.9 B. adolescentis 
99.0 B. pseudocatenulatum 
N ambiguous bases 
"^similarity from a pair-wise comparison 
4 and T decreasing and increasing intensity in the DGGE profile from 0-sample to 2-sample 
+ appearing amplicon in the DGGE profile 
3-4 3-8 
2 3 4 BM? 0 2 3 4 
•
Ml i t i aut 
^ ^ ^ K ream: ^ ^ ^ ^ 
^ ^ ^ ? ^ ^ ^ B ^^^W 
«n* WM 
| g i i 
Fig. 2. Detection of B. lactis Bb-12 using primers Bif 164-mod-f 
and Bif662-GC-r from the fecal samples of two volunteers (3-4 
and 3-8) before (0) and after (2) two weeks administration of 
Elix'or and Bb-12, and one (3) and two (4) weeks after the end 
of the administration. 
from Bb-12 was run alongside the fecal samples in DGGE 
(Fig. 2). One volunteer (2-1) was found to contain Bb-12-
like bifidobacteria (amplicon in the same position in 
DGGE) in the feces before the feeding period, whereas all 
other volunteers of groups 2 and 3 were found to be Bb-
12 negative in pre-feeding samples. A PCR amplicon cor-
responding to Bb-12 was detected in the fecal samples of 
all volunteers from groups 2 and 3 after two weeks of Bb-
12 administration. All volunteers were again Bb-12 nega-
tive after one week after the end of the administration 
(sample 3), with the exception of one volunteer (2-10), 
who had the Bb-12 like amplicon in the 3-sample, but not 
in the 4-sample taken one week later. A Bb-12-like se-
quence was detected in the pre-feeding fecal sample of 
volunteer 2-1. Food products containing Bb-12 are on the 
market in Finland and volunteer 2-1 could have con-
sumed a Bb-12 containing product previously, which had 
led to a long-term colonisation. Another explanation is 
that she accidentally consumed Bb-12-containing yoghurt 
already during the pre-feeding period. The latter explana-
tion is more likely, since the subsequent fecal samples 
taken one and two weeks after the end of the administra-
tion were again Bb-12 negative. 
In the present study, DGGE was found to be a conve-
nient tool for large scale monitoring of fecal samples for 
qualitative changes in bifidobacterial communities, since 
the 16S rDNA sequence diversity of the whole target pop-
ulation could be monitored by a single PCR reaction. 
More detailed characterisation of the shifts in popula-
tions could be done by subsequent cloning and sequenc-
ing of the DNA amplicons as illustrated here for the most 
conspicuous alterations (Table 2). 
The administration of Elix'or alone or in combination 
with B. lactis Bb-12 did not affect the qualitative compo-
sition of indigenous Bifidobacterium populations, al-
though Bb-12 transiently colonised the gut. ALANDER et 
al. (ALANDER et al., in press) analysed the same feeding 
trial material using selective plating for the quantification 
of bifidobacteria and observed a significant increase in bi-
fidobacterial numbers in both group 2 (Bb-12 alone) and 
group 3 (Elix'or and Bb-12). In group 1 (Elix'or alone) a 
slight increase was observed in the bifidobacterial counts, 
but this was statistically not significant. Although intesti-
nal species of bifidobacteria generally utilise GOS in vitro 
(HOPKINS et al., 1998), it seems that no significant quan-
titative (ALANDER et al., in press; ALLES et al., 1999) or 
qualitative changes can be introduced to the intestinal Bi-
fidobacterium population of healthy adult volunteers by 
the ingestion of GOS-containing Elix'or. 
In previous trials it has been demonstrated that the 
consumption of significant amounts of probiotics have 
none or little effect on the dominant microbial communi-
ties of adults (VAUGHAN et al., 1999) which are very sta-
ble over time (ZOETENDAL, et al., 1998). Fecal bifidobac-
terial communities have also been shown to be relatively 
stable in most adults for a time period comparable to or 
longer than in this feeding trial (MCCARTNEY et al., 1996; 
MANGIN et al., 1999; SATOKARI et al., 2001). This is con-
firmed by the present study that shows fecal bifidobacte-
rial communities to be unaffected by the passage of the 
probiotic strain Bb-12. 
According to the DGGE analysis the simultaneous ad-
ministration of Elix'or with Bb-12 (a synbiotic approach) 
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did no t pro long the persistence of the probiot ic strain in 
the gut, which is in agreement wi th the results obta ined 
by A L A N D E R et al. Similar results were obta ined in a pre-
vious synbiotic trial in which inulin w a s not found t o im-
prove the colonisat ion of an exogenous Bifidobacterium 
sp. in the h u m a n gut (BOUHNIK et al. , 1996). 
In conclusion, molecular monitor ing by a combinat ion 
of genus-specific 16S r D N A PCR and D G G E allow the 
qualitative analysis of fecal microbiota, in part icular the 
screening of diversity and changes in the communi ty struc-
ture. T h e method has a high th roughput enabling the anal-
ysis of large numbers of fecal samples in feeding trials. 
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Chapter 6 
Diversity of Bifidobacterium and Lactobacillus spp. 
in breast-fed and formula-fed infants as assessed 
by 16S rDNA sequence differences 
Modified version of this chapter has been submitted for publication. 
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Abstract 
A qualitative molecular monitoring approach based on PCR and denaturing 
gradient gel electrophoresis (DGGE) was used to study the diversity of dominant 
bacteria, bifidobacteria and lactobacilli in vaginally delivered full-term infants. 
Seven breast-fed and six formula-fed infants participated in the study. 16S 
rDNA targeted primers were used for the specific PCR amplification of 
fragments from bacteria, bifidobacteria and lactobacilli from faecal samples that 
were collected before and after weaning at the age of approximately one and 
seven months, respectively. The PCR fragments were subsequently resolved in a 
sequence-dependent manner by DGGE. In addition, cloning and sequence 
analysis of the PCR fragments was used to identify the species from which they 
originated. Based on the number of fragments in the DGGE profiles it was 
estimated that breast-fed and formula-fed infants harboured bacterial 
communities of equal complexity. There was no conspicuous difference in the 
distribution of Bifidobacterium or Lactobacillus species between breast-fed and 
formula-fed infants. The most frequently found representatives of these genera 
were B. infantis and species belonging to the L. acidophilus -group in both 
groups of infants. The predominant Bifidobacterium and Lactobacillus 
populations in most infants consisted of only one or two species. 
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Introduction 
Microbial colonisation of the human Gl-tract starts at birth when the newborn 
infant comes in contact with the microbes from the mother and surrounding 
environment. Colonisation proceeds in several stages until a complex, diverse 
and stable microbiota resembling that of an adult is developed (6, 17). The first 
one to two weeks of life are considered as the initial period of bacterial 
colonisation, during which diverse bacteria transit through infants Gl-tract and 
can be found in the feces. Facultative anaerobic bacteria such as Escherichia coli 
and streptococci colonise the gut during this period. During the next stage 
anaerobic bacteria such bifidobacteria, Bacteroides and Clostridia are found in 
the feces of infants. In breast-fed infants bifidobacteria predominate, whereas in 
formula-fed infants a more diverse microbiota develops (6, 17). Once dietary 
supplementation begins, the difference in the faecal microbiota between breast-
fed and formula-fed infants disappears. The last stage represents the period of 
conversion to adult microbiota after the weaning is completed. Factors that 
influence the microbial succession and colonisation include both host-related 
(36) and external factors such as the mode of delivery (vaginal or caesarean), 
microbial load of the surrounding environment (hygienic conditions), type of 
feeding (breast- or formula-feeding) and possible antibiotic therapy of the infant 
(17,24). 
Early culture-based and microscopic investigations showed that 
bifidobacteria were the predominant microorganisms in feces of breast-fed 
infants but not in formula-fed infants (5, 32). However, several other culturing 
studies have shown that both groups of infants have equal frequency and level of 
bifidobacterial colonisation by the age of approximately one month or earlier (3, 
12, 16). Conflicting results have also been obtained regarding other groups of 
bacteria such as Bacteroides, Clostridia, enterococci, lactobacilli and 
enterobacteria in breast-fed and formula-fed infants. Culture-based studies have 
shown a more diverse microbiota in formula-fed infants in comparison to those 
breast-fed (1, 32). Moreover, in some studies formula-fed infants were found to 
have more complex faecal short-chain fatty acid (SCFA) profiles than breast-fed 
infants, which indicates a more complex microbiota in the aforementioned group 
(23, 30). In contrast, earlier studies based on cultivation showed no difference in 
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the composition of anaerobic and facultative anaerobic bacteria between breast-
fed and formula-fed infants (16, 31). 
New microbiological, biochemical and molecular biological methods for 
detection of different bacterial groups and species have been developed in order 
to describe the microbial communities more accurately (17, 35). Modern 
molecular ecology techniques based on direct detection and sequence 
comparison of nucleic acids (DNA or RNA) have been applied in numerous 
studies to characterise adult human Gl-tract microbiota (29, 33, 35), but only in 
a few to describe infant microbiota (7, 10). A widely used approach is to detect 
the target molecules 16S rDNA or rRNA by using fluorescent in situ 
hybridisation (FISH), dot blot hybridisation, and PCR-based techniques (10, 29, 
33, 35). Recently, culture-independent study based on FISH was reported that 
supported the predominance of bifidobacteria in breast-fed infants in comparison 
to formula-fed infants and suggested a more diverse microbiota in the latter 
group (10). 
Combination of PCR amplification of 16S rDNA and rRNA fragments 
with temperature or denaturing gradient gel electrophoresis (TGGE and DGGE, 
respectively) can be used to achieve sequence-specific separation of PCR-
fragments obtained from bacterial communities in gastrointestinal samples (26, 
37). This approach has been used to follow the colonisation of new-born infants 
in considerable detail (7). It is also possible to target separate genera or groups 
of bacteria with specific PCR primers in order to obtain DGGE community-
fingerprints of certain bacterial populations (11, 26). In this study we used a 
culture-independent molecular approach based on DGGE of 16S rDNA 
amplicons to compare the diversity of the microbiota in breast-fed and formula-
fed infants before and after weaning. Cloning and sequencing of 16S rDNA 
derived PCR fragments was used to identify the predominant Bifidobacterium 
and Lactobacillus species present in feces of breast-fed and formula-fed infants. 
Materials and methods 
Infants, faecal samples and DNA extraction. Thirteen vaginally delivered 
infants (seven breast-fed and six formula-fed) were recruited to the study (Table 
1). Two infants, S and D are Dutch, whereas all other infants are Scottish. All 
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infants were in general good health and were not treated with antibiotics during 
the sampling period. The weaning of infants (introduction of solid food) took 
place from weeks 12 to 21 after birth. The infants continued taking breast or 
formula milk (Milumil for infant 49 and Aptamil for all others, Milupa, GmbH 
& Co.KG, Friedrichdorf, Germany) after weaning during the whole sampling 
period with the exception of infants S and D from whom breast-milk was 
withdrawn at 1,5 and 6,5 months, respectively. Faecal samples were collected 
before and after weaning, at the age of approximately one month and seven 
months and kept frozen at -20 °C until the analysis. Isolation of DNA from 
faecal samples was performed as described elsewhere (37). 
Table 1. Infants and faecal samples. 
Code 
1 
2 
33 
40 
52 
S 
D 
Sex 
F 
M 
F 
M 
F 
F 
M 
Breast-fed 
Weaning age 
(weeks) 
15 
13 
21 
14 
12 
17 
19 
Sampling 
times (month) 
land 7 
1 and 8 
1 and 6 
1,5 and 8,5 
land 7 
land 7 
land 7 
Code 
9 
13 
24 
28 
49 
54 
Sex 
F 
F 
F 
F 
F 
F 
Formula-fed 
Weaning age 
(weeks) 
12 
12 
16 
14 
13 
12 
Sampling 
times (month) 
land 7 
land 7 
land 7 
l and7 
1 and 6 
3 weeks and 7 
Primers. All primers used in the study are targeted on the 16S rRNA gene 
(Table 2). Bacterial PCR products were produced with primers 968-GC-f and 
1401-r, Bifidobacterium genus-specific PCR was performed with primers 
Bifl64-f and Bif662-GC-r and a nested PCR with primer sets 7-f and 06771ab-r, 
followed by 124-GC-f and 515-r was used to detect lactobacilli and related 
bacteria. A 40 bp GC-clamp was attached to the 5' end of Bif662-GC-r, 124-
GC-f and 968-GC-f primers (see Table 2) in order to facilitate the analysis of the 
PCR products by DGGE. Primers T7 and Sp6 labelled with IRD800 were used 
for sequencing. All primers were purchased from MWG-Biotech (Ebersberg, 
Germany). 
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Table 2. Primers. 
Primer 
968-GC-f 
1401-r 
Bif-164-f 
Bif-662-GC-r 
7-f 
0677-lab 
124-GC-f 
515-r 
Sp6 
T7 
Sequence 5 'to 3' 
CGCCCGGGGCGCGCCCCGGGCGGGGCGGGGGCAC 
GGGGGG-AACGCOAAGAACCTTA 
CGGTGTGTACAAGACCC 
GGGTGGTAATGCCGGATG 
CGCCCGCCGCGCGCGGCGGGCGGGGCGGGGGCAC 
GGGGGG-CCACCGTTACACCGGGAA 
AGAGTTTGAT C/T A/C TGG CTCAG 
CACCGCTACACATGGAG 
CGCCGGGGGCGCGCCCCGGGCGGGGCGGGGGCAC 
GGGGGGCACGG-ATCCGGACGGGTGAGTAACACG 
ATCGTATTACCGCGGCTGCTGGCAC 
GATTTAGGTGACACTATAG 
TAATACGACTCACTATAGGG 
Use 
PCR 
PCR 
PCR 
PCR 
PCR 
PCR 
PCR/nested 
PCR/nested 
Sequencing 
Sequencing 
Target 
bacteria 
bacteria 
bifidobacteria 
bifidobacteria 
lactobacilli 
lactobacilli 
lactobacilli 
lactobacilli 
pGEM-T 
pGEM-T 
Ref 
13 
13 
14,26 
** 
11,13 
11 
11,13 
11,13 
Promega 
Promega 
PCR amplification. PCR reactions were performed as described previously (11, 
26, 37) using Taq DNA polymerase kit from Life Technologies (Gaithersburg, 
Md., US). The reaction mixture consisted of 20 mM Tris-HCl (pH 8.4), 50 mM 
KC1, 3 mM MgCl2, 0.2 mM dNTP, 0.2 uM of each primer, 1.25 U of Taq 
polymerase and 1 ul of appropriately diluted template DNA in a final volume of 
50 ul. The PCR thermocycling program with primers 968-GC-f and 1401-r was 
the following: 94 °C for 5 min; 35 cycles of 94 °C for 30 s, 56 °C for 20 s, 68 °C 
40 s; and 68 °C for 7 min. The reactions were subsequently cooled to 4 °C. The 
annealing temperature was set at 62 °C with primers Bifl64-f and Bif662-GC-r 
and at 66 °C with primers 7-f and 0677-lab-r. For the nested PCR, the 
Lactobacillus-like 7-f to 0677-lab-r PCR products were purified with the 
QIAquick PCR purification kit (Qiagen, Hilden, Germany) according to the 
manufacturer's instructions and eluted into 50 ul of milliQ water (autoclaved, 
sterile-filtrated and UV-treated). One microliter of the resulting eluent was used 
as a template in the subsequent PCR with primers 124-GC-f and 515-r and using 
the same thermocycling program as described above for primers 968-GC-f and 
1401-r. The size and amounts of PCR products were estimated by analysing 5 pi 
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samples by 1.2 % agarose gel (w/v) electrophoresis and ethidium bromide 
staining. 
DGGE analysis of PCR products. DGGE analysis of PCR amplicons was 
performed essentially as described previously (21, 22) using the DCode or 
DGENE System apparatus (BioRad, Hercules, CA, US). Polyacrylamide gels 
(8% w/v, acrylamide : bisacrylamide - 37.5 : 1) in 0.5 x TAE with a denaturing 
gradient were prepared with a gradient mixer and Econo-pump (BioRad). The 
following denaturing gradients were used: 40 to 50 % for bacterial, 45 to 60 % 
for bifidobacterial and 30 to 60 % for lactobacilli PCR products, respectively. A 
100 % denaturant corresponds to 7 M urea and 40 % (vol/vol) formamide. PCR 
amplicons were separated by electrophoresis at a constant voltage of 85 V and a 
temperature of 60 °C for 16 h. The DNA fragments were visualised by AgNC>3 
staining and developing as described previously (25). 
Analysis of the DGGE gels. DGGE gels were scanned at 400 dpi and analysed 
using the Molecular Analyst 1.12 software (BioRad). Similarity indexes of 
compared profiles were calculated from the densitometric curves of DGGE 
profiles by using the Pearsons product-moment correlation coefficient. For the 
assessment of the diversity of 16S rDNA sequences in DGGE, a manual check 
was performed to ensure that all fragments in a gel track were found by the 
software. The surface area of fragments was calculated and the fragments 
constituting less than 1% of the total surface area of all fragments were omitted 
from the account of fragments for the diversity assessment. Student's t-tests 
were used for the statistical analysis of the data. 
Cloning of the PCR products. The PCR products were purified with the 
QIAquick PCR purification kit (Qiagen, Hilden, Germany) according to 
manufacturer's instructions and cloned in E. coli JM109 by using the pGEM-T 
vector system (Promega, Madison, Wis., US). Colonies were picked and 
transferred into 20 ul of TE, boiled for 15 min to lyse the cells and the cell 
lysates were used to screen the transformants by the Bifidobacterium- or 
Lactobacillus- specific PCR followed by DGGE analysis. Clones for subsequent 
sequence analysis were selected according to the migration position of the clone 
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PCR fragment in DGGE in comparison to the fragments in the original sample 
DGGE profile. Plasmid DNA of selected transformants was isolated using 
QIAprep spin miniprep kit (Qiagen). 
Sequence analysis. Sequencing of the cloned PCR fragments was carried out 
using purified plasmid DNA and sequencing primers T7 and Sp6 
complementary to the adjacent sequences of the pGEM-T cloning site. 
Sequencing reactions were performed with the Sequenase sequencing kit 
(Amersham, Slough, United Kingdom) according to manufacturer's instructions. 
The sequences were analysed with automatic LI-COR DNA sequencer 4000L 
(Lincoln, Nebr., US) and corrected manually. Sequence alignment of the 
complementary strands was carried out using DNASTAR SeqMan program 
(Madison, Wis., US). Similarity searches of 16S rDNA sequences derived from 
faecal clones were performed using the BCM Nucleic acid sequence search 
service available on the internet (http://www.searchlauncher.bcm.tmc.edu). 
Results 
DGGE profiles of predominant bacterial communities 
In this study the diversity of the microbiota in breast-fed and formula-fed infants 
before and after weaning was compared. The faecal samples were collected at 
one and seven months of age. In order to assess the diversity and changes of the 
bacterial populations in the infant faecal samples, PCR fragments generated with 
primers 968-GC-f and 1401-r were analysed by DGGE (Fig. 1). Differences seen 
in the faecal DGGE profiles between the samples taken before and after weaning 
reflected changes occurring in the faecal microbiota. The changes varied in both 
groups of infants from a complete or almost complete change of the fragments in 
the profile (infants 24 and 33, Fig. 1) to appearance and disappearance of some 
fragments in the profile (infants 13 and 40, Fig. 1). The similarity indexes 
between the DGGE profiles of pre- and post-weaning samples from each infant 
were calculated. The similarity indexes of the breast-fed infants (mean 51.3; SD 
26.0) and the formula-fed infants (mean 46.2; SD 23.8) did not differ 
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significantly (P = 0.72) showing an equal extent of profile changes in both 
groups. 
In order to compare the relative diversity of the predominant bacterial 
populations in breast-fed and formula-fed infants, the numbers of predominant 
individual fragments in the DGGE profiles were compared. No significant 
difference was found in the number of fragments in the DGGE profiles between 
breast-fed and formula-fed infants at approximately one month or seven months 
of age (P values 0.98 and 0.95, respectively). These results suggest that the 
diversity in predominant species or strains do not differ significantly between the 
two groups of infants before or after weaning. 
The DGGE profiles from different infants had some fragments in common 
(Fig. 1). The uppermost fragment (a) in common to the infants was cloned and 
sequenced from the one month samples of infants 1, 9 and 13. The sequences of 
these fragments showed highest similarity (96 to 98 %) to that of Ruminococcus 
gnavus 16S rDNA sequence. The lowest fragments (c) from the one month 
samples of infants 9 and 13 were identified as Bifidobacterium spp. sequences 
(96 and 97 % similarity). The common fragment appearing in the middle part of 
the gel (b) was cloned and sequenced from the one month sample of infant 1 and 
it appeared to have originated from Escherichia coli (similarity 99 %). 
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BF BF FF FF 
M 1 2 33 40 M 52 S D 9 13 M 24 28 49 54 M 
<c 
B 
(<c 
Figure 1. Bacterial DGGE profiles of faecal samples from breast-fed (BF) and 
formula-fed (FF) infants at approximately one month (A) and seven months (B) 
of age. Lanes are marked with the code of the infant (see also Table 1). The lane 
containing the marker is indicated with M. Positions where fragments were 
found in the majority of samples are labelled with a, b and c, and marked with 
arrowheads. 
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Detection and identification of bifidobacteria 
In order to find out whether the changes detected in the dominant bacterial 
population were also reflected to the bifidobacteria! populations, the samples 
were analysed using genus-specific PCR combined to DGGE and cloning and 
sequencing of the specific PCR fragments. Bifidobacteria were detected in five 
out of seven breast-fed infants and in all six formula-fed infants at one month of 
age. At seven months of age bifidobacteria were detected in six out of seven 
breast-fed and five out of six formula-fed infants. One breast-fed infant (coded 
52) lacked bifidobacteria at both sampling times. The bifidobacterial DGGE 
profiles from all positive samples are shown in Fig. 2. Sequence-specific 
separation of the amplified bifidobacterial 16S rDNA fragments revealed that in 
most infants the predominant Bifidobacterium population consisted of one or 
two dominant species (Fig. 2). Comparison of bifidobacterial profiles before and 
after weaning was possible in the case of ten infants when PCR products were 
obtained from both one and seven month faecal samples. Three breast-fed (33, S 
and D; Fig. 2) and three formula-fed (9, 24 and 54; Fig. 2) infants showed no 
changes in their bifidobacterial profiles before and after weaning. Three infants 
(2, 13 and 28; Fig. 2) showed some changes in their Bifidobacterium DGGE 
profiles, whereas one infant (40; Fig. 2) showed a complete change in the 
composition of his Bifidobacterium population. Although the DGGE profiles of 
dominant bacterial populations changed in all infants during the weaning at least 
to some extent (Fig. 1), the specific bifidobacterial profiles remained unaltered 
in half of the infants (Fig. 2). 
The predominant Bifidobacterium species of most samples were identified 
by subsequent sequence analysis of the 16S rDNA PCR fragments. The PCR 
fragments were first cloned into E. coli and clones with an insert that produced a 
PCR fragment corresponding to a predominant fragment in the original DGGE 
profile of the faecal sample were selected for sequencing. Comparative sequence 
analysis with the databases revealed that all fragments had high similarity, (97 % 
or higher) to the 16S rDNA sequences of known Bifidobacterium species (Fig. 
2). Most of the sequenced fragments resembled typical infant Bifidobacterium 
species, such as B. infantis, B. bifidum, B. breve, and B. dentium. Four infants 
were also found to harbour B. pseudocatenulatum -like species, which is found 
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more typically in adults. In general, no prominent difference was found in the 
distribution of bifidobacterial species between breast-fed and formula-fed infants 
in the faecal samples from either one month or seven months. Based on 
sequencing of the PCR amplicons, B. infantis was the most frequently found 
species in both groups of infants (Fig 2). B. breve was detected in two of the 
breast-fed infants, but not in the formula-fed infants, and B. dentium was 
detected in one formula-fed infant. B. ruminantium, which is not considered to 
be a human-associated Bifidobacterium species was found in a faecal sample 
from one breast-fed infant. However, it remains debatable whether the amplified 
16S rDNA fragment derived from B. ruminantium or its closely related species 
B. dentium or B. adolescentis because an unequivocal species identification can 
not be obtained based only on the 16S rDNA sequence data. 
BF FF 
1* 2 2* 9 9* 13 13* 24 24* 28 28* 
ftfgr M , y 
BF FF BF 
33 33* 40 40* 49 54 54* D D* S S* 
1.8. infantis 98% 
2. 8. infantis 99 % 
3. B. pseudocatenulatum 98 % 
4.6. infantis 98 % 
5. a infantis 99 % 
6. a bffidum 97 % 
7. a infantis 98 % 
8. a pseudocatenulatum 99 % 
9. a Mtdum 99 % 
10. a infantis 99% 
11. S. pseudocatenulatum 99 % 
12. B. infantis 99% 
13. a pseudocatenulatum 99 % 
14. a /nfenffs 97% 
15. a infantis 99% 
16. a cte/rt/um 98 % 
17. B.biUdum 97% 
18. B./nfanft's 98% 
19.a«fitfum99% 
20. a Wfitfum 100 % 
21. S. ruminantium 98 % 
22. a infantis 98% 
23. a breve 97% 
24. B. infantis 99% 
25. B. infantis 99 % 
26. a breve 98 % 
27. a breve 99% 
28. a infantis 99 % 
29.8. pseudocatenulatum 99 % 
30. a pseudocatenulatum 100 % 
Figure 2. Bifidobacterial DGGE profiles of feces and PCR fragments identified 
by cloning and sequencing from breast-fed (BF) and formula-fed (FF) infants at 
approximately one month and seven months of age. Lanes are marked with the 
code of the infant (see also Table 1) and the approximate 7 month sample is 
indicated with an asterisk. 
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Detection and identification of lactobacilli 
Lactobacilli form a well-studied bacterial group and are found in variable but 
usually low numbers in infants (10,17). To analyse the effect of diet and time on 
the diversity of lactobacilli, a similar approach as for bifidobacteria was used 
consisting of a group-specific PCR combined to DGGE and cloning and 
sequencing of the specific PCR fragments (11). Lactobacilli were detected by 
PCR in eight of the thirteen infants, five breast-fed and three formula-fed (Fig. 
3). Subsequent DGGE analysis revealed that the predominant Lactobacillus 
population, like the predominant Bifidobacterium population, consisted of one or 
two dominant species or strains (Fig. 3). Lactobacillus-specific PCR products 
were obtained from both the one- and seven-month samples from four infants, 
28, 40, D and S (Fig. 3). In the two infants 28 and 40 (Fig. 3), the major 
Lactobacillus fragment in the one-month sample was replaced with another 
fragment in the seven-month sample. It is noteworthy, that for the same infants 
complete changes of the bifidobacterial DGGE profiles were observed (Fig 2). 
In the other two infants, D and S (Fig. 3), the Lactobacillus population appeared 
more stable; the same predominant fragment was present in both one and seven-
month samples, but also some fragments appeared or disappeared in the seven-
month sample as compared to the one-month sample. Infants D and S did not 
have any major changes in their Bifidobacterium DGGE profiles either. 
The most commonly detected Lactobacillus species was L. acidophilus 
(sensu lato). The species L. acidophilus, L. johnsonii and L. gasseri share 16S 
rDNA sequences with high similarity, thus, the PCR fragments with highest 
similarity to L. acidophilus may have originated from any of these three species. 
Other species found with the Lactobacillus-group specific are listed in Fig. 3. In 
general, the Lactobacillus-group primers had a good specificity for the target 
group, which includes Lactobacillus, Pediococcus, Weissella and Leuconostoc, 
but occasionally PCR fragments from other bacteria such as streptococci and 
enterococci were also amplified (Fig. 3). 
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BF FF BF FF 
31. L casei I paracasei 99 % 
32. Streptococcus pleomorphus 97 % 
33. L mucosae 99 % 
34. L. acidophilus 98 % 
35. L ruminus 97 % 
36. Leuconostoc mesenteroides 99 % 
37. L acidophilus 98 % 
38. L salivarius 98 % 
39. L pentosus /plantarum 98 % 
40. L acidophilus 97 % 
41. L. acidophilus 98 % 
42. Enterococcus avium 99 % 
43. L acidophilus 98 % 
44. L acidophilus 97 % 
45. L acidophilus 98 % 
46. L casei / paracasei 99 % 
Figure 3. Lactobacilli DGGE profiles of feces and PCR fragments identified by 
cloning and sequencing from breast-fed (BF) and formula-fed (FF) infants at 
approximately one and seven months of age. Lanes are marked with the code of 
the infant (see also Table 1) and the approximate 7 month sample is indicated 
with an asterisk. 
Discussion 
In this study the diversity of dominant bacteria was monitored by amplifying 
16S rDNA fragments from bacteria and subsequently separating the amplicons 
in a sequence-specific manner by DGGE. The abundance of fragments in DGGE 
profiles representing different 16S rDNA sequences reflects the bacterial species 
diversity. The diversity of fragments in DGGE profiles of 13 infants indicated 
that there was no significant difference in the complexity of the predominant 
bacterial community between breast-fed and formula-fed infants before or after 
weaning. Tannock (34) and Orrhage & Nord (24) compared the results from 
numerous original cultivation studies and concluded that differences in the 
infants' intestinal microbiota due to breast-feeding or formula-feeding are minor 
and apply mainly to Clostridia that are found more frequently and in higher 
numbers in formula-fed infants. The results of our molecular study are in 
agreement with this observation. This deviation from the original idea that 
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bifidobacteria are found mainly in breast-fed infants may be due to numerous 
factors. Firstly, the composition of infant formulae has been improved over the 
years (15, 34), which is likely to have led to a more breast-fed-like colonisation 
pattern in formula-fed infants. Secondly, delivery with few exposures to 
microbes due to the use of vaginal antiseptics at the time of birth or caesarean 
section can lead to an altered intestinal colonisation in infancy (8, 9,16). Finally, 
there are significant geographical differences in the composition of intestinal 
microbiota of infants (28, 31). It is noteworthy that a fragment in the DGGE 
profile may include different sequences with the same mobility and in some 
cases one species can produce more than one fragment in DGGE (26). 
Nevertheless, PCR-DGGE can give a reasonable indication on the bacterial 
diversity. 
Ruminococcus gnavus-like sequences corresponding to an upper dominant 
band in the DGGE profiles were detected in several of the faecal samples and 
appears to be one of the major species at least in some infants. This fragment 
was previously cloned and sequenced also from infant D and was tentatively 
identified to have derived from Ruminococcus gnavus (96 % similarity) (7). The 
use of alternative universal 16S rRNA primers with modification of the 
denaturing gradient resulted in different migration for some of the upper bands 
(data not shown) suggesting that species other than ruminococci may be 
responsible for some of these dominant bands. Occasionally, fragments from 
different species migrate to the same position in DGGE (26), so identity 
confirmation by cloning and sequencing or hybridisation is necessary. 
The changes in bacterial communities between one and seven months 
were comparable in both feeding groups. This disagrees with cultivation studies 
indicating that breast-fed infants have more intense shifts in their bacterial 
communities due to weaning (32). The intestinal microbiota in infants of both 
groups seem to undergo equally intense changes, at least at the level of bacterial 
species and strains. Interestingly, the bifidobacterial communities remained 
stable in many infants despite the weaning period. The Bifidobacterium species 
typically found in adults are different from those in infants (18). According to 
our results, the shifts in the species composition of the bifidobacterial 
populations do not occur directly in response to weaning, i.e., the species / strain 
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composition of the Bifidobacterium populations was not generally affected by 
the introduction of solid food to the infants diet. 
The colonisation frequency of infants by bifidobacteria, as detected by 
genus-specific PCR, was comparable in both feeding groups or even higher in 
the formula-fed group. This result is in contrast with the classical idea that 
breast-fed infants are more frequently colonised by bifidobacteria. Some of the 
faecal samples in this study have also been subjected to quantitative 16S rDNA 
dot blot analysis with specific probes for different bacterial groups or genera 
(27). The dot blot analysis confirmed our finding that not all breast-fed infants 
were colonised by bifidobacteria. Our results are in line with several studies that 
show equal, either high (3, 12) or low (9, 16, 31), frequency of bifidobacterial 
colonisation in both groups. Previous observations that the bifidobacterial 
populations of infants generally consist of one to three species (4, 18, 19) are 
confirmed by our findings. The most commonly found Bifidobacterium species 
in infants vary from one study to another (2, 3, 4, 18, 19). This may reflect 
divergent distribution of Bifidobacterium species in various geographical regions 
or ethnic groups. It can not be excluded that variation in the predominant species 
between different studies may also be due to differences in the identification 
procedures (phenotypic or genotypic methods). However, in most studies there 
was no difference in the species distribution between breast-fed and formula-fed 
babies (3, 4, 18). In this study, B. infantis was the most frequently found 
Bifidobacterium species in both feeding groups. Concerning lactobacilli, our 
molecular results support the findings of previous culture-based studies that L. 
acidophilus (sensu lato) is the most common Lactobacillus species in infants 
irrespective of the type of feeding (3, 20). 
In conclusion, PCR-DGGE is a useful method for comparison of the 
microbial diversity in individual samples and following shifts in populations in 
time. The possibilities for comprehensive analysis of intestinal microbiota can be 
further improved by developing of PCR-DGGE methods for other bacterial 
groups and by using the qualitative tools in combination with quantitative 
molecular tools such as FISH. 
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Chapter 7 
Summary and concluding remarks 
Summary and concluding remarks 
Bifidobacteria and lactobacilli are considered to be members of the beneficial 
microbiota in the human gastrointestinal (GI) -tract. Traditionally bifidobacteria 
and lactobacilli are detected in intestinal samples, most commonly faeces, by 
cultivation on selective nutrient media. Bifidobacteria are strictly anaerobic 
bacteria and anaerobic practise has to be followed for their cultivation, which 
hampers the sample collection and handling. In many cases phenotypic 
characterisation is not enough to identify Bifidobacterium and Lactobacillus 
strains at the species level. The studies described in this thesis involve the 
development and validation of new molecular methods for the detection and 
analysis of bifidobacteria and lactobacilli (Chapters 2, 3 and 4) and the 
application of new methodologies to trace ingested probiotic strains (Chapters 4 
and 5). The indigenous Bifidobacterium and Lactobacillus populations in the 
human intestine were also investigated using these techniques (Chapters 2, 5, 
and 6). 
Methodological considerations 
Molecular fingerprinting methods are highly discriminatory on the strain level, 
which allows a comprehensive diversity assessment of isolates recovered from 
cultivation plates. The main drawback of this approach to study the diversity is 
its labour-intensity. Chapter 2 describes the development and validation of a 
method based on genus-specific PCR of 16S rDNA and denaturing gradient gel 
electrophoresis (DGGE) for profiling Bifidobacterium populations in human 
faeces. The PCR-DGGE method is a qualitative tool for assessing species and/or 
strain composition of complex communities by a single PCR reaction and 
subsequent resolution of the amplification products by DGGE in a sequence-
dependent manner. The approach greatly facilitates the monitoring of faecal 
samples from large numbers of subjects to reveal bifidobacterial diversity and 
shifts occurring in it, either spontaneous or by introduction of an ingested 
probiotic strain to the ecosystem (Chapters 2, 5 and 6). The identification of 
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DGGE fragments can be done by subsequent cloning and sequencing of the PCR 
products, but ultimate species identification is hampered by the high similarity 
of 16S rDNA sequences between closely related Bifidobacterium species. 
The PCR-DGGE method revealed intragenomic 16S rDNA sequence 
heterogeneity in B. adolescentis E-981074T (Chapter 2). The strain was found 
to harbour five copies of 16S rDNA, two of which were sequenced and found to 
differ in eight positions over almost the total length of the gene. The sequenced 
copies showed highest similarity (>99 %) to each other over all the sequences 
available in the public databases and it was concluded that the variability 
resulted from mutations in one copy of the gene. The intragenomic 16S rDNA 
heterogeneity in bacteria seems to be rather exceptional, but nevertheless it has 
an important impact on the phylogeny of organisms and molecular studies that 
apply these sequences such as biodiversity estimates. The genetic diversity of 
rRNA sequences in an organism can cause identification problems, especially if 
the sequences differ greatly as a result of horizontal gene transfer (31). 
Therefore, definite species identification still rely on polyphasic taxonomy, 
which integrates phenotypic, genotypic, and phylogenetic information (30). 
The L. casei -group lactobacilli including L. casei, L. paracasei, L. 
rhamnosus, and L. zeae form an important group of intestinal lactobacilli and 
several strains of these species are used in probiotic preparations. The 
identification of L. casei -group lactobacilli is not reliable by phenotypic 
methods, which prompted the development of genotypic methods for their 
identification and characterisation (Chapter 3). Moreover, a L. rhamnosus 
species-specific PCR was developed and validated. Specific PCR primers are 
now available for all members of the L. casez-group and they provide a practical 
means, due to rapid and easy performance, for identifying species of this group. 
Species-specific PCRs and three genetic fingerprinting methods, pulsed 
field gel electrophoresis (PFGE), randomly amplified polymorphic DNA 
(RAPD) and ribotyping were used to identify and characterise 24 strains of the 
L. casei -group lactobacilli (Chapter 3). The obtained results supported the 
proposed new classification of the L. casei -group, namely the reclassification L. 
casei type strain (ATCC 393) as L. zeae and the rejection of L. paracasei and its 
inclusion in L. casei. Furthermore, the discriminatory power of the three 
fingerprinting techniques was compared. All three techniques were highly 
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effective in differentiating strains below the species level and they can be placed 
in the following order with respect to their discriminatory power: PFGE > 
ribotyping > RAPD. This finding is in agreement with several other studies that 
have compared two or more molecular methods for typing of lactobacilli (4, 11, 
18, 21, 23, 26, 27, 32). All aforementioned fingerprinting methods have higher 
discriminatory power than amplified ribosomal DNA restriction analysis 
(ARDRA). 
Molecular typing methods are accurate tools for assessing the genetic 
diversity in a population, tracing probiotic strains, and they can also be applied 
for identification purposes. The choice of a typing method depends on its 
application. For example in tracing of a probiotic strain in the Gl-tract good 
discrimination power and high throughput capacity are needed in order to screen 
a large number of isolates, whereas for species identification discrimination at 
the species level is adequate and the reproducibility of the technique should be 
emphasised. The identification of bacterial species by typing methods 
necessitates the construction of a fingerprint library of well-characterised and 
correctly identified strains and an appropriate image analysis system and 
software for the efficient comparison of fingerprints. The more discriminative 
the technique is, the greater the variety of fingerprints produced by strains of one 
species, and consequently larger numbers of strains are needed to construct a 
comprehensive identification library. 
The molecular techniques available today provide a powerful toolkit for a 
comprehensive analysis of different microbial groups in the Gl-tract. This is 
optimally achieved by combined use of different methods that complement each 
other. For example, cells labelled by fluorescent in situ hybridisation (FISH) can 
be enumerated using flow cytometry and simultaneously sorted and collected. 
Subsequent diversity screening is then possible by other methods such as PCR 
combined with DGGE or 16S rDNA sequence analysis. Further improvements in 
molecular monitoring of intestinal microbiota can be expected when new high-
throughput techniques such as DNA-microarray technology will become 
applicable for Gl-tract molecular ecology studies. 
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Survival of probiotic strains in the Gl-tract 
Newly developed molecular methods were used to trace ingested probiotic 
strains L. rhamnosus GG (LGG) and B. lactis Bbl2 in the Gl-tract. The identity 
of LGG colonies was verified using a species-specific PCR (Chapter 4) and 
Bbl2 was detected using the PCR-DGGE method modified for this purpose 
(Chapter 5). Both probiotic strains colonised the gut transiently and they were 
no longer detected in the faeces one week after the end of the administration in 
most subjects. The synbiotic approach with galactooligosaccharide (GOS) did 
not prolong the persistence of Bbl2. In the LGG trial biopsy samples were also 
examined. The study confirmed the in vivo attachment of LGG to human colonic 
mucosa (1), which correlates with the in vitro adherence of LGG to the Caco-2 
intestinal cell line (8). Furthermore, LGG was found to persist in colonic mucosa 
for one to two weeks after the end of the administration, i.e. longer than it could 
be detected in the faeces suggesting that the study of faecal samples alone may 
underestimate the persistence of a probiotic strain. 
Survival of the probiotic strain in the Gl-tract is usually a prerequisite for 
its functionality. Adhesion to intestinal epithelium is considered important for its 
persistence and certain probiotic functions such as immune stimulation (7). The 
comparison of the in vitro and in vivo properties of probiotic strains is relevant 
in order to evaluate the present in vitro screening procedures and to improve 
them further for a more rational selection of new probiotic strains (7). The 
successful introduction of exogenous bifidobacteria and lactobacilli into the Gl-
tract and their adhesion to the intestinal epithelium opens new possibilities for 
their use as vehicles to deliver therapeutically active compounds such as 
antigenic epitopes (vaccines) or enzymes to defined locations in the Gl-tract 
(28). Strains of lactic acid bacteria have already been genetically modified to 
express foreign antigens and successfully used to vaccinate mice (22). Likewise 
a genetically modified Lactococcus lactis strain has been used to deliver active 
interleukin-10 (IL-10) in the gut lumen of mice with inflammatory bowel disease 
(IBD). The therapeutic effect was comparable with the conventional treatment, 
but due to the local delivery lower amounts of IL-10 were required (29). In 
designing such treatments for humans and selecting strains for particular 
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applications prior knowledge about the preferential adhesion sites and the 
persistence of different strains in the gut may prove valuable. 
The effect of diet on indigenous Bifidobacterium and Lactobacillus 
populations 
In Chapter 5 qualitative changes in adult faecal Bifidobacterium populations in 
response to B. lactis Bbl2 and/or GOS administration were monitored using 
PCR-DGGE method. In most subjects two weeks administration of Bbl2 and/or 
GOS (3 x 1010 cfu and 8 g per day, respectively) did not affect the qualitative 
composition of indigenous bifidobacterial populations, while Bbl2 transiently 
colonised the gut. Previously, it was demonstrated that GOS administration (8 to 
14 g per day for at least two weeks) had no effect on the faecal counts of 
bifidobacteria (2, 3). It can be hypothesised that in general, the composition of 
the intestinal microbiota in healthy adult subjects is affected more by the host-
derived nutrients (mucin, dead epithelial cells) and other host factors (such as 
immune response) than the diet. Several observations support this possibility. 
Firstly, no major differences were found in the numbers of major microbial 
groups when people with different diets were compared by using cultivation (5, 
9). Secondly, molecular community fingerprinting revealed that the predominant 
faecal microbiota was stable in two healthy adult individuals with usual 
unrestricted diet over a six to seven months study period (34). Furthermore, 
molecular studies showed that the host genotype or/and colonisation history has 
more impact on the composition of the dominant bacterial community than diet 
or environment (33). Thus, in healthy adults the fully developed complex and 
diverse microbiota is not prone to notable fluctuations, and in general, the 
potential of probiotics and prebiotics to modulate the intestinal microbiota of 
healthy adults seems fairly marginal. It still remains speculative, whether even 
minor changes would have significant effect on the host health and whether 
probiotics could play a role in the prophylaxis of various illnesses (25). In 
summary, healthy adults are a group of choice to study the tolerance to 
prebiotics and probiotics and the survival and colonisation of probiotics, but it is 
difficult to prove the efficacy of pre- and probiotics (prevention of disorders) in 
this target population. 
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The intestinal microbiota in infants, elderly and people with different GI-
tract disorders such as IBD can be affected more readily in healthy adults. The 
administration of exogenous bifidobacteria resulted in an enormous increase of 
approximately four logarithmic units in the initially low faecal counts of 
bifidobacteria in patients with IBD, either ulcerative colitis or pouchitis (6). 
Many successful applications of probiotics as therapeutic agents to alleviate 
clinical symptoms of various disorders have been reported, but more clinical 
trials are still needed to confirm the efficacy (20, 24, 25). Another major task of 
probiotic research in future is to establish the mechanisms of action on how 
bifidobacteria and lactobacilli influence the human host. 
Chapter 6 describes a qualitative molecular analysis of the bacterial, 
bifidobacterial and lactobacilli populations in faeces of breast-fed and formula-
fed infants before and after weaning at approximately one and seven months of 
age. Genus and group-specific PCRs combined with DGGE and subsequent 
sequencing of the amplified 16S rDNA fragments revealed no difference in the 
prevalence or species distribution of Bifidobacterium and Lactobacillus between 
the two groups of infants. In general, DGGE patterns of 16S rDNA showed 
equal complexity of bacterial communities in breast-fed and formula-fed infants. 
Equally intensive changes occurred in the faecal microbiota in infants of both 
groups due to weaning. Human milk contains various bifidogenic factors (10) 
and bifidobacteria are thought to be the most characteristic microbial group in 
breast-fed infants. Our results showed that breast-feeding does not ensure, 
however, the development of bifidobacterial population, since bifidobacteria 
were not found in two of the seven breast-fed infants examined at the age of one 
month. On the other hand, current infant formulas (supplemented with 
bifidogenic factors) also support the growth of bifidobacteria. This and several 
other studies (13,14,19) emphasise the importance of other factors than the type 
of feeding in the microbial community development in infants. An overly 
hygienic life-style with few exposures to microbes or cesarean delivery can lead 
to an altered intestinal colonisation in infancy (13, 14, 19). The development of 
the microbial community likely proceeds through a complex regulatory network 
of host-microbe and microbe-microbe interactions dependent on intra- and 
interspecies communication systems in order to efficiently exploit and develop 
suitable nutrient sources (15). Studies with mice have shown that the host GI-
120 
tract during its development influences the microbiota, and vice versa, the 
microbiota has an impact on host tissue development (16). Thus, the introduction 
of each microbe into the Gl-tract or the absence of certain microbes may have 
consequences in the chain reaction of development of both the microbiota and 
the host. Indeed, the latest studies with human neonates suggest that the 
composition of the intestinal microbiota during infancy has a crucial role in the 
maturation of the immune system (12, 17). It is not well known how 
bifidobacterial and lactobacilli populations in particular influence the postnatal 
development, and whether healthy infants lacking bifidobacteria or lactobacilli 
would benefit from inoculation with probiotic preparations. 
In conclusion, new molecular techniques provide efficient tools to assess 
the composition and fluctuations in bifidobacterial and lactobacilli communities 
in the Gl-tract, which will facilitate a more comprehensive description of these 
bacterial groups in different human populations. This will give us a deeper 
understanding about the Gl-tract ecology of bifidobacteria and lactobacilli, and 
consequently, about the possibilities to modulate the intestinal microbiota to the 
benefit of host health. 
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Samenvatting 
De humane darm herbergt een diverse gemeenschap van talrijke micro-
organismen die algemeen wordt aangeduid als microbiota. Deze microbiota 
bestaat deels uit potentieel gevaarlijke en gunstige micro-organismen. 
Bifidobacterien en lactobacillen zijn leden van de darmmicrobiota, waarvan voor 
de mens een gunstige werking wordt veronderstelt. Van beiden wordt 
veronderstelt dat ze een gezonde, gebalanceerde microbiele gemeenschap in de 
darm in stand houden en dat daarnaast de totale lichamelijke gezondheid van de 
gastheer wordt gestimuleerd. De mogelijkheid dat lactobacillen en 
bifidobacterien gunstig zijn voor de mens heeft geleid tot pogingen hun aantallen 
in de darm te verhogen door het toedienen van levende bifidobacterien of 
lactobacillen (probiotica) of stoffen welke de groei bevorderen (prebiotica). 
Prebiotica zijn meestal koolwaterstoffen zoals inuline, fructo- en 
galactooligosacchariden. 
Van oudsher worden, door het gebruik van selectieve media, 
bifidobacterien en lactobacillen gedetecteerd in darmmonsters, veelal feces. 
Bifidobacterien zijn strikt anaeroob, waardoor het toepassen van anaerobe 
technieken noodzakelijk is voor cultivatie. Praktisch gezien bemoeilijkt dit het 
verzamelen en verwerken van dit soort monsters. De identificatie van 
Bifidobacterium en Lactobacillus stammen op soortniveau, is in hoge mate 
gebaseerd op fenotypische kenmerken zoals celmorfologie en suikerfermentatie 
eigenschappen. Vaak is dit echter niet voldoende voor een betrouwbare 
soortidentificatie. In de laatste jaren is een toenemend aantal moleculair-
biologische technieken ontwikkeld en toegepast voor de identificatie en 
differentiatie van geisoleerde Bifidobacterium en Lactobacillus stammen en de 
directe detectie, zonder cultivatie, van deze micro-organismen in fecale 
monsters. 
De studies welke beschreven staan in dit proefschrift hebben betrekking 
op de ontwikkeling en validatie van nieuwe moleculaire methoden voor 
bifidobacterien en lactobacillen (hoofdstuk 2, 3 en 4). Verder wordt beschreven 
hoe de nieuwe methoden is gebruikt om probiotische bacterien te volgen na 
inname (hoofdstuk 4 en 5) en de studie van endemische Bifidobacterium en 
Lactobacillus populaties in de humane darm (hoofdstuk 2, 5 en 6). 
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De microbiele diversiteit in een monster wordt vaak vastgesteld door een 
moleculaire vingerafdruk (fingerprint) te maken van kolonies die op een vast 
voedingmedium groeien, waarbij de arbeidsintensiviteit het grootste nadeel is. In 
hoofdstuk 2 wordt de ontwikkeling en validatie beschreven van een methode, 
welke een combinatie is van een genus-specifieke PCR op het 16S ribosomaal 
RNA (rDNA) gen en denaturerende gradient gel electroforese (DGGE). De 
PCR-DGGE techniek is een kwalitatieve methode waarmee, met een enkele 
PCR reactie en de scheiding van de ontstane amplicons op basepaar-
samenstelling door DGGE, de soort en/ of stamsamenstelling van een complexe 
gemeenschap vastgesteld kan worden. De methode werd gebruikt om de 
diversiteit binnen de groep van bifidobacterien in humane feces vast te stellen. 
Deze benadering vereenvoudigt de bestudering van de bifidobacteriele 
diversiteit en eventuele verschuivingen, welke spontaan voorkomen dan wel 
geinduceerd worden door de consumptie van probiotica (hoofdstuk 2, 5 en 6). 
Middels klonering en sequentie-analyse van DGGE fragmenten kunnen de 
ontstane DGGE patronen worden ge'identificeerd. Deze werkwijze wordt echter 
bemoeilijkt doordat binnen de groep van Bifidobacterium de sequentie-
overeenkomsten in het 16S rDNA groot zijn. 
De PCR-DGGE methode maakte duidelijk dat er intragenomische 16S 
rDNA sequentie-heterogeniteit bestaat in B. adolescentis E-981074T (hoofdstuk 
2). Het bleek dat in deze stam 5 kopieen van het 16S rDNA op het genoom 
aanwezig zijn. Van twee kopieen werd de sequentie bepaald en daaruit volgde 
dat er op 8 posities verschillen bestonden, die verspreid zijn over het gen. De 
kopieen vertoonde meer gelijkenis (>99%) met elkaar dan met alle andere 
sequenties aanwezig in de publieke databanken, en er werd geconcludeerd dat de 
variatie zijn oorsprong moest hebben gevonden in mutaties binnen een kopie van 
het gen. De intragenomische 16S rDNA heterogeniteit lijkt uitzonderlijk te zijn, 
maar zal zeker zijn weerslag hebben op de fylogenie van micro-organismen en 
de moleculaire studies die deze sequenties gebruiken voor een schatting van 
microbiele diversiteit. De genetische diversiteit van 16S rRNA sequenties in een 
organisme kan problemen veroorzaken op het vlak van de identificatie, zeker 
wanneer sequenties grote verschillen vertonen door bijvoorbeeld horizontale 
genoverdracht. Daarom moet worden gestreefd naar een polyfasische taxonomy, 
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waarin fenotypische, genotypische en fylogenetische informatie wordt 
geintegreerd. 
Het Lactobacillus cluster van L. casei (L. casei, L. paracasei, L. 
rhamnosus en L. zeae) vormen een belangrijke groep van darmlactobacillen en 
wordt gebruikt in probiotische preparaten. De identificatie van de L. casei-groep 
met de traditionele fenotypische methoden is niet betrouwbaar. Dit initieerde de 
ontwikkeling van genotypische methoden voor de identificatie en karakterisering 
van deze groep lactobacillen (hoofdstuk 3). De ontwikkeling en validatie van 
een L. rhamnosus soort-specifieke PCR is beschreven in dit proefschrift. 
Specifieke PCR primers zijn nu beschikbaar voor alle leden van de L. casei-
groep, en zijn door de snelle en praktische werkwijze eenvoudig toe te passen 
voor de identificatie van soorten binnen dit cluster van lactobacillen (hoofdstuk 
3). De soortspecifieke PCR's en drie genetische fingerprint methoden, pulsed 
field gel electrophoresis (PFGE), randomly amplified polymorphic DNA 
(RAPD) en ribotypering, werden gebruikt voor de identificatie en 
karakterisering van 24 stammen van de L. casei-gjrocp lactobacillen. De 
verkregen resultaten onderbouwen de voorgestelde nieuwe classificatie van de L. 
casei-gcoep, namelijk de herklassificatie van L. casei stam (ATCC 393) als L. 
zeae en de verwerping van L. paracasei en het behoren tot L. casei. Verder werd 
het onderscheidende vermogen van de drie fingerprint methoden vergeleken. 
Gezamenlijk zijn de technieken zeer onderscheidend en in staat tot het 
differentieren op stamniveau. Op volgorde van onderscheidend vermogen werd 
tot de volgende conclusie gekomen: PFGE>ribotypering>RAPD, wat 
overeenkomt met een aantal eerdere studies waarin twee of meer moleculaire 
methoden werden vergeleken bij de typering van lactobacillen. Door het hoge 
dscriminatoire vermogen op bacterieel stamniveau, zijn de beschreven 
moleculaire typeringstechnieken accurate methoden voor de bepaling van de 
genetische diversiteit in een populatie, het volgen van probiotische stammen en 
identificatie. 
Nieuw ontwikkelde moleculaire methoden werden gebruikt om het lot van 
ingenomen probiotische stammen L. rhamnosus GG (LGG) en B. lactis Bbl2 in 
de darm te volgen (hoofdstuk 4 en 5). Beide probiotische stammen lieten een 
tijdelijke kolonisatie van de darm zien, maar waren in de meeste proefpersonen 1 
week nadat het toedienen was gestopt, niet meer te detecteren. De persistentie 
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van een probiotische stam in de darm werd niet bevorderd door het simultaan 
toedienen van galactooligosacchariden (GOS) en Bbl2 (synbiotische 
benadering). In de proef met L. rhamnosus GG werden biopten bestudeerd naast 
de genomen fecale monsters. Dit bevestigt de in vivo aanhechting van L. 
rhamnosus GG aan mucosaecellen van de humane dikke darm en correleert met 
de hechting welke deze stam aan darmcellen vertoont onder laboratorium 
omstandigheden (in vitro). Daarnaast was het opmerkelijk dat L. rhamnosus GG 
1 a 2 weken en zelfs langer na het stoppen van inname persisteerde in mucosae, 
terwijl de stam op de genoemde tijdstippen niet meer gedetecteerd werd in feces. 
Dit plaatst het onderzoek van alleen feces in een ander daglicht en kan leiden tot 
een onderschatting van de werkelijke persistentie van probiotische stammen. Het 
overleven van het maagdarmkanaal is een vooropgestelde eigenschap voor de 
functionaliteit van een probiotische stam. Adhesie aan het darmepithelium wordt 
als zeer belangrijk beschouwd voor de persistentie en bepaalde probiotische 
eigenschappen als immuunstimulatie. De vergelijking van in vivo en in vitro 
eigenschappen van een probiotische stam is relevant om de huidige in vitro 
onderzoekmethoden te evalueren en te verbeteren om tot een meer rationele 
selectie te komen van nieuwe probiotische stammen. De succesvolle introductie 
van exogene bifidobacterien en lactobacillen in het maagdarmkanaal en hun 
adhesie aan het darmepithelium, opent nieuwe wegen voor het gebruik ervan als 
transportmiddel voor therapeutisch actieve stoffen, zoals antigene epitopen 
(vaccines) of enzymen naar specifieke locaties in het maagdarmkanaal. 
In hoofdstuk 5 worden kwalitatieve veranderingen bestudeerd met PCR-
DGGE. De feces van volwassenen werd onderzocht op Bifidobacterium 
populaties in reactie op het toedienen van B. lactis Bbl2 en /of GOS toediening. 
In de meeste proefpersonen had het twee weken toedienen van Bbl2 en /of GOS 
(respectievelijk, 3 x 1010 cfu en 8 g per dag) geen effect op de compositie van de 
endogene bifidobacteriele populatie, terwijl Bbl2 de darm wel tijdelijk kon 
koloniseren. Eerder werd aangetoond dat GOS toediening (8 tot 14 g per dag 
voor tenminste twee weken), geen effect had op de fecale plaattellingen van 
bifidobacterien. Hypothetiserend kan worden gesteld, dat de samenstelling van 
de darmmicrobiota in gezonde volwassen proefpersonen over het algemeen meer 
beinvloed wordt door van de gastheer afkomstige nutrienten (mucine, dode 
epithelium cellen) en andere gastheerfactoren (zoals immuunrespons), dan door 
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dieet. Verschillende observaties onderbouwen deze hypothese. Ten eerste 
werden eerder geen grote verschillen gevonden in aantallen van de dominante 
microbiele populaties van bevolkingsgroepen met een verschillend dieet. Ten 
tweede blijkt de dominante fecale microbiota in gezonde volwassenen zeer 
stabiel over een periode van 6 tot 7 maanden, wanneer een normaal niet-
restrictief dieet wordt gevolgd. Verder is aangetoond dat het genotype van de 
gastheer en /of de kolonisatie geschiedenis meer van invloed op de bacteriele 
gemeenschap is dan dieet of omgeving. Daarom is het in gezonde volwassenen 
met een volledig ontwikkelde en diverse microbiota zeer onwaarschijnlijk dat 
grote fluctuaties zullen optreden. Over het algemeen zal, de mogelijkheid dat 
pro- en prebiotica grote veranderingen in de darmmicrobiota veroorzaken, zeer 
marginaal zijn. Het blijft speculeren of zelfs kleine veranderingen een significant 
effect zouden hebben op de gezondheid van de gastheer en of probiotica een rol 
zouden kunnen spelen in het voorkomen van verschillende ziektes. Veel 
succesvolle proeven zijn uitgevoerd met probiotica welke symptomen verlichten 
van verscheidene aandoeningen. Er moeten echter meer klinische proeven 
worden opgezet welke de uitwerking moeten bevestigen. Voor de toekomst is 
een belangrijke taak voor het probioticumonderzoek weggelegd in het 
ophelderen van mechanismen waarmee bifidobacterien en lactobacillen de 
humane gastheer beinvloeden. 
Hoofdstuk 6 beschrijft een kwalitatieve moleculaire analyse van de 
dominante bacteriele, en specifieke bifidobacteriele en lactobacillen populaties 
in feces van borst- en flesgevoede baby's. Als meetpunten werden ongeveer de 
eerste en zevende maand na geboorte gekozen, waarin de zevende maand de 
periode vormt waarin wordt overgegaan op vast voedsel. De genus/ groep-
specifieke PCR gecombineerd met DGGE and het vervolgens sequentie-analyse 
van de 16S rDNA amplicons, liet geen verschillen tussen beide groepen baby's 
zien in de soortsamenstelling van Bifidobacterium en Lactobacillus. Over het 
algemeen lieten DGGE patronen van het 16S rDNA eenzelfde complexiteit van 
bacteriele gemeenschappen zien in borstgevoede en flesgevoede baby's. In de 
overgang van vloeibaar naar vast voedsel was eenzelfde verandering te zien. 
Humane moedermelk bevat bifidogene factoren en bifidobacterien worden als de 
meest karakteristieke microbiele groep gezien in baby's die borstvoeding 
krijgen. Onze resultaten laten echter zien dat in twee van de zeven borstgevoede 
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baby's geen Bifidobacterium werd aangetoond, en dat het krijgen van 
moedermelk de ontwikkeling van een bifidobacteriele gemeenschap daarom niet 
kan verzekeren. Aan de andere kant kan flesvoeding (aangevuld met bifidogene 
factoren) de groei van bifidobacterien ondersteunen. Deze en een aantal andere 
studies benadrukken de betekenis van andere factoren, dan het type voeding, in 
de ontwikkeling van de microbiele gemeenschap in babies. Als voorbeeld geldt 
de al te hygienische leefstijl met maar weinig blootstelling aan microben of de 
geboorte via een keizersnede, welke een veranderde kolonisatie van de darm tot 
gevolg kan hebben. Er wordt gedacht dat de darmmicrobiota van invloed is op 
de ontwikkeling van de gastheer, met als voorbeeld de ontwikkeling van het 
immuunsysteem. Het is niet duidelijk hoe in het bijzonder bifidobacterien en 
lactobacillen de postnatale ontwikkeling beinvloeden, en of gezonde babies die 
geen bifidobacterien en lactobacillen herbergen een voordeel zouden hebben 
wanneer ze worden ge'inocculeerd met probiotische preparaten. 
Concluderend kunnen we stellen dat de moleculaire en conventionele 
technieken die vandaag de dag beschikbaar zijn, een krachtig methodisch 
gereedschap vormen in de vergelijkende analyse van verschillende microbiele 
groepen in de darm van uiteenlopende bevolkingsgroepen. Momenteel wordt 
daar optimaal gebruik van gemaakt door een combinatie van verschillende 
methoden die elkaar goed aanvullen. Verdere verbeteringen in de moleculaire 
analyse van de microbiota, zullen tot stand komen wanneer nieuwe high-
troughput methoden zoals de DNA-microarray techniek aangepast worden voor 
de bestudering van de microbiele diversiteit in de darm. Hierdoor zal men 
uiteindelijk tot een beter begrip komen van de darmecologie van 
Bifidobacterium en Lactobacillus en de mogelijkheid de darmmicrobiota te 
veranderen. 
Vertaald in het Nederlands door Hans Heilig. 
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